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Metalloenzymes can simply be defined as enzymes that contain one or more metal ions as an integral part 
of their active site, or as a structural cofactor. They are responsible for catalyzing various physiological 
reactions.[1,2] A large number of these catalytic reactions are carried out in conjunction with small molecules 
such as O2, N2, H2, CO2, N2O, and CH4. These elementary reactions are pertinent to energy storage and 
release, in the form of making and breaking of chemical bonds which is important for viable fuel and 
chemical feedstock formation.[3] While some of these small molecules have shown to be significant to the 
environment and climate change, others are notably important to the chemical industry. Despite being 
readily abundant in nature, these small molecules are quite thermodynamically stable which makes their 
direct usage rather difficult. The activation step required for these small molecules is associated with 
reaction pathways involving multielectron redox processes and proton transfer reactions, which are 
thermodynamically demanding and mechanistically complex.[4–11] A deeper understanding of these 
processes puts forward a major challenge to the scientific community. 
 In contrast, bioinorganic chemistry is a field that inspects the role of metals in biology. Gaining an insight 
into how these natural enzymes function with the ultimate goal to exploit catalytic activity is a key endeavor 
of this field. Hence, substantial efforts have been applied to generate model systems capable of emulating 
the fascinating activity of these biological systems in order to design and develop efficient catalysts.  
Of the different metals present in nature, Copper and Iron have proved to be of high importance and are 
present in the active sites of several metalloenzymes.[12] The following sections give a brief overview of the 
different dimetallic copper and iron containing metalloenzymes, and their biological functions that are 
carried out by activating various small molecules present in nature.  
 
1.2 Diiron metalloenzymes 
Iron plays an important role in various metabolic processes and is present in the active site of various 
enzymes. A few examples are Nitrogenase, Hemerythrin, FNOR’s, Hydrogenase and sMMO.  
Nitrogenase : The enzyme Nitrogenase is commonly produced by certain bacteria and cyanobacteria and 
plays a crucial role in the process of nitrogen fixation.[13–16] A homodimeric Fe protein and a heterodimeric 
MoFe protein together form the Nitrogenase motif (Fig. 1.1). The former unit consists of an identical Fe4S4 
clusters responsible for the supply of electrons, while the latter and larger unit consists of an alpha subunit, 





Figure 1.1 Schematic representation of the FeMoco of molybdenum dependent nitrogenase. Recent studies have elucidated 
the presence of a carbide core within the cluster.[16] 




The overall enthalpy of this reaction for the equilibrium formation of ammonia from molecular nitrogen 
and hydrogen is negative, but with a high activation energy.[17] The enzyme Nitrogenase behaves as a 
catalyst reducing this energy barrier and allowing the reaction to occur at feasible temperatures.  
Today, the famous Haber-Bosch process which was developed in the first half of the early 20th century is 
the main artificial nitrogen-fixation process used in industry for the generation of ammonia. Iron surfaces 
promoted by alkali metals in the presence of high temperature and pressure replicate the biological process 
on a large scale.[18] 
 
Hydrogenase: Hydrogenases are divided into three subcategories depending on the metal ion present within 
their active site.[19] They are responsible for the reversible catalytic oxidation of molecular hydrogen which 
is essential for energy release.[20] The three subcategories of Hydrogenases are the [FeNi], [FeFe] and the 
[Fe] only hydrogenase (Fig. 1.2). The active sites of the first two resemble each other and have iron-sulfur 
clusters, along with carbon monoxide and cyanide as ligand systems.[21,22] The [Fe] only hydrogenase 




Of all three subcategories, the [FeFe] hydrogenase is most active in molecular hydrogen production.[22] 
Hydrogenases have been found in deep sea settings where due to the lack of other sources of energy, the 
hydrogenase is used to generate energy. Mimicking biological hydrogenases in order to generate systems 
capable of capturing and storing renewable energy as fuel, where the production of hydrogen is used as a 
fuel source, is an extensive ongoing area of research.  
 
Of the large number of Iron-oxygen proteins/enzymes found in nature, Hemerythrin and sMMO are 
dinuclear. With the aid of dioxygen, sMMO carries out catalytic activity whereas Hemerythrin behaves as 
an oxygen transporter. 
Hemerythrin is an oxygen transporter found in marine invertebrates. It consists of a pair of iron centers 
where the iron atoms are bound to the protein matrix via a carboxylate side chain of glutamate, aspartate 
and 5 Histidine residues (Scheme 1.1).[25–28] Unlike Hemoglobin, which has per protein subunit a heme 
group containing only a single iron center and is responsible for oxygen transport in vertebrates, 
Hemerythrin does not contain any heme unit.[29]  
Figure. 1.2 Schematic representations of the three subcategories of Hydrogenases.[21–23] 













sMMO: Methanotrophic bacteria use carbon as their only source of energy. They convert methane to 
methanol, the BDE of methane being quite high, 105 kcalmol-1.[30,31] This impressive catalysis is carried out 
by soluble Methane Monoxygenase (sMMO), a non heme diiron protein having 2 iron atoms within its 
active site coordinated by histidine and glutamate residues.[32] The two iron centers are bridged by a 
carboxylate group. Dioxygen binds to the sMMO forming the active iron-oxygen intermediate which then 










As methane forms one of the major components of natural gas and is produced as a side product in a large 
number of industrial reactions, significant efforts are being made in order to replicate a functional sMMO 
model that can be used industrially to benefit optimal conversion of natural gas into fuels and chemicals. 
 
Nitric Oxide reductases: NOR’s are a class of enzymes present in various bacteria that help in catalyzing 
the reduction of nitric oxide to nitrous oxide.[34,35] Nitric oxide is an important molecule which plays a
Scheme 1.1 Schematic representation of dioxygen binding in Hemerythrin.[28] 
Scheme 1.2 Active site of the hydroxylase unit of sMMO in its active reduced form (MMOHred), and its resting state 
(MMOHox).[32] 




crucial role not only in muscle contraction/relaxation, vasodilation, and intracellular messaging but also in 
immune defense against tumor cells. When present in high concentration nitic oxide is toxic and can be 
fatal.  
 Flavo-diiron Nitric Oxide reductases (FNOR’s) are dinuclear iron containing enzymes. The iron centers 
are linked to glutamate, histidine and aspartate residues, bridged by the carboxylate group of an aspartate 
linker and a hydroxide bridge.[36,37] Evolved in certain pathogenic microbes, these FNORs detoxify NO by 











1.3 Dicopper metalloenzymes 
Of the different copper proteins present in nature, CuA, Type 3 and Type 4 all contain an active site with 
dinuclear copper centers. 
CuA: CopperA proteins contain two cooper ions and are found in cytochrome c oxidase and nitrous oxide 
reductase. The copper atoms are coordinated by two histidine, one methionine, a protein backbone carbonyl 
oxygen and two bridging cysteine residues.[38]  
Cytochrome c oxidase, found in various bacteria and mitochondria is a large transmembrane protein.[39] A 
large and complex structure made up of several subunits, the binuclear CuA centers play a vital role in 
transport of electrons to and from the different subunits, effectively reducing dioxygen to two molecules of 
water. 
Nitrous oxide reductase, a copper containing enzyme catalyzes the final denitrification step wherein nitrous 
oxide is reduced to dinitrogen. Composed of a Cuz site made up of 4 copper atoms and a CuA unit, the CuA 
unit undergoes one electron redox changes, and the Cuz site is responsible for catalytic processes.[40] 
Type 3: These copper proteins comprise of Hemocyanin (Hc), Catechol Oxidase (CO) and Tyrosinase 
(Ty).[41] They each contain a pair of copper centers bound by three histidine residues. Hemocyanin 
reversibly binds dioxygen and serves as an oxygen transporter in arthropods and mollusks (Scheme 
1.4).[42,43] Catechol oxidase and Tyrosinase bind dioxygen to carry out the catalytic conversion of 
monophenols to catechols (only Ty) and the two electron oxidation of catechol to quinone (CO and Ty), 
which is significant in the formation of melanin in the body.[44,45] 
Scheme 1.3 Active site of FNOR in Desulfovibrio gigas and the catalyzed reaction. 












pMMO: Similar to sMMO mentioned earlier, pMMO is a methane monooxygenase but  is known to have 
a dinuclear copper center within its active site instead of iron.[46,47] One copper is coordinated by two 
histidine imidazoles while the other is ligated by a histidine imidazole and a primary amine of an N terminal 
histidine (Fig. 1.3).[46] Present in methanotrophic bacteria and formed in the presence of iron starvation, 
pMMO binds dioxygen to form an active copper dioxygen intermediate which is responsible for converting 










In conclusion, it is evident that diiron and dicopper metalloenzymes in conjunction with small molecules 
carry out a variety of biological processes in different organisms vital for their existence. The following 
chapters shall focus on dicopper and diiron mentalloenzymes activating dioxygen and nitric oxide. A 
detailed introduction to these systems in comparison with synthetic analogues is described in Chapter 2 (for 
copper) and Chapter 10 (for iron). The primary focus of this work is based on these systems. 
Scheme 1.4 Active site of Hemocyanin(Hc) in its reduced form Hcred and oxidized form Hcox after binding dioxygen.[42] 
Figure 1.3 Schematic representation of the active site of pMMO.[46] 




1.4 An Introduction to Bis(oxazoline) ligands 
Bis(oxazoline) ligands commonly referred to as BOX ligands have been investigated since 1990.[51,52] This 
class of ligands contain two oxazoline rings linked by a methylene spacer. They are C2- symmetric when 
the substituents at the backbone are identical and are often termed as privileged chiral ligands. Exploitation 
of the chiral nature of these ligands in combination with suitable metals have proved that metal-BOX 
complexes are one of the most resourceful class of chiral catalysts capable of promoting a large number of 
organic reactions.[51] The electronic properties and coordination geometry of metal-BOX’s are the key 
factors responsible for asymmetric induction. With the aid of techniques such as X-ray and NMR 
spectroscopy, over time rules have been devised to understand the mechanism and function of these 
catalysts.[53] As a result, their impact in the field of asymmetric catalysis and coordination chemistry has 
attracted much attention and contributed largely to the general approach of organic synthesis. Dating back 
to 1991, Evans et al. reported the catalytic asymmetric cyclopropanation reaction of olefins with a Cu(I)-
BOX complex with ligand A (Fig. 1.4).[54]  Shortly after, Corey et al. designed a Fe(III)-BOX complex with 
ligand B suitable for enantioselective catalysis of Diels-Alder additions (Fig 1.4).[55] This followed the 
development of several other BOX ligands due to their feasible and flexible synthesis and an extensive 
usage thereafter in a wide range of other reactions.[51]  






Besides the classical BOX ligands, derivatives such as Pyridine BOX (PyBOX) and aza-BOX are also used 
in enantioselective catalysis (Fig.1.5).[56,57] Recently it was shown by Sibi et al. that the aminoindanol 
derived BOX ligand (C) along with Cu(OTf)2 proved to be a promising precursor for the kinetic resolution 
of racemic α, β unsaturated pyrazolidinone imides.[58] This emphasizes the advantage of this class of ligands 
proving indeed their flexibility and privilege. 







Figure 1.4. BOX ligands used in A and B used with Copper(I) and Iron (III) respectively for asymmetric catalysis.[54][55] 
Figure 1.5. Derivatives of BOX ligands, PyBOX[56], aza BOX[57] and ligand C[58] ( C has been used for kinetic resolution). 




Bis(oxazoline)s are primarily expressed as dimine systems. For ligand systems having only a single R 
substituent in the backbone, tautomerism of the ligand may occur.  A shift of the H atom from the bridging 
carbon to one of the nitrogen atoms of the oxazoline rings gives the iminoenamine form which may have 
either an E or a Z configuration (Fig 1.6). This is quite the opposite to β-diketones, where the enol form is 
more stable than the keto form. Similar tautomerism also occurs in  case of semicorrins[59] when there exists 
a strong electron withdrawing group at the bridging carbon, eg in CNBOXs. Some aza-semicorrins are 











Evidence of the iminoenamine tautomer of BOXs, in solution or in solid state is rare and little is known. 
Ligands [H{Me,HBOX-Me2}]+ [61] and [H{Me,HBOX-Ph,H}]+ [62]  (x,yBOX-AB:where x and y represent the 
substituents on the bridging carbon, and A and B represent the substituents on the ring) are amongst the 
few that were isolated in the solid state and shown to exist in the (Z)- iminoenamine form. The  H,HBOX-
tBu-H ligand was shown to exhibit a small amount of the iminoenamine isomer in solution which was 
confirmed by UV-vis spectroscopy[63]. The pCF3(C6H4)CH2,HBOX-H2 ligand system was recently isolated in the 
solid state as the iminoenamine tautomer.[64] More recently, investigation on the H,PhBOX-Me2 ligand by 
Meyer et al. revealed the ligand to exist in the iminoenamine form in the solid state, but as a tautomeric 
mixture in solution (Fig.1.7).[65] This tautomeric equilibrium was studied via temperature dependent 1H-
NMR spectroscopy which showed at low temperatures the iminoenamine form was preferred, whereas at 
room temperature a mixture of the two existed. The phenyl residue present in the backbone accounted for 
stabilization. Such tautomeric equilibrium is uncommon and seldom reported. 
    
 
 
   
Figure 1.6. A: BOX ligand shown in the dimine form, and its tautomeric isomers. B: Ligand classes related to bis(oxazoline)s 
represented in their sole tautomeric form. 
Figure 1.7 Tautomeric isomers of the H,PhBOX-Me2 ligand, known to be in equilibrium at room temperature in solution. 




   
The deprotonation of the neutral bidentate BOX ligands leads to monoanionic bis(oxazolinate)s (D) which 
are similarly bidentate but anionic, and are similar to the β-diketiminate (NacNac) ligands (Fig.1.8).[66] This 
suggests that R,HBOXs are proton responsive in nature, which represents an add-on advantage to this ligand 
class. The monoanionic bis(oxazolinate)s have been well established as well and have proved to be equally 
versatile and to effectively chelate various metal centers such as Magensium, Aluminium, Copper, Zinc 
and even lanthanides such at Yttrium and Lanthanum.[66] Intramolecular hydroamination,[67,68] ring opening 
polymerization[69] and cyclopropanation of styrene[70] are among the few organic reactions where these 
metal complexes are used. This robust and stable class of ligands are capable of a substantial degree of 
assymetric induction in enantioselective catalysis. 






Though BOX ligands have been vastly used in the field of organic synthesis, their application as suitable 
scaffolds for small molecule activation with appropriate metals is less common. Very recently, work by 
Meyer et al. revealed that this privileged ligand class is well suited for supporting biomimetic Cu/O2 
chemistry.[71] 
 With that in mind, the main focus of this work was to synthesize new, well suited, neutral and anionic 
ligands capable of mimicing biological scaffolds and study in further detail their recctivity towards small 
molecules such as dioxygen and nitric oxide with their corresponding copper and iron complexes. This shall 
be discussed in further detail in the upcoming chapters. 
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2.1 Copper Proteins 
The easily attainable (I)/(II) redox couple and biological abundance contributes to copper’s diverse role in 
nature. A large range of metalloenzymes contain copper within their active site and can broadly be classified 
into seven different categories, based on structural and spectroscopic properties (Fig.2.1).[72–74] These 
enzymes are involved in O2 binding, activation and reduction, substrate activation, NO2- and N2O reduction, 
and electron transfer(ET) reactions.[38] The mononuclear blue copper sites (Type 1) and the binuclear CuA 
sites, wherein the copper centers are ligated to sulphur donors of cysteine residues, carry out ET 
reactions.[75] Mononuclear CuB centers catalyze the one electron reduction of nitrite to NO in bacterial 
denitrification, while Cuz, a novel catalytic site comprising of a cluster of four copper ions bonded by seven 
histidine and three other ligands, catalyzes the final step of bacterial denitrification in which nitrous oxide 
is reduced to dinitrogen.[38] The remaining three classes, Type 2, Type 3 and Type 4 use dioxygen as an 
electron acceptor for oxidation and oxygenation of organic substrates.[41] The following sections focus on 




Figure 2.1 Different types of copper proteins found in nature. Type 3 and Type 4 copper proteins and their synthetic analogues 
form the focal point of this work.[38]  




2.2 Type 3 Copper Proteins: Hemocyanin, Catechol oxidase and Tyrosinase 
The Type 3 copper proteins, Haemocyanin (Hc), Catechol oxidase (CO), and Tyrosinase (Ty), comprise a 
pair of copper(I) centers within their active site, each coordinated by three histidine residues.[76] They 
exhibit distinct spectroscopic features upon dioxygen binding, and have been extensively investigated.[77–
79] All bind dioxygen in a characteristic side-on bridging form, whereby the deoxy CuI center is converted 
to CuII in the oxy state (Fig. 2.2).[80] This results in their active sites bearing a close resemblance in geometric 
and electronic properties, and hence a similarity in their crystallographic structures and spectroscopic 
parameters.[81,82] The dioxygen binding to the copper centers in the deoxy state of these enzymes is spin 
forbidden. Extensive work by Solomon et al. has shown that this spin forbiddeness is overcome by a 
delocalization of the unpaired electrons onto the metal centers, and superexchange coupling between the 

















Though similarly bound to dioxygen, these enzymes differ with respect to their functions. Hc behaves as 
an oxygen transporter in arthropods and mollusks, reversibly binding dioxygen and transporting it.[85] Ty 
on binding dioxygen mediates the o-hydroxylation of monophenols to catechols, and both CO and Ty 
perform two electron oxidation of catechols to quinone.[86] This has physiological importance in the
Figure 2.2. Schematic representation of dioxygen binding in Hemocyanin, Catechol Oxidase and Tyrosinase.[42]  
Scheme 2.1. Schematic representation of the dioxygen binding pathway in Type-3 copper proteins.[83] 




synthesis of melanin in the body, where Ty is the rate limiting enzyme that converts L-tyrosine to L-






The intermediate responsible for the functioning of the enzymes Hc, Ty and more recently CO, is known 
to be a µ-η2:η2 peroxo dicopper(II) (SP) species.[42] Interconversion of the SP to the bis µ-oxo dicopper(III) 
(O) isomer has recently been observed in several synthetic analogues and raises a pertinent question in 
context to the significance of the O isomer in biological systems.[88–94] The impressive selective catalytic 
oxidation of phenols in Ty has mechanistically been elucidated to follow an electrophilic aromatic 
substitution (EAS) mechanism, where the phenolic substrate binds to one of the copper centers in the active 
site, and is then hydroxylated.[95,96] Wether isomerization between the SP and O species occurs during this 
bio-catalytical cycle is still under speculation. Several synthetic analogues have been developed to gain 
further insight into the functioning of this class of enzymes.[97–107] These are discussed in the following 
sections. 
 
2.3 Modes of Dioxygen Binding 
Over the last few decades, a variety of synthetic analogues have been uncovered and have helped gain 
insights into the different binding modes of dioxygen to copper sites.[88,108–110] The  2:1 Cu/O2 ratio which 
parallels the stoichiometry in the Type 3 and Type 4 enzymes suggests that dioxygen could bind either SP, 





2.3.1 TP vs CP binding mode: Snapshots into Dioxygen Binding 
Dating back to 1988, the first strusturally elucidated copper-dioxygen system was reported by Karlin et 
al.[110,111] With assistance of the TPA ligand, the dioxygen was shown to be bound in a  trans µ-1,2 mode 
resulting in the Cu···Cu distance of 4.4 Å.  LMCT from the peroxide ligand to the copper centers leads to 
absorption features at 500 nm (strong, in plane, πσ* to d), and 600 nm (shoulder, out of plane, πv* to d) in TP 
complexes, and the O-O stretch herein occurs around 800-830 cm-1 when investigated by resonance Raman 
Scheme 2.2. Hydroxylation and oxidation of tyrosine to dopaquinone mediated by Tyrosinase.[87] 
Figure 2.3 Different binding modes of dioxygen to copper in a 2:1 stoichiometric ratio of Cu/O2. 




spectroscopy (rR).[111–131] The large dihedral angle of 180º of the Cu-O-O-Cu core in these TP complexes 
causes large magnetic overlap of the Cu/O2 orbitals, resulting in strong antiferromagnetic coupling between 
the two copper centers and a singlet S = 0 ground state.[132] Tetradentate ligand systems with four strongly 
coordinating donors, such as tetb[133] and tren,[124,125,131] have proved to be successful scaffolds for the TP 
binding mode (Fig. 2.4). Though several synthetic TP complexes have been characterized over time, this 
binding mode is not considered biologically relevant but is pertinent to dioxygen coordination to the 








Very recently, Meyer et al. showed that an end-on cis binding mode of dioxygen to the copper centers was 
possible. With aid of a pyrazolate/tacn ligand system, the first CP was crystallographically characterized, 
and exhibited surprisingly diminished antiferromagnectic coupling (Fig.2.5 left).[109] This resulted from the 
reduced magnetic overlap of the Cu/O2 orbitals due to the ligand system supporting a Cu-O-O-Cu torsion 
of 65 o (as opposed to 180º observed in TP complexes). This CP motif was previously considered a transient 
intermediate in spin forbidden dioxygen binding and is the first of its kind to be structurally characterized. 
Though it differs in terms of magnetic properties with respect to the TP motif, its spectroscopic features are 
similar. Soon after, the first ferromagnetically coupled dicopper(II) peroxo system with a triplet ground 
state (S = 1) was reported in the same group, wherein the previously used pyrazolate/tacn ligand system 
was modified to constrain the Cu-O-O-Cu to 104o thus resulting in a vanishing overlap of the magnetic 
orbitals (Fig. 2.5 right).[134] This ferromagnetically coupled peroxo system was assigned as neither cis nor 
trans, as it differed with respect to the coordination chemistry when compared to other crystallographically 
characterized trans systems, and in terms of torsion angles and Cu-Cu distances when compared to the cis 
peroxo system. Till date, this is the only reported dicopper peroxo system that does not exhibit any anti-
ferromagnetic coupling, and can be considered a snapshot in the initial stages of dioxygen binding in Type 





Figure 2.4. Ligand systems shown to bind dioxygen in a TP fashion.[110,124,131,133] 
Figure 2.5. Left: Copper complex with a TACN ligand system shown to exhibit an end-on cis binding mode of dioxygen. 
Right: Copper complex with a TACN system shown to form the first ferromagnetically coupled dicopper(II) peroxo 
species.[109,134] 




2.3.2 The SP Binding Mode: A Hemocyanin Model 
The first SP complex with the tridentate HB(3,5-iPr2pz)3 ligand system was structurally characterized by 
Kitajima et al. in 1989.[108] The µ-η2:η2 binding mode of dioxygen to the copper centers results in diagnostic 
CT features divergent from the TP motif. A strong band at 350 nm and a weak band at 500 nm arises due 
to an in plane (πσ* to d) and out of plane (πv* to d) overlap of the peroxide and copper orbitals respectively 
(Fig. 2.6).[80,108,135–161] The Cu···Cu bond length typical for SP complexes lies in the range of  ̴ 3.5 Å and the 
O-O distance lies in the range of  ̴ 1.5 Å. The rR observed O-O stretching frequency for this motif  is  ̴ 750 
cm-1, being much lower than for other dicopper-peroxo intermediates.[108,136,141,142,144,146,162–165] Theoretical 
calculations on the bonding description of these complexes rationalized the weak O-O bond as a result of 
back donation of the electron density from the Cu(II) dx2-y2 orbitals to the peroxide σ* orbitals in the HOMO. 
Strong antiferromagnetic coupling that results from the large overlap between the Cu/O2 magnetic orbitals 



















Figure 2.6.  Schematic molecular orbital diagram for the side-on (µ-η2:η2 ) peroxide bridged dicopper(II) species SP. The red 
arrows indicate the assigned UV-vis features in SP, in plane πσ* to d and out of plane πv* to d (peroxo to CuII2) CT transitions 
at ~ 350 nm and ~500 nm respectively.[41,132] 




Though a large number of SP complexes have been characterized, structural characterization still remains 
a challenge for this binding motif. Tridentate N-donor ligands capable of facial coordination, such as 
iPr3tacd, and tBu3tacn have proved to be most beneficial in this case.[142,144] This stems from these type of 
ligands being bulky in nature, capable of shielding the reactive unit from subsequent decomposition. 
Recently, Karlin et al. isolated a new SP complex with the tridentate MeAN ligand, having the longest O-
O bond reported to date.[164] The weak O-O bond however did not reflect an increase in backbonding into 
the σ* orbital of the peroxide, and further did not result in O-O cleavage. Till date, only one bidentate ligand 
system, α-Sp, has been reported to isolate a SP complex with structural elucidation (Fig. 2.7).[162] 
 
 
Soon after the first SP complex was structurally characterized, this motif was identified as the novel binding 
mode in the Type 3 copper protein oxyHc, which marks a pioneering achievement in bioinorganic 
chemistry.[42] The analogy of structural and spectroscopic features of these model complexes with that of 
the native system forms the focal point of fundamental ideas that emphasize bioinorganic modeling 
attempts. For example, simple model complexes that are easily attainable in aprotic solvents under 
abiological conditions could in turn put forward possible intermediates involved in the mechanism of these 
biochemical systems, thus leading us closer to a better understanding of these important enzymes.  
 
 
2.3.3 The Bis µ-oxo Motif: Breaking the O-O Bond 
 The previously unknown bis(µ-oxo) dicopper (III) system (O), a Cu2O2 motif lacking an O-O bond was 
initially reported by Tolman et al. with the 1,4,7-triazocyclononane system.[88] The weak O-O bond in SP 
species arising from the backbonding of copper to the oxygen orbitals, helps to rationalize this O-O bond 
scission, justifying easy isomerization of the two forms.[79,80,90,93] The O form differs significantly from its 
SP isomer as being more compact and having a shorter Cu···Cu bond distance of ~2.8 Å.[88,138,166–171] The 
two CT bands are more intense due to a higher degree of covalency. The band at ~300 nm has similar 
origins to that of 350 nm observed in the SP form (πσ* to d), however, the second band at ~400 nm is 
characteristic of the bis µ-oxo core, and results from overlap of the σ* orbital of oxo to d orbitals of copper 
(Fig.2.9).[167,172,173] The O isomer is EPR silent and the diamagnetic nature of these complexes gives rise to 
NMR spectral features in the range of 0 to 10 ppm.[138] rR observed stretching frequency indicates an oxygen 
isotope sensitive feature at  ~600 cm-1, due to the symmetric vibration of the Cu2O2 core.[161,174,175]  
Figure 2.7. Different ligand systems shown to bind dioxygen in an SP fashion.[108,144,162,164] 
























 A large number of ligand systems have been employed in generating the O species making this one of the 
most recognized Cu/O2 forms. Structural characterization with bidentate ligands such as 
R21R22eda,[161,168,173,174,176–179] tridentate ligands such as R-PYAN,[88,138,143,175] and tetradentate ligands such 
as 6-R-tpa[167,180] have revealed a rather square planar geometry of the bridging oxide (O2-) and the two 
copper centers, making the core more close packed in comparison to the P binding motif.  Moreover, the 
Cu centers bear an oxidation state of +3 as opposed to+2 which is observed in all other Cu/O2 forms 
described above. Most of the structurally characterized O species are cationic in nature with neutral 
ligands.[88,138,166–170] Monoanionic ligands forming neutral O species are uncommon and rare, with only one 
system comprising the [But2P(NSiMe3)2]- ligand being reported till date (Fig.2.10) .[171]  
 
Figure 2.9 Schematic molecular orbital diagram for the bis(µ-oxo) bridged dicopper(III) species O. The red arrows indicate 
the assigned UV-vis features in O, σ* to d and  πσ* to d  (oxo to CuIII) CT transitions at ~ 400 nm and ~300 nm respectively. 
[41][132] 




As has been initially shown by Tolman et al., and investigated by several groups thereafter, there exists an 
equilibrium between the O and the SP species.[38,91] The weak O-O bond in SP species helps to rationalize 
this O-O bond scission, accounting for easy isomerization of the two forms. Though the O motif has yet to 








2.3.4 SP vs O: Insights into the O-O bond Scission and Tuning the Equilibrium. 
The ubiquitous SP and O isomers have been shown to exist in equilibrium with each other in measurable 
quantities.[181,182] The facile isomerization of the two stems from easy cleavage of the O-O bond.  On 
elongation of the O-O bond, the σ* orbital in SP involved in backbonding decreases in energy, oxidizing the 
copper HOMO and becoming fully occupied (Fig.2.11).[93] A number of systems wherein this equilibrium 
has been well characterized have shown that the O species is enthalpically stabilized, whereas the SP species 
is stabilized entropically.[92,166,183] Thermodynamic parameters determined for the isomerization revealed a 
small entropy difference between these two binuclear Cu/O2 species, justifying easy interconversion of the 











Figure 2.10 Ligand systems shown to bind dioxygen in an O fashion.[168][143][180] 
Figure 2.11 Orbital correlation diagram for the SP/O isomerization.[93] 




Several groups have investigated in detail factors controlling the SP/O equilibrium. Thermodymanic 
parameters determined for this equilibrium reveal that temperature dependence is only weak. Ligand 
structural effects have proved to be most dominant in controlling the formation of the two isomers. Studies 
with different types of ligands demonstrated that increasing the steric demand of a particular ligand 
facilitates the formation of the SP form rather than the O form.[88,138,140,184–186] The rationale being that 
intramolecular interactions are higher in the O as compared to the SP isomer due to its close packed 
structure. This was also in accordance with theoretical calculations on space filled models conducted by 
Stack et al.[184]  
Besides ligand structural effects, the coordinating ability of the counterion too has an influence on isomeric 
preference. Solomon et al. demonstrated with aid of the Me,Mepd ligand (Fig. 2.12) that using the triflate 
counterion favored the formation of the SP isomer as opposed to O.[183] The more exposed Cu2O2 core of 
the SP complex, in conjunction with the Cu(II) being able to axially coordinate ligands makes axial 
counterion coordination feasible, which in some cases leads to extra stability. The nature of the solvent 
suggests that for bidentate and tridentate amine ligands, more polar solvents favor the formation of the O 
species while less polar solvents shift the equilibrium in the direction of the SP species.[92,138,183,184] However, 
in the first ever reported equilibrium case by Tolman et al. using the iPr3tacd ligand system, the ratio of two 
solvents, THF:CH2Cl2 determined which isomer preferentially formed. This was accounted for by solvent 
coordination to the complex exhibiting an additional stabilization.[88] 
The MePy2 ligand family as shown by Karlin and Fukuzumi independently has demonstrated that electronic 
effects of the ligand also control the isomerization in addition to structural effects.[140,185] Increasing the 
electron donating ability of the ligand stabilizes the +3 oxidation state of the copper, favoring the O 








Though a large number of factors have successfully been uncovered in influencing the equilibrium of these 
two 2:1 Cu/O2 species, biologically it has yet not been observed.  Interestingly, the biological scaffolds that 
host the cooper sites in these novel enzymes are comprised mainly of histidine imidazole residues, with 
available protons in the vicinity. This raises the credibility of interconversion being triggered by 
(de)protonation events by a change in local pH, which may lead to further insights into the biochemical 
pathway.
Figure 2.12 Ligand systems known to form equilibrium mixtures of SP and O isomers.[88,140,183,184] 




2.4 Particulate Methane Monoxygenase: pMMO 
The most extensively investigated dicopper protein presently is pMMO. This integral membrane protein 
present in methanotrophic bacteria converts methane into methanol.[49] On account of its difficulty to 
isolate, it falls behind with reference to insights into its active site and biological mechanism compared to 
other copper proteins.[187] Till only very recently, the resting phase of pMMO was determined to have a 
dicopper site, which was located in one of the three subunits of the enzyme.[46] Rather unique as compared 
to other copper enzymes, in pMMO one copper is coordinated by two histidine imidazoles and the other is 
ligated by a histidine imidazole and a primary amine of an N terminal histidine, making the active site non 
symmetrical in nature.[47,48] The two copper ions are roughly at a distance of 2.5 Å. Investigations by 
Rosenzweig et al. of the pMMO enzyme with oxidants suggested plausible binding of dioxygen to the 
active site. A  µ-η2:η2 peroxo species was observed as the  intermediate, whose spectroscopic features 
disappeared on reaction with methane.[188] This highlighted the relevance of this dioxygen binding motif 
which could potentially help identify the nature of the active intermediate in pMMO. Till date however, no 
certain characterization of the dioxygen bonded adduct or possible intermediate for methane oxygenation 
has been identified. 
Solomon and Schoonheydt suggested the copper loaded aluminosilicate zeolite, Cu-ZSM-5, to be most 
similar to pMMO.[189] The Cu(I) centers herein were oxidized to Cu(II) by dioxygen, and a CuII2(µ-oxo) 
species was identified. Independent DFT studies in conjunction with experimental findings suggested this 
motif to replicate similar activity of the enzyme, when modeled into the inorganic Cu-ZSM-5 and pMMO 
active site. 
 
Recently, Stack et al. proposed a dicopper(III) bis (µ-oxide) to be a potential intermediate for pMMO.[190] 
With low temperature ligand exchange as a method of assembling the O motif, a complex similar to the 
coordination sphere of pMMO was produced suggesting histidine imidazole ligands to replicate this method 
of core capture to attain a Cu(III) bis(µ-oxo) motif as an active intermediate (Fig. 2.14). The Cu(III) 
complexes also mediated C-H activation of exogenous substrates. These findings present pMMO as the 
only copper enzyme to have a potential Cu(III) intermediate within its active site.  
Computational calculations jointly with molecular mechanics conducted by Yoshizawa et al. recently have 
put forward the active intermediate to be a µ-η2:η2 peroxo species, similar to the proposal of Rosenzweig 
et. al..[191] TD-DFT calculations on the resting phase of pMMO and dioxygen suggested the intermediate 
resembled that of Hc and Ty, a side on peroxo motif.  The calculated Cu···Cu and O···O bond lengths were 
in agreement with analogous and native models. 
Figure 2.13 Schematic representation of different dioxygen binding modes proposed for pMMO. Shown on the right Cu-ZSM-
5, an inorganic model proposed for the enzyme active site.[189] 









Optimal conversion of natural gas of which methane forms a major component is still an ongoing challenge. 
Though a large number of industrial catalysts have been developed, they have proved to be costly and 
insufficient. In contrast, pMMO uses methane as its sole form of carbon and energy to convert it into 
methanol. A better understanding of this enzyme in its biological pathway would be a seminal achievement 
in bioinorganic chemistry. Scientific findings have proposed both the O and SP form to be potential key 
intermediates of this enzyme. Taking into account the biological histidine scaffolds with amenable protons 
in the vicinity, credibility of conversion of the two by protonation/deprotonation is of significant biological 
importance. 
 
2.5 Catalytic Reactivity of Tyrosinase models towards external monophenolic substrates 
The catalytic reactivity executed by Type 3 copper proteins has aroused large interest over the last few 
decades. All three Type 3 copper proteins bind dioxygen to form a SP intermediate. Though the oxy forms 
of these enzymes resemble each other spectroscopically, they differ in terms of their reactivity.[42,44,81,86] 
The enzyme Hemocyanin behaves as an oxygen transporter in arthropods and mollusks, reversibly binding 
dioxygen, but exhibits no catalytic activity. This lack of dioxygen reactivity towards external substrates is 
associated with the active site of the enzyme being deeply buried within the protein matrix, making it 
inaccessible to external substrates.[192] Comparatively, the active sites of Catechol oxidase and Tyrosinase 
after activation are easily accessible to substrates for catalytic activity.[44,86] 
Tyrosinase catalyzes the ortho-hydroxylation of tyrosine to DOPA, and subsequent two electron oxidation 
of DOPA to dopaquinone which forms the first step of melanin synthesis.[43,76,193,194] This catalytic activity 
exhibited by similar model complexes has been investigated in detail by several groups. Based on kinetic 
data and different intermediates that have been successfully isolated during the course of study, a reactive 
scheme containing two interpenetrating cycles (monophenolase cycle and diphenolase cycle) has been 
established.[76,95] The monophenolase cycle (Scheme 2.3 blue cycle) starts from the oxy form of Tyrosinase, 
where monophenols are converted to o-diphenols and subsequently to o-quinones. The deoxy site is formed 
again, regenerating the Cu(I) centers for subsequent O2 binding and catalytic activity. The diphenolase 
activity expressed by both CO and Ty (Scheme 2.3 green cycle) accounts for the conversion of external 
catechols to o-quinone. During the course of this cycle, the met-derivative of Tyrosinase is generated which 
is responsible for the two electron oxidation of catechol, such that two molecules of diphenol are converted 
to o-quinone. The general reactivity observed in Tyrosinase as well as other synthetic analogues is in 
agreement with an electrophilic substitution mechanism.[44,45,195,196] Hammett type experiments conducted 
with small molecule model systems support this pathway, though radical pathways have also been 
proposed.[197] 
Figure 2.14 Ligand systems employed by Stack et al. that propose dioxygen to bind as an O motif in pMMO.[190] 






A large number of binuclear copper complexes mimicking the active site of the Tyrosinase enzyme have 
been synthesized and spectroscopically characterized.[95,100,103,105–107,145,198] Investigations of their reactivity 
towards organic substrates have helped in elucidating the mechanism of the analogous biochemical 
reaction. The first conformation of this kind of reactivity was reported by Karlin et al. with the help of a 
binucleating XYL ligand system (Fig. 2.15).[199] The system was shown to form a SP complex which was 
detected by rR spectroscopy. Thermal decomposition of the complex resulted in endogenous arene 
hydroxylation analogous to intermolecular phenol hydroxylation. 
Apart from this, individual SP, O and TP systems have also been found to exhibit monophenolic substrate 
activity. The first small molecule model of Tyrosinase forming a stable dioxygen intermediate and 
mediating o- hydroxylation of phenols, was reported by Casella et al. with the ligand system L66 (Fig. 
2.15).[157,200]  Initially shown in 1991 that the Cu(I) complex mediated the catalytic conversion of sodium 
2,4-di-tert-butyl phenolate (DTBP) to 3,5-di-tert-butyl quinone(DTBQ) in the presence of dioxygen with a 
TON of 1.2, reinvestigation of the same Cu(I) complex a decade later revealed that a SP intermediate was 
responsible for catalytic conversion.[157] Following this, several other small molecule models have been 
synthesized, emulating catalytic activity of the enzyme. Most recently, a SP system developed by Herres-
Pawlis and Stack with aid of the bis(pyrazolyl)(2-pyridyl)methane (HC(3-tBuPz)2(Py))2 mononucleating 
ligand (Fig. 2.15), showed impressive catalytic activity with a TON of 15.  A range of para substituted 
Scheme 2.3.  Generally accepted mechanism displaying two interpenetrating cycles for the ortho-hydroxylation of tyrosine to 
DOPA exhibited by Tyrosinase. Monophenolase activity is depicted in blue and diphenolase activity depicted in green.[76][95] 




substrates were also investigated with the complex which resulted in a negative slope of the Hammett 




Cu(I) systems wherein the active intermediates were not successfully isolated have also shown to be 
competent in monoxygenation reactions.[101,202,203] Reglier et al. first reported reactivity of 
Cu(I)BiPh(impy)2) (Fig. 2.16), successfully oxidizing DTBP to DTBQ in the presence of triethyl amine and 
dioxygen with a TON of 16.[202] Tuczek et al. have demonstrated a series of mononuclear Cu(I) complexes 
and simple bidentate ligands exhibiting impressive TON’s for catalytic activity. Most recently, a Cu(I) 
model system containing a benzimidazole moiety Lbzm within the ligand, reported a highest TON of 31 (Fig. 
2.16).[204] The reactivity studies were carried out similar to that of Reglier et al. and formation of the quinone 










Figure 2.15.  Ligand systems shown to bind dioxygen in an SP binding mode that display similar catalytic activity as 
Tyrosinase.[199–201] 
Figure 2.16. Ligand systems that form Cu(I) complexes and successfully carry out monoxygenation reactions.[202,204] 




In addition, the O isomer which is known to exist in rapid equilibrium with the SP isomer, and has yet to 
be biologically detected, has too demonstrated catalytic activity with external substrates.[12] In most cases 
however, the unphysiological radical based C-C and C-O coupling products are observed.[12,79,205] Stack et 
al. first illustrated O activity with the Cu(I) DBED system (Fig. 2.17).[206] The complex formed the SP 
isomer with dioxygen at low temperatures. Addition of substrate resulted in the cleavage of the O-O bond 
forming the O isomer, which was shown to be responsible for activity. In 2008, the Cu(I)2(M-XYLMeAN) 
(Fig. 2.17) system published by Company et al. was the first example of an independent O intermediate 
demonstrating catalytic activity in 67% yield. [207] Soon after, Herres-Pawlis and Stack reported similar 
activity for an O complex with the ligand system 2L (Fig. 2.17), exhibiting catecholase activity in >95% 
yield.[208] The evidence of catalytic activity exhibited by O complexes raises a pertinent question in context 
to weather the SP species is responsible for catalysis, or if substrate binding to the SP core triggers O 










The TP binding mode which has been considered as an initial dioxygen binding motif for Type 3 copper 
proteins, has recently reported monophenolic oxygenation.[89,209,210] Garcia-Bosch et al. demonstrated a TP 
complex with the m-XylN3N4 ligand system, capable of hydroxylating external phenols.[211] The oxygenated 
species was characterized by UV-vis and rR spectroscopy along with DFT calculations. 39% conversion of 
the substrate was observed after workup, and a Hammett plot indicated an electrophilic attack on the 
phenolic substrate similar to that observed in SP synthetic analogues and the biological system. However, 
further investigations on this system proved the active species to be an O intermediate which was shown to 
be in equilibrium with the TP form.[212] 
 
Figure 2.17 Ligand systems shown to bind dioxygen in an O fashion that display similar catalytic activity as Tyrosinase.[206–
208] 




2.6 Bis(oxazoline) ligands in Copper chemistry 
Though BOX ligands have been vastly used in the field of organic synthesis and their complexes have 
proved to be the most resourceful class of chiral catalysts capable of promoting a large number of organic 
reactions, their application as suitable scaffolds for small molecule activation with appropriate metals is 
poorly developed.[53]  
Previously, several ligands of the type R,HBOX with modifications in the backbone residues showed to have 
an influence on ligand redox non-innocence, which was unexpectedly encountered. Upon coordination with 
CuCl2, the ligands were oxidised, and during the course of the reaction were shown to undergo consecutive 
reactions such as dimerization by C-C radical coupling and mono-oxygenation. The selectivity of these 
reactions were dependent on the bulkiness of the backbone substituent demonstrating that more sterically 




In contrast to the copper(II) complexes of these ligand systems, the air sensitive copper(I) complexes 
demonstrated reversible dioxygen binding at low temperatures. Bulky dimethyl residues at the oxazoline 
rings were beneficial in sterically shielding the sensitive copper oxygen moiety. Spectroscopic 
characterisation of the adducts identified them as µ-η2:η2-peroxodicopper(II) complexes (Scheme 2.5).[71] 
Though the µ-η2:η2-peroxodicopper(II) complexes were identified with these ligands, characterization of 
theses complexes via X-ray crystallography still remianed a challange, and none of the compelxes showed 









Scheme 2.4: Schematic representation of the non-innocence displayed by Cu(II) complexes of BOX ligands investigated in previous 
work.   
Figure 2.18 Set of BOX ligands used in previous work.  









As was mentioned earlier in Chapter 1, BOX ligands are known to exist in their tautomeric forms[61,64] A 
detailed investigation of the free bis(oxazoline) Ph,HBOX (used in previous work) evidenced an equilibrium 
mixture between the diimine and iminoenamine tautomers.[65] The latter are reminiscent of β-diketimines 
that are extensively used as anionic ligands after deprotonation, suggesting that R,HBOXs may serve as 
proton responsive ligands.[66] We have now exploited this concept in bioinspired Cu/O2 chemistry which 
shall further be discussed in Chapters 6 and 7. 
 


















Dioxygen binding to copper in the active site of metalloenzymes has attracted much attention in the past 
few decades. These metalloenzymes stand as ideal prototypes for selective oxidation and oxygenation of 
C-H bonds which is essentially relevant for viable fuel and chemical feedstock formation. Gaining an 
insight into how these enzymes function, and synthetically mimicking their active sites to reproduce 
catalytic activity is a challenge in the field of bio-inorganic chemistry.  
An array of Cux/O2 intermediates with different dioxygen binding modes have meanwhile been uncovered, 
and their diagnostic spectroscopic features and distinct reactivities are reasonably well understood[38].The 
copper centers in these impressive copper proteins are usually ligated to N donors of either histidine residues 
or amines, making the biological scaffold of these enzymes prone to protonation and deprotonation.  
Binuclear complexes with a µ-η2:η2 peroxo dicopper(II) core, as found in the oxygenated forms of type 3 
copper proteins such as Haemocyanin or Tyrosinase, are among the most prominent species. As discussed 
earlier, it has been shown that the SP core can be transformed into the bis µ-oxido dicopper(III) core (O) 
that lacks the O-O bond. While the relevance of the copper(III) state has mostly been excluded for biological 
systems, recent studies addressing the O2 activation in bacterial particulate methane monoxygenase 
(pMMO)[50] have emphasized the potential importance of both the SP and O cores in the enzyme.[12,13,14,15] 
More generally, interconversions between different Cu2/O2 species are increasingly recognized as potential 
scenarios for modulating and elaborating the reactivity of these intermediates.[88,92][214][215]   
The BOX ligands previously used in Cu/O2 chemistry were all neutral and bidentate in nature. Dioxygen 
binding of their copper(I) complexes yielded their µ-η2:η2-peroxodicopper(II) complexes. The first 
objective of this work was to extend the range of BOX ligand scaffolds by modifying their electronic 
properties and backbone substituents, and investigate the impact on their corresponding copper complexes. 
This study should then comprise of various techniques such as UV-vis, IR, Raman, X-ray crystallography 
and ESI-MS in order to gain insights into the reactive intermediates formed. 
Furthermore, the evidence that certain free bis(oxazoline)s R,HBOX could exist as an equilibrium mixture 
between the diimine and iminoenamine tautomers suggested that the R,HBOXs may serve as proton 
responsive ligands. The iminoenamine form bears a close resemblance to β-diketimines that are extensively 
used as anionic ligands after deprotonation. The second objective therefore was to examine if this feature 
of the neutral ligand could be exploited, in analogy to the biological ligand scaffold being prone to 
protonation/deprotonation, and applied to interconversion of reactive intermediates.  
The final goal would be to study the effect of these reactive intermediates on small organic molecules 
similar to those encountered in the biological system, and analyse the potential of these synthetic analogues 

























4.1     Introduction 
4.2     Synthesis of neutral BOX ligands 















[Note: Experimental procedures for this chapter are described in detail under Chapter 15, section 
15.2] 
 





Bis(oxazoline) ligands have been investigated in detail over more than the last two decades, and their 
application in organic synthesis has been well established.  Ligands HL1, HL2, HL3, HL4 (Fig. 2.18), 
previously used in Cu/O2 chemistry were all neutral and bidentate in nature. In this work, four new ligand 
systems HL5, L6, [L2]- and [L3]- , with modifications in electronic properties and backbone substituents have 
been introduced, to extend the range of BOX ligand scaffolds and study their impact on Cu/O2 chemistry. 
The ligands differ with respect to being neutral-bidentate, (HL5) and (L6), and monoanionic-bidenatate 
([L2]-, [L3]-) in nature. Though HL1, HL2 and HL3, were previously used to generate their µ-η2:η2-
peroxodicopper(II) complexes, they have further been used in this work to study in detail the equilibrium 
between their respective SP and O isomers (this shall be discussed in detail in Chapter 7 ). A detailed study 
of substrate reactivity of their corresponding µ-η2:η2-peroxodicopper(II) complexes with suitable organic 
molecules has also been performed (this shall be discussed in further detail in Chapter 8). Scheme 4.1 
illustrates the set of BOX ligands used in the present work. Described below is the synthetic procedure of 













4.2 Synthesis of neutral BOX ligands 
Ligands HL1, HL2, HL3, HL5, and L6 were prepared in a three step synthetic procedure. First the bishydroxy 
malonamide precursors X were synthesized from their respective diethylmalonates, which were obtained 
from commercial suppliers, and an amino alcohol (2-amino-2-methyl-1-propanol). This mixture, together 
with a catalytic amount of sodium hydride was heated to 413 K for four hours, under an atmosphere of 
Argon. There was no solvent used during this step. The ethanol produced was removed under vaccum, and 
the malonamides were yielded quantitatively. The obtained malonamide could be used in the following step 
without further purification (Scheme 4.2).  
Scheme 4.1. A: Set of ligands used in previous work as well as this work. B: New ligands that have been synthesized and 
used in this work. 




   
 
 
The corresponding bishydroxymalonamides were then treated with methanesulfonyl chloride (MsCl) in the 
presence of triethylamine in dichloromethane to obtain their respective mesylates Y. This was done in order 






For ring closure, the corresponding mesylates Y were treated with sodium hydroxide in a 1:1 mixture of 
water and methanol and refluxed for two hours. Ligands HL1, HL2, and L6 were obtained as colorless oils 
after purification by bulb-to-bulb kugelhohr vacuum distillation. Ligands HL3 and HL5 precipitated in the 
final synthesis step and were obtained as white and pale yellow powders, respectively. All ligands were 










Scheme 4.2. Synthesis of the respective bishydroxy malonamides X. 
Scheme 4.3. Generation of the mesylates Y from their corresponding bishydroxy malonamides X. 
Scheme 4.4. Synthetic route for ring closure to obtain the desired BOX ligand. 





4.3 Synthesis of monoanionic BOX ligands 
The monoanionic-bis(oxazolinate) ligands [L2]- and [L3]- were prepared as their lithium salts in a one step 
synthetic procedure. The corresponding protonated ligands HL2, HL3 were taken up in hexane and cooled 
to 233 K, under an atmosphere of argon. 1 equivalent of 1.6M n-BuLi in hexane was added dropwise, and 
immediately a colorless solid precipitated. The pure ligands were obtained as white solids by washing with 
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The synthesis of Cu(I) complexes with BOX ligands and their reactivity towards dioxygen has been 
investigated in an earlier project.[71] Reactions with suitable Cu(I) salts were shown to generate air sensitive 
mononuclear Cu(I)BOX complexes which demonstrated reversible dioxygen binding at low temperatures. 
The Cu/O2 species were identified as µ-η2:η2-peroxodicopper(II) complexes, where the Cu(I) centers were 
oxidized to Cu(II), and thermodynamic and kinetic parameters for O2 binding were determined.[71] The 
ligand systems employed previously were all proton responsive in nature, and while their SP complexes 
were characterized in the solid state and in solution, structural elucidation still remained a challenge. 
The following section describes the Cu(I) complexes of HL1, HL2, HL5 and L6 (Fig. 5.1) and focuses 
particularly on the dioxygen reactivity with HL2, HL5 and L6. The two new ligand systems, HL5 and L6 
introduced herein, have been modified to study electronic effects on Cu/O2 complexes generated by BOX 
ligands. In contrast to the previously used HL3, HL5 was designed to have an additional methyl group on 
the phenyl ring in order to investigate inductive effects. On the other hand, L6, unlike the other ligand 
systems was designed to be non-proton responsive in nature. As mentioned earlier, the ligand systems 
previously used were prone to deprotonation by virtue of a relatively acidic proton within the ligand 
backbone. L6 however, hosts two methyl groups within its backbone with no protons available for 








5.2 Synthesis and characterization of Cu(I) BOX complexes with proton responsive ligands HL1, HL2 
and HL5 
The general scheme employed for the generation of Cu(I) complexes with proton responsive ligands is 
depicted in Scheme 5.1. Ligands HL1 and HL5 were individually treated with 1.1 equivalents of 
tetrakis(acetonitrile)copper(I) hexaflourophosphate in THF to yield colorless solutions of their Cu(I) 
complexes respectively (1 and 3). In the case of HL2, tetrakis(acetonitrile) copper(I) perchlorate was used 
as the Cu(I) source to generate the Cu(I) complex 2. ESI-MS analysis of the colorless solution of 1 in THF 
(Fig 5.2 left) revealed one major peak, namely [HL1Cu(I)MeCN]+ (m/z = 314). The two other peaks could 
be assigned to [HL1Cu(I)]+ (m/z= 273) and [(HL1)2Cu(I)]+ (m/z = 483.1). ESI-MS analysis of the colorless 
solution of 2 (Fig 5.2 right) revealed a major peak which corresponded to the monomer [HL2Cu(I)MeCN]+ 
(m/z = 328.1) and a second peak corresponding to the dimer [(HL2)2Cu2CN]+ (m/z = 600.2).  
Figure 5.1 Ligand systems employed in the present study of copper dioxygen chemistry. HL5 and L6 are the new systems 
introduced. 













ESI-MS analysis of the crude copper(I) complex in THF with HL5 (Fig 5.3) revealed one major peak 
consistent with the mass of [HL5Cu(I)MeCN]+ (m/z = 404.1). The two other peaks could be assigned to 





Scheme 5.1 General scheme for the synthesis of Cu(I) BOX complexes. 
Figure 5.2 Left: ESI-MS of 1 in THF. The two major peaks are assigned to the copper(I) complex of HL1, differing by an 
acetonitrile molecule. The inset shows an enlargement of the peak at m/z = 314, together with a simulation of the isotopic 
pattern corresponding to [HL1Cu(I)MeCN]+. Right: ESI-MS spectrum of 2 in THF. The two major peaks could be assigned 
to the monomer and dimer of the copper(I) complex of HL2. The inset shows an enlargement of the peak at m/z = 328.1 together 









The diamagnetic nature of the Cu(I) complexes enabled 1H-NMR spectroscopy to be used as a means of 
characterization. The analysis of 1 in a solution of CD3CN (Fig 5.4) is in agreement with the solid state 
structure (Fig 5.6 left) and indicates a high C2v symmetry due to the CH2 moiety present in the ligand 




Figure 5.3 ESI-MS of 3 in THF. The two major peaks could be assigned to the copper(I) complex of HL5, differing by an 
acetonitrile molecule. The inset shows an enlargement of the peak at m/z = 404.1 with a simulation of the isotopic pattern, 
corresponding to [HL5Cu(I)MeCN]+. 
 
Figure 5.4: 1H NMR spectrum of 1 in CD3CN at 293 K. Solvent peaks marked with .  
 
 











5.2.1 Structural elucidation of 1 and 3 
The Cu(I) complexes 1 and 3 were also characterized via X-ray crystallography. Addition of Et2O to a 
solution of 1 resulted in precipitation of the crude complex as a white powder. Recrystallization from THF 
and Et2O under inert conditions yielded single crystals of [HL1Cu(I)MeCN]PF6 (1) (Fig 5.6 left) suitable 
for X-ray diffraction in 50% yield. Slow diffusion of Et2O into a 1:1 (THF:CHCl3) solution of 3 afforded 
colorless single crystals of [HL5Cu(I)MeCN]PF6 (3) suitable for X-ray diffraction in 60% yield (Fig 5.6 
right). 1 and 3 crystallize in the monoclinic space groups P21 and P21/c respectively. The copper ions are 
coordinated in a trigonal planar fashion to the bidentate HL1 and HL5 ligands with an exogenous acetonitrile 
solvent molecule. The boat shaped coordination taken up by these Cu(I) complexes places the oxazoline 
rings with the copper and acetonitrile moiety on a single plane, while the two methyl groups of the CMe2 
groups lie above and below the plane. The ideal trigonal planar geometry of 120º is slightly deviated in 
both cases due to the small bite angle of N2-Cu-N1, 94.9º in 1 and 94.4º in 3. In comparison to the Cu(I) 
complex of HL3 which was crystallized in a previous study[71] the bite angle formed by N2-Cu-N1 in 3 as 
well as the angle between the residue R and the N3Cu coordination plane is much larger (94.4º > 93.4 º and 
109º > 80º, respectively ).  
 
 
Figure 5.5: 1H NMR spectrum of 3 in CD3CN at 293 K. Solvent peaks marked with . 
 
 







5.3 Dioxygen reactivity of 1, 2 and 3 at low temperatures to yield Cu2(µ-η2:η2-O2) intermediates 
Dioxygenation of Cu(I) BOX complexes 1, 2 and 3 at 193 K gave rise to deep purple colored solutions of 











Figure 5.6 Left: Molecular structure of 1 in the crystal together with a partial labelling scheme. Thermal displacement 
ellipsoids are drawn at 30%. Anions and hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]:Cu1–
N1 1.9700(17), Cu1–N2 1.9869(18), Cu1–N3 1.8787(19); N3–Cu1–N1 131.654(8), N3–Cu1–N2 133.337(8), N1–Cu1–N2 
94.978(7). Right: Molecular structure of 3 in the crystal together with a partial labelling scheme. Thermal displacement 
ellipsoids are drawn at 30%. Anions and hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]:Cu1–
N1 2.0037(17), Cu1–N2 1.9745(18), Cu1–N3 1.8664(19); N3–Cu1–N1 126.018(8), N3–Cu1–N2 139.469(8), N1–Cu1–N2 
94.499(7). 
 
Scheme 5.2 Activation of dioxygen with Cu(I) BOX complexes in solution at 193 K to yield SP complexes 5,6,7, and 
8. 





5.3.1 Properties in solution 
Purple colored solutions of the formation of [(HL1)2Cu2(µ-η2:η2-O2)] (5) (Fig 5.7 left), [(HL5)2Cu2(µ-η2:η2-
O2)] (7) (Fig 5.7 right) and [(HL2)2Cu2(µ-η2:η2-O2)] (6) (Fig 5.8) were monitored using UV-vis 
spectroscopy, where two intense optical features at ~350 nm and ~500 nm were observed, which are typical 
for a dicopper µ-η2:η2-peroxo species and comparable to the spectroscopic features of oxyhemocyanin and 
oxytyrosinase.[216] The distinctive spectrocopic features for SP complexes are in direct correlation with the 
side-on peroxide binding mode,[93] and theoretical studies conducted by Solomon et al. have made them 
well understood (Refer to sec. 2.3.2 of introduction, fig. 2.6). The highest occoupied peroxide orbitals are 
composed of degenerate π* levels. Approaching the metal center, these levels split up into πσ* and πv* 
orbitals. The πσ*  orbital lies in plane with the Cu2O2 core, which results in a  σ overlap with the half filled 
Cu(II) dxy orbitals. This leads to an intense LMCT band obsereved around 300-350 nm, assigned as O22- πσ*  
to Cu(II) dxy orbitals; 330 nm (ε = 7422 M-1cm-1) for 5,  330 nm (ε = 19113 M-1cm-1) for 6 and 333 nm (ε = 
4403 M-1cm-1) for 7. The second πv* orbital however, lies perpendicular to the Cu2O2 plane allowing only 
small π bonding interaction with the copper centers. This leads to the second LMCT band observed around 
500 nm, assigned to transitions between O22- πv* to Cu(II) dxy orbitals; 501 nm (ε = 454 M-1cm-1) for 5,  500 
nm (ε = 1530 M-1cm-1) for 6 and 504 nm (ε = 357 M-1cm-1) for 7. The intensity of the two bands are ususally 





Figure 5.7 Left: Formation of [(HL1)2Cu2(µ-η2:η2-O2)] (5) with bands at 330 nm and 501 nm in THF at 193 K monitored by UV/Vis 
spectroscopy. The inset displays formation of the band at 330 nm with time. Right: Formation of [(HL5)2Cu2(µ-η2:η2-O2)] (7) with 
bands at 333 nm and 504 nm in THF at 193 K monitored by UV/Vis spectroscopy. The inset displays formation of the band at 333 
nm with time. 
 
 




   
 
5.3.2 Structural elucidation of a Cu2(µ-η2:η2-O2) dicopper(II) complex (6) with an unusually long O-O 
bond 
The stability of 6 at 193 K made it possible to store solutions of the complex at low temperatures over 
several months. Formation of  [(HL2)2Cu2(µ-η2:η2-O2)] was confirmed by X-ray crystallography. Single 
crystals sutiable for X-ray diffraction were grown by diffusion of Et2O into a 1:1 THF/acetone solution of 
6 at 193 K. X-ray diffraction analysis revealed a centrosymmetric molecular structure of the cation  6 
Figure 5.8: Formation of [(HL2)2Cu2(µ-η2:η2-O2)] (6) with bands at 333 nm and 500 nm in THF at 193 K monitored by UV/Vis 
spectroscopy. The inset shows formation of the band at 333 nm with time. 
 
 
Fig 5.9 Plot (30% probability thermal ellipsoids) of the molecular structure of one of the two crystallographically independent 
cations in 6 (hydrogen atoms and disorder omitted for clarity). Selected distances [Å] and angles [°]: Cu1–O3 1.916(3), Cu1–
O3' 1.919(3), Cu1–N2 1.942(4), Cu1–N1 1.959(3), Cu1–O4A 2.328(6), O3–O3' 1.583(6), Cu1∙∙∙Cu1' 3.4921(8); O3–Cu1–O3' 
48.78(15), O3–Cu1–N2 105.38(14), O3'–Cu1–N2 152.73(14), O3–Cu1–N1 157.01(14), O3'–Cu1–N1 109.49(14), N2–Cu1–
N1 94.36(15), O3–Cu1–O4A 91.4(3), O3'–Cu1–O4A 90.0(4), N2–Cu1–O4A 100.5(4), N1–Cu1–O4A 96.5(3), Cu1–O3–Cu1' 
131.22(15). Symmetry transformation used to generate equivalent atoms: (') 1–x, 1–y, –z. 
 




(Fig 5.9) with two perchlorate anions. The molecule crystallizes as two crystallographically independent 
units. 
Each copper ion was found to be coordinated in a slightly distorted square pyramidal (SP-5) environment 
(τ = 0.14; where τ5 is the geometry index for SP-5 complexes defined as (β-α)/60º, where β and α are defined 
as the largest bond angles for the coordinated ion) constituted by the HL2 BOX capping ligand, the peroxide 
moiety and an additional THF solvent molecule bound axially. Exemplary complexes bearing copper and 
ethylene diamine ligand systems with comparable transitions to that of 6 have also shown to contain an 
additional weakly bound axial ligand which could either be the counterion or a solvent molecule,[137,217] 
similar to this case. The Cu-O distance of the bridging side-on μ-η2:η2 peroxide was determined to be 1.91 
– 1.92 Å. The Cu-O distance of the THF molecule bound in the apical position was 2.33 Å. The large 
difference in these Cu-O distances suggests that the solvent molecule is only weakly bound to the copper 
centers compared to the peroxide ligand. The Cu∙∙∙Cu separation of 3.49 - 3.51 Å is typical for a SP core,[41] 
and the O-O bond length of the central peroxide at 1.58 Å is the longest O-O bond reported so far for any 
synthetic or biological Cu2(µ-η2:η2-O2) system.[108,136,141,142,144,162–165] The additional acetonitrile molecule 
bound to the copper(I) complex observed by ESI-MS does not appear in the crystal structure of the 




5.4 Synthesis and characterization of a Cu(I) BOX complex with a non-proton responsive ligand L6 
Ligand L6 was suitably designed to be non-proton responsive in nature, with two methyl groups present in 
the ligand backbone. The copper(I) complex of L6 (4) was prepared by treating a 1:1 equivalent of L6 with 
tetrakis(acetonitrile) copper(I) perchlorate in THF (Scheme 5.1). ESI-MS analysis of the crude reaction 
mixture in THF (Fig 5.11 left) revealed one major peak, namely [L6Cu(I)MeCN]+ (m/z = 342.1). The two 
other peaks could be assigned to [L6Cu(I)]+ (m/z = 301) and [(L6)2Cu2(I)CN]+ (m/z = 628.2).  The 
diamagnetic nature of 4 enabled the usage of 1H NMR for characterization in solution.  
Fig 5.10 Plot (30% probability thermal ellipsoids) of the molecular structure of one of the two crystallographically independent 
cations in 6 (hydrogen atoms and the THF disorder are omitted for clarity). Selected distances [Å] and angles [°]: Cu2–O13' 
1.924(3), Cu2–O13 1.926(3), Cu2–N11 1.953(3), Cu2–N12 1.955(4), Cu2–O14A 2.272(15), O13–O13' 1.572(4), Cu2∙∙∙Cu2' 
3.5148(7); O13'–Cu2–O13 48.20(14), O13'–Cu2–N11 154.34(14), O13–Cu2–N11 107.60(13), O13'–Cu2–N12 107.74(14), 
O13–Cu2–N12 154.48(14), N11–Cu2–N12 94.23(15), O13'–Cu2–O14A 93.3(13), O13–Cu2–O14A 92.5(10), N11–Cu2–
O14A 96.7(17), N12–Cu2–O14A 98.0(14), Cu2'–O13–Cu2 131.80(14). Symmetry transformation used to generate equivalent 
atoms: (') –x, 1–y, 1–z. 
 
 






5.4.1 Structural characterization of 4 
Single crystals suitable for X-ray diffraction were obtained in 50% yield by slow diffusion of Et2O into a 
THF solution of 4.  X-ray diffraction analysis revealed 4 to coexist with its dimer in the solid state. Both 
the monomer and dimer cocrystallize in the triclinic space group P 1. The monomer (Fig 5.12 left), similar 
to 1 and 3, has a copper ion coordinated to the ligand and an acetonitrile molecule in a slightly distorted 
trigonal planar geometry. The boat shaped coordination is maintained, with the oxazoline rings being flat 
and planar. The methyl groups of the CMe2 units present in the ligand backbone and in the oxazoline rings 
orient themselves above and below the plane. The bite angle formed by N2-Cu-N1 is the smallest, 92.8º, 
compared to the other copper(I) complexes 1 and 3 reported above.  
The dimer (Fig 5.12 right) crystallizes with two copper ions and two ligand molecules per single unit with 
each copper ion coordinated to two nitrogen atoms of different ligands. Unlike the monomer, the copper 
ions exhibit a linear coordination, with no exogenous acetonitrile molecule. The metal-ligand Cu-N bond 
lengths herein are slightly shorter compared to the monomer, which could be accounted for by a lower 
coordination number of the metal center. 1H NMR studies in combination with DOSY analysis of 4 in 
THF-d8 revealed the presence of only a single species, the monomer within solution. No peaks 
corresponding to the dimer were observed. This suggests that though 4 exists as a monomer and dimer in 
the sold state, within solution, only the monomeric species is retained.      
Figure 5.11 Left: ESI-MS of 4 in THF. The two major peaks could be assigned to the copper(I) complex of L6, differing by 
an acetonitrile coligand. The inset shows an enlargement of the peak at m/z = 342.1, together with a simulation of the isotopic 
pattern corresponding to [L6Cu(I)MeCN]+. 








5.5 Dioxygen activation of 4 at low temperatures to yield a Cu2(µ-η2:η2-O2) intermeditae with 
complete characterization 
5.5.1 Properties in Solution 
Oxygenation of a solution of 4 at 193 K in THF yielded the [(L6)2Cu2(µ-η2:η2-O2)] (8) complex according 
to Scheme 5.2. Monitoring the reaction by UV-vis spectroscopy (Fig5.13) led to intense optical features at 
Figure 5.12 Left: Plot (30% probability thermal ellipsoids) of the molecular structure of one of the two crystallographically 
independent cations of 4 (hydrogen atoms omitted for clarity). Selected bond lengths [Å] and angles [°]: Cu1–N1 1.9469(17), 
Cu1–N2 1.9909(18), Cu1–N3 1.8540(19); N3–Cu1–N1 141.13(8), N3–Cu1–N2 125.90(8), N1–Cu1–N2 92.83(7). Right: Plot 
(30% probability thermal ellipsoids) of the molecular structure of one of the two crystallographically independent cations of 4 
(hydrogen atoms omitted for clarity). Selected distances [Å] and angles [°]: Cu2–N11 1.8699(17), Cu2–N12' 1.8738(17), Cu2∙∙∙ 
Cu2' 3.4313(5); N11–Cu2–N12' 171.43(8). Symmetry transformation used to generate equivalent atoms: (') 1–x, 1–y, 1–z. 
 
Fig 5.13 Formation of [(L6)2Cu2(µ-η2:η2-O2)] (8) with bands at 333 nm and 500 nm in THF at 193 K monitored by UV/Vis 
spectroscopy. Inset shows the formation of the band at 333 nm with time. 
 




333 nm (ε ≈ 21440 M-1cm-1) and 500 nm (ε ≈ 895 M-1cm-1), typical for the LMCT transitions of dicopper 
µ-η2:η2-peroxo species.  
 
5.5.2 Resonance Raman spectroscopy 
A deeper insight into the dioxygen binding mode of 8 was obtained from resonance Raman (rR) 
spectroscopy. An excitation wavelength of 633 nm was used due to diminished fluorescence in comparison 
to the 457 nm laser. THF solutions of 4 were exposed to either naturally abundant or isotopically labelled 
dioxygen (18O2) at 193 K in young NMR tubes. Solutions of 8 in a dry-ice/acetone bath at 193 K showed 
an oxygen isotope sensitive feature at 740 cm-1 which shifts to 700 cm-1 on isotopic labelling (Δ16O2-Δ18O2 
= 40 cm-1) (Figure 5.14). This was assigned to the µ-η2:η2 coordinated peroxide, and is comparable to the 
side on µ-η2:η2 copper(II) dioxygen complexes having νO-O = 730-760 cm-1 (Δ[18O2] ca. 40 cm-1), rR cm-1 
(Δ18O2) = -744(-39) for oxy-hemocyanin[218], and -755(-41) for oxy-tyrosinase[219] ). In the case of µ-η2:η2-
peroxodicopper(II) complexes, due to backbonding which occurs from the HOMO of Cu(II) dxy orbitals to 
the in-plane, unoccupied high energy σ* orbital of the peroxide, the O-O stretch is weakened compared to 
the O-O stretch observed with H2O2 (νO-O = 880 cm-1), 1,2-trans-peroxo (νO-O = 830 cm-1 (Δ[18O2] 46)), 1,2-
cis-peroxo (νO-O = 800 cm-1 (Δ[18O2] 45)), and bis(µ-oxo) (νCu-O = 600 cm-1 (Δ[18O2] 28)) dicopper systems. 
rR spectroscopy confirmed the absence of a MeCN molecule bound to [(L6)2Cu2(µ-η2:η2-O2)] which was 
in accordance with X-ray crystallography (Fig. 5.16). There was no evidence of a bis(µ -oxo) dicopper(III) 
species which is expected to exhibit a vibrational mode at 580-650 cm-1 with a Δ[18O2] shift of 23-30 cm-1 
due to the oxo core. 
 
 
Figure 5.14. Resonance raman spectrum of 8 in THF at 193 K. 16O2 spectrum indicated in black and 18O2 spectrum indicated 
in red. Residual solvent signals are marked with an asterisk (*). 
 






5.5.3 Properties in solid state 
Isolated solid purple material of complex 8 was also characterized by solid state UV-vis and IR 
spectroscopy. When compared to the solution spectrum, the reflectance spectrum (Fig 5.15 left) of a ground 
sample of the dioxygen adduct showed similar distinctive peaks. Two intense bands at 337 nm and 480 nm 
similar to those in solution were observed indicating that the SP structure is present both in solution and in 
the solid state. The IR spectrum of the naturally abundant dioxygen adduct of 8 (Fig 5.15 right) was 
measured in a KBr pellet, which revealed a stretch at 747 cm-1 which could possibly be assigned to the O-





5.5.4 Structural elucidation of 8 
Single crystals of 8 were sucessfully grown from a 1:1 THF:acetone /Et2O solution at 193 K confirming 
the µ-η2:η2-peroxo binding mode. X-ray diffraction analysis (Figure 5.16) revealed a centrosymmetric 
molecular structure of the cation  8, similar to that of 6 with two perchlorate anions and a disordered acetone 
molecule. Each copper ion displays a slightly distorted square pyramidal geometry (𝜏 = 0.16) constituted 
by the ligand L6, the peroxide moiety, and the apical bound THF solvent molecule. The two Cu-N equatorial 
bond lengths were determined to be 1.94 Å(avg), which is slightly longer than that reported for system 6. The 
apical bound THF solvent molecules displayed a Cu-O distance of 2.324 Å and Cu-O equatorial bonds 
contributed by the peroxide were 1.924 Å and 1.929 Å. The bond length between the two copper centers 
was 3.52 Å and the O-O bond length of the peroxide was 1.56 Å, which is fairly long compared to other 
structurally reported SP complexes. The absence of MeCN bound to 8, as confirmed by rR spectroscopy 
was in accordance with X-ray structural analysis. 
Fig 5.15 Left: UV-vis features of 8 in the solid state. Bands at 337 nm and 480 nm are also present in UV-vis solution. Right: 
IR spectra of 8 measured with a KBr pellet. Possible ν(O-O) for naturally abundant dioxygen adduct of 8 marked with *. 






5.5.5 Magnetic measurements  
The thermal stability of 8 allowed its magnetic properties to be determined. Magnetic susceptibility 
measurements were carried out using a Quantum Design MPM-5S superconducting quantum interference 
device (SQUID magnetometer). The temperature dependence of χmolT within the temperature range of 2-
295 K for crystalline material of 8 was negligible, suggestive of very strong antiferromagnetic coupling 
between the two cupric ions and maximum population of the singlet ground state (Fig 5.17.) Simulations 
of the data using the Heisenberg-Dirac-van Vleck Hamiltonian; H = -2JS1·S2, showed the lower limit of the 
exchange coupling to be -2J ≥ 1600 cm-1, which is rather high for reported SP systems. In order to confirm 
this lower limit, simulations with fixed J values were performed (black dashed lines; Fig. 5.17). These 
indicated the molar susceptibility to be far higher than what was experimentally observed, thus conforming 
the lower limit.  Decomposition of 8 with temperature did not permit high temperature (> 300 K) magnetic 
measurements to be conducted.   
Experimental data for magnetic coupling in Cu2/O2 systems by SQUID magnetometry are still relatively 
scarce due to the thermal lability of such intermediates. Oxyhemocyanin also exhibits a large singlet-triplet 
splitting of -2J ≥ 600 cm-1. In the system reported by Karlin et al.[220], a µ-η2: η2peroxo bridged model 
system, the singlet-triplet splitting was reported at -2J ≥ 600 cm-1, and -2J ≥ 800 cm-1 for the system 
reported by Kitajima and Solomon et al.[221]. In the case of trans-1,2-peroxo coordinated model systems, 
the splitting was reported to be -2J ≥ 600 cm-1. Recently in 2014, the first cis-peroxo binding geometry was 
reported by Meyer et al. where the peroxo exhibits only a weak antiferromagnetic coupling of -2J ≥ 144 
cm-1 with a Cu-O-O-Cu torsion of 65o. [109] Subsequently, the first ferromagnetically coupled dicopper(II) 
peroxo system with a triplet ground state (S = 1) was reported in the same group, wherein the Cu-O-O-Cu 
torsion was constrained to close to 90o. [134] To date, this is the only reported dicopper peroxo system that 
Fig 5.16 Plot (30% probability thermal ellipsoids) of the molecular structure of the cationic part of 8 (hydrogen atoms and 
disorder omitted for clarity). Selected distances [Å] and angles [°]: Cu1–O3 1.929(3), Cu1–O3' 1.924(3), Cu1–N1 1.942(3), 
Cu1–N2 1.950(3), Cu1–O4A 2.318(5), O3–O3' 1.564(5), Cu1∙∙∙Cu1' 3.5214(7); O3'–Cu1–O3 47.90(13), O3'–Cu1–N1 
107.96(13), O3–Cu1–N1 153.99(13), O3'–Cu1–N2 154.15(13), O3–Cu1–N2 108.16(12), N1–Cu1–N2 93.09(14), O3'–Cu1–
O4A 92.02(18), O3–Cu1–O4A 89.55(19), N1–Cu1–O4A 102.4(2), N2–Cu1–O4A 98.03(18), Cu1'–O3–Cu1 132.10(13). 
Symmetry transformation used to generate equivalent atoms: (') 1–x, 1–y, –z. 
 




does not exhibit any antiferromagnetic coupling. The experimental data for the magnetic measurements of 
8 confirms a singlet S = 0 ground state, with strong antiferromagnetic coupling of -2J ≥ 1600 cm-1 between 




Figure 5.17.  χmT vs T measurement of 8 obtained from SQUID measurements at 0.5 T. The red solid line corresponds to the 
best fit for two anitferromagnetically coupled S = 1/2 ions with g = 2.0 Additional fit parameters: temperature independent 
paramagnetism and paramagnetic impurity. The fit gives lower limit of -J ≥ 800 cm-1. The black lines represent simulations 
assuming weaker coupling (smaller J values). 
 
 





5.6 Comparison of 6 and 8 with other structurally characterized Cu2(µ-η2:η2-O2) complexes 
The first structurally elucidated synthetic SP complex was demonstrated by Kitajima et al. with sterically 
demanding  fac, monoanionic, tris(pyrazolyl) borate ligands TpR3,R5 (R3= Me, iPr, Ph; R5= Me, iPr).[108] 
The spectroscopic features exhibited by these complexes were similar to that of oxyHc, which put forward 
the idea that dioxygen binds similarly in the enzyme. Soon after, the structural characterization of oxyHc 
from horseshoe crab (Limilus polyphemus)[42,222,223] and octopus (Octopus dofleini)[224] confirmed the side-
on binding mode. The octopus oxyHc structure measured at 2.3 Å revealed a symmetric core with a Cu···Cu 
distance of 3.54 Å and an O-O bond length of 1.38 Å. This differed slightly from the horseshoe crab oxyHc, 
where the Cu centers were bound in a distorted SP-geometry, with Cu···Cu and O-O bond lengths being 
3.60 Å and 1.41 Å respectively. These parameters however, were quite similar to the synthetic system 
reported by Kitajima (Cu···Cu 3.56 Å and O-O 1.41 Å). Following this, only a handful of SP complexes 
have successfully been characterized within the last two decades, proving structural elucidation to be a  
challenging task for these complexes. Most SP systems have been crystallographically characterized with 
tridentate bulky ligand systems capable of encapsulating the (µ-η2:η2-O2) unit within the copper centers. 
The sterically demanding binucleating bitripy ligand,[142] sterically hindered hexapyridine system,[163] as 
well as macrocyclic ligands such as iPr3tacd and tBu3tacn belong to this ligand class.[144,165] The SP complex 
reported by Gorun et al. which was structurally characterized with the tris(pyrazolyl)borate TpCF3,Me ligand, 
demonstrated enhanced stability for several days when compared to other SP systems, which are inherently 
known to be thermally labile.[146] This was accounted for by the inertness and the electron withdrawing 
nature of the CF3 groups making this complex more thermally stable. The SP complex reported by Masuda 
et al. with the aid of  (–)-α-isosparteine capping ligands, demonstrated a carboxylate bridged µ-η2:η2  
butterfly structure constraining the planarity between the copper centers and the peroxide ligand.[162] This 
led to the Cu···Cu bond distance (3.26 Å) within the complex to be the shortest reported so far. The O-O 
bond distance of 1.49 Å remained within the normal realm of SP complexes. Moreover, this is the only 
bidentate ligand system reported to date that is known to isolate a SP complex. Recently Karlin et. al. 
isolated a new SP complex with the tridentate MeAN ligand which has the longest O-O bond reported to 
date (1.54 Å).[164] However, this did not reflect in an increase in backbonding nor result in O-O bond 
cleavage. 
In contrast to the ligand systems mentioned above, BOX systems are simple bidentate ligands. This ligand 
class has proved efficient in isolating SP complexes. Of the SP complexes isolated during the course of this 
work, complex 6 which was generated with the proton responsive HL2 ligand now demonstrates the longest 
O-O bond (1.58 Å) reported in any synthetic or biological system. Complex 8, which was obtained with the 
non-proton responsive L6 ligand also demonstrates an unusually long O-O bond (1.56 Å). This too did not 
affect the backbonding as the rR values for 8 lie within the normal reported range of SP complexes. In 
analogy to the system reported by Karlin et. al., the long O-O bond did not result in any O-O bond cleavage.  






Table 5.1. Geometric and Spectroscopic features of  μ-η2:η2-peroxodicopper(II) (BOX)complexes , and all μ-η2:η2-peroxodicopper(II) complexes 














UV-vis; λ, nm 






Me,MeP (8) ClO4- THF 3.52 1.56 XRD 333(2.1) 
500(0.9) 
744(40) This work 
Me,HP (6) ClO4- THF 3.49 1.58 XRD 333(19) 
500(1.3) 
735(39) This work 
H,HP PF6- THF 3.52  EXAFS 330(>30), 
504(>0.8) 
742(39) [71] 
tBuP PF6- THF, 
acetone 
3.51  EXAFS 333(48), 500(2.1) 731(39) [71] 
oxy-hemocyaninb   3.60 1.41 XRD 345(20), 550(1) 744(39) [42,85] 
oxy-hemocyaninc   3.54 1.38 XRD  749(40) [42,85] 
oxy-tyrosinased   3.55 1.50 XRD 345, 600 755(41) [76,86,219] 
TpiPr,iPr e acetone 3.56 1.412 XRD 349(21), 551(>0.8) 741(43) [108,136,221] 
TpCF3,Me e CH2Cl2 ~3.5  XRD 334, 550 765(40) [141,146] 
bitripy PF6- CH2Cl2 3.477 1.485 XRD 360(25), 532(1.5) 760(41) [142] 
iPr3tacd SbF6- CH2Cl2 3.519 1.367 XRD 380(22), 520(2.3) 739(43) [144] 
L2f PF6- g 3.52av 1.49av XRD 366(24), 537(1.5) 765(41) [163] 
MeAN PF6- acetone 3.533 1.540 XRD 360(22), 540(2.5) 721(38) [143,164] 
(–)-α-isosparteine SbF6- h i.a. CH2Cl2 3.265 1.498 XRD 372(20), 745(1.3) 756(41) [162] 
tBu3tacn CF3SO3- CH2Cl2 3.63 1.47 XRD 400, 550 773(44) [165] 
aStructural data from EXAFS or from X-ray diffraction(XRD) measurements. bLimulus Polyphemus. cOctopus dof leini. dMushroom (Agaricus 
bisporus). eNeutral complex. fTwo independent molecules in the unit cell. gCH2Cl2/acetone, 3:0.002, mixture. hAn additional bridging µ-Bz- ligand 
is present 
 





5.7 Kinetic and Thermodynamic analysis of Cu/O2 binding with HL5 and L6 
The kinetic and thermodynamic parameters for a range of Cu/O2 systems has led to a well-accepted scheme 
for the mechanism of dioxygen activation (Scheme 5.3).[132]  
   
 
As evident from the processes A and B, a total of three cases arise for the formation of a Cu/O2 complex. 
In case(I) the rates of both A and B are slow and well defined, which would allow for kinetic investigations 
of the individual processes. In case (II), A>>B in terms of the rates of reaction, and B forms the observable 
rate determining step. In case (III), B>>A, and A forms the observable rate determining step. 
In correlation to a previous study of Cu/O2 complexes with BOX ligands, and in concordance to the present 
work[71], case (III) is operative with Cu(I)BOX complexes for dioxygen activation. No accumulation of any 
intermediates was observed during the formation of Cu2(µ-η2:η2-O2) complexes by UV-vis spectroscopic 
analysis, which suggested the formation of a single species from the Cu(I)complex and dioxygen. 
Moreover, stopped flow analysis and oxygen-concentration dependent experiments conducted on a 
Cu(I)tBu system previously (where tBu represents ligand HL4, refer to Chapter 2, fig. 2.18), led to 
established pseudo first order reaction conditions, where the rate is independent of the concentration of 
dioxygen when present in excess. The following section describes the kinetic and thermodynamic 
parameters for oxygenation of 3 and 4, and compares them to the previously investigated Cu(I)tBu system. 
 
5.7.1 Determination of the rate constant (kobs) for dioxygen binding in 3 and 4 
Dioxygen reactivity for 3 and 4 to yield 7 and 8 was shown to follow first order kinetics. The traces at ~333 
nm and ~500 nm were fitted with a single exponential function to obtain the rate constants for their 
respective reactions.  While the previously described systems, tBu,HP and Ph,HP ( x,yP: where x and y represent 
the residue of the ligand backbone, and P respresents SP complexes) were described to be sufficiently 
soluble under reaction conditions, and H,HP and Me,HP were found to precipitate upon formation, the two 
new systems introduced herein were found to be readily soluble and did not precipitate within short 
timescales. The formation of Me,MeP (8) from its copper(I) complex was completed after approximately 12 
minutes, while the formation of p-Tol,HP (7) was observed to be much slower compared to all the other 
systems and full formation required over 50 minutes to an hour (Table 5.2). The reaction kinetic profiles 
were deconvoluted with SPECFIT/32 global analysis software. Time resolved spectra of both complexes 
Me,MeP and p-Tol,HP gave rise to a single exponential growth with the corresponding logarithmic plot bearing 
a linear relationship. The calculated kobs values for Me,MeP was 0.545 min-1 (Fig 5.18) and that for p-Tol,HP 
was 0.098 min-1 (Fig. 5.19), both determined  at 195 K from the non-linear curve fits. Table 5.2 gives an 
overview of the rate constant of all Cu(BOX) SP complexes at 195 K synthesized so far.[225] 
Scheme 5.3 Mechanistic framework for dioxygen activation of Cu(I) complexes. 




























SP -Complex Ligand kobs (min-1)  
H,HP HL1 ≥ 1 Previous work 
Me,HP HL2 ~ 1.5 Previous work 
Ph,HP HL3 0.71 Previous work 
tBu,HP HL4 0.25 Previous work 
p-Tol,HP HL5 0.098 This work 
Me,MeP L6 0.545 This work 
Fig 5.18 Left: Kinetic time trace of Absorbance (333 nm) and a non-linear first order fit at 195 K for formation of Me,MeP(8). 
Right: First order plot of ln(At-A0) vs t based on the absorbance changes at 333 nm with linear regression. kobs= 0.545 min-1. 
Fig 5.19 Left: Kinetic time trace of Absorbance (333 nm) and a non-linear first order fit at 195 K for the formation of p-
Tol,HP(7). Right: First order plot of ln(At-A0) vs t based on the absorbance changes at 333 nm with linear regression. kobs= 
0.098 min-1. 
Table 5.2 Overview of rate constants of formation at 195 K for all Cu(BOX) SP complexes synthesized so far.  
 





Comparing the systems Me,HP with Me,MeP, an additional methyl group in the ligand backbone results in a 
decrease of kobs by a factor of 3. Similarly, the p-Tol,HP system containing a methyl group on the phenyl ring 
has a lower kobs than Ph,HP.  Thus an increase in steric bulk of the ligand system tends to slow down the 
oxygenation reaction process leading to a decrease of the rate constants. This observation is in agreement 
to that reported in a previous study.[71] 
 
5.7.2 Determining the activation parameters for the formation of 7 and 8 
Kinetic parameters for dioxygen activation for the formation of 7 and  8 were obtained from Eyring plots 
of ln(k/T) vs 1/T from experiments conducted at 203 K, 193 K, 183 K and 173 K for 7 (Fig. 5.20 left) and 
193 K, 183 K and 173 K for 8 (Fig. 5.20 right). The generally reported activation enthalpy for oxygenation 
of copper(I) complexes is rather small (ΔH‡on ≈ 5 to 10 kcal mol-1), and usually in conjunction with an 
unfavorable activation entropy (ΔS‡on ≈ -14 to 2 cal K-1 mol-1).[79] 
 
 
The activation enthalpies, ΔH‡ for the formation of 7 and 8 were calculated at 2.77 ± 0.64 kcal mol-1 (Fig. 
5.20 left) and 3.68 ± 0.3 kcal mol-1 (Fig. 5.20 right) respectively. These rather small values are indicative of 
a low barrier, which is representative of a diffusion controlled process. Structural elucidation of the 
copper(I) complexes, 3 and 4 display the copper(I) centers to be coordinated by the capping ligand and an 
acetonitrile moiety, with low steric hindrance around the metal. This would permit direct attack of dioxygen 
on the vacant coordination sites around the copper center with high feasibility and low inhibition, thus 
resulting in an almost barrier free process. The slightly higher ΔH‡ values that have been reported for 
synthetic Cu/O2 systems mainly comprise tridentate ligands, which are bulkier in nature in comparison to 
the bidentate BOX ligands. This results in a higher steric bulk around the metal, leading to larger 
magnitudes of activation enthalpy.






The unfavorable activation entropies ΔS‡ of -47.9 ± 3.4 calK-1mol-1 for the formation of  7, and -39.2 ± 2 
calK-1mol-1 for the formation of 8 can be explained by the thermolability of the system, along with the steric 
bulk of the methyl groups on the oxazoline ring. The strong negative entropies result in the rates being 
entropically controlled. Thus, the rate of dioxygen binding to the Cu(I) complexes in solution (0.098 min-1 
for 7 and 0.54 min-1 for 8) is rather slow. The associative mechanism reflected in the large negative 
magnitudes of ΔS‡ is suggestive of fewer degrees of freedom available for energy distribution after dioxygen 
binds to the copper site. Table 5.3 gives an overview of the activation parameters for the formation of  SP 








The entropically most disfavored reaction for p-Tol,HP (7) is reflected in its kobs, which is the smallest in 




In summary, the Cu(I) complexes of ligands HL1, HL2, HL5 and L6 were prepared and characterized with 
structural elucidation in case of  HL1, HL5 and L6. The former two exist solely in their monomeric forms 
in the solid state, while the latter coexists with its dimer. The dioxygen reactivity of all Cu(I) complexes 
mentioned above generated their dicopper(II) (µ-η2:η2-O2) complexes.  This was investigated in detail in 
solution. The SP complex of HL2 was successfully characterized via X-ray crystallography, which 
unambiguously determined the binding mode of dioxygen within the complex. Moreover, the O-O bond 
length measured herein is the longest in any biological or synthetic analogue.  
The new ligand system L6 which was introduced to extend the range of BOX ligand scaffolds and study 
their impact on Cu/O2 chemistry, proved to be quite successful. The dicopper(II)  (µ-η2:η2-O2) complex was 
characterized both in solution and in the solid state. UV-vis spectroscopic features along with data obtained 
from rR studies were shown to be consistent with other reported SP complexes. Magnetic measurements 
revealed  very strong antiferromagnetic coupling between the two cupric ions, as is expected for SP 
complexes. Final determination of the dioxygen binding mode was elucidated by X-ray crystallography 
measurements. The O-O bond length of SP complex with L6 was also unusually long, but this did not 
translate into any unusual O-O stretching vibration (as observed in rR measurements).  
SP -Complex ΔH‡  
 kcal mol -1 
ΔS‡   
cal K-1 mol-1 
 
p-TolP (7) 2.77 ± 0.64 -47.9 ± 3.4 This work 
Me,MeP (8) 3.68 ± 0.3  -39.2 ± 2 This work 
    






Thus, two new SP complexes were structurally characterized during the course of this work. It should be 
noted that structural characterization of synthetic SP analogues is a challenging task, and only a hand-full 
of examples are known in literature.  
The kinetic and activation parameters for the formation of SP complexes with the new ligand systems HL5 
and L6 were also determined. The electronic effect of the methyl group introduced in the design of HL5 
was found to have a significant impact on the Cu/O2 system, which was observed in its kobs value.  
In conclusion, bis-oxazoline ligands are simple and bidentate in nature. Termed as a privileged class of 
ligands, they have been extensively used in asymmetric catalysis but not explored in small molecule 
activation. Their use in Cu/O2 chemistry has proved to be of significant benefit, which is reflected in their 
capacity to lead to crystalline SP complexes, a challenging task. This makes this class of ligands privileged 
in the field of bio-inorganic chemistry as well. Moreover, the simplicity and proton responsive nature of 
the ligand systems has led to insights into the plausible mechanism of substrate reactivity and equilibrium 
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The proton responsive BOX ligands that were previously synthesized demonstrated reversible dioxygen 
binding to form their µ-η2:η2-peroxodicopper(II) complexes. Spectroscopic characterization of the adducts 
in solution and in the solid state confirmed these to be SP systems.[71] Furthermore, evidence that certain 
free bis(oxazoline)s, R,HBOX exist as an equilibrium mixture between the diimine and iminoenamine 
tautomers, suggested that R,HBOXs may serve as proton responsive ligands.[65] The iminoenamine tautomer 
is reminiscent of β diketiminates that have been extensively used as anionic ligands after deprotonation.[174] 
With that in mind, two new monoanionic-bidentate ligands, [L2]- and [L3]-, were synthesized from their 
protonated counterparts as lithium salts to study the electronic effects on Cu/O2 chemistry.  





6.2 Synthesis and characterization of Copper(I) complexes with mono-anionic BOX ligands [L2]-  and 
[L3]-  
Ligands [L2]- and [L3]-  were individually treated with 1.1 equivalents of tetrakis(acetonitrile)copper(I) 
perchlorate in THF to yield air sensitive yellow and blue green colored solutions of their Cu(I) complexes 
(13 and 14) respectively (Scheme 6.1). ESI-MS analysis of the yellow copper(I) complex 13 in THF (Fig 
6.2 left), revealed one major peak belonging to ([L2]- Cu(I)(MeCN)2Li)+ (m/z = 376.1). The two other peaks 
could be assigned to ([L2]- Cu(I)(MeCN)H)+ (m/z = 328.1) and [([L2]-)2Cu(I)]+ (m/z = 509.1). ESI-MS 
analysis of the blue-green copper(I) complex 14 in THF (Fig 6.2 right), revealed one major peak belonging 





Figure 6.1 New monoanionic-bidentate ligand systems [L2]- and [L3]- employed in the present study of copper dioxygen 
chemistry. 
Scheme 6.1 General scheme for the synthesis of 13 and 14. 
 






The diamagnetic nature of complexes 13 and 14 enabled 1H-NMR spectroscopy as a means of 
characterization, Fig. 6.3 (for 13) and Fig 6.4 (for 14). The well resolved signals with corresponding 
integrals indicate a high symmetry for both the molecules in solution. The complexes were also analyzed 












Figure 6.2 Left: ESI-MS of 13 in THF. The two major peaks could be assigned to the copper(I) complex of [L2]-, differing by 
an acetonitrile molecule, a lithium ion and a proton. The inset shows an enlargement of the peak at m/z = 376.1, together with 
a simulation of the isotopic pattern corresponding to [[L2]- Cu(I)(MeCN)2Li]+. Right: ESI-MS of 14 in THF. The two major 
peaks could be assigned to the copper(I) complex of [L3]-  and a proton, differing by an acetonitrile molecule. The inset shows 
an enlargement of the peak at m/z = 390.1, together with a simulation of the isotopic pattern, corresponding to [[L3]- 
Cu(I)MeCNH]+. 
Figure 6.3 1H NMR spectrum of 13 in THF-d8 at 293 K. Solvent molecules marked with . 
 







6.3 Dioxygen reactivity of 13 and 14 at low temperatures to yield Cu/O2 intermediates 












Figure 6.4 1H NMR spectrum of 14 in THF-d8 at 293 K. Solvent molecules marked with . 
 
Scheme 6.2 General scheme for the activation of dioxygen with 13 and 14 to form 10 and 11, respectively, in THF 
solution at 193 K. 




6.3.1 Structural elucidation of a rare neutral dicopper(III) bis(µ-oxo) complex (10) 
Single crystals of 10 suitable for X-ray diffraction were grown by slow diffusion of Et2O into a 1:1 
MeTHF:pentane solution at 193 K which unambiguously confirmed O2 to bind in a bis(µ-oxo) fashion. 10 
reveals a molecular structure with a D2 symmetry in the solid state. Each copper ion is bonded to one 
bidentate ligand [L2]- and two bridging oxo atoms (Figure 6.5 left), making the complex neutral. Though 
most bis(µ-oxo) dicopper (III) complexes display a rather square planar geometry, in case of 10, the N1-
Cu-N2 and O3-Cu-O4 coordination planes (of each coppe center) are twisted at an angle of 24.5º, causing 
a tilt between the two copper coordination planes (Fig. 6.5 right). This tilt deviates the overall complex 
from bearing an ideal square planar geometry, as would be expected for Cu(III) ions bearing a coordination 
number of four. Of the few crytallographically characterized bis(µ-oxo) dicopper (III) complexes, most of 
them are dicationic or monocationic in nature, with only one neutral complex being reported till date (Table 
6.1). The Cu···Cu bond distance of 2.86 Å in 10 is rather long compared to other synthetic analouges, with 
the O···O non bonding interaction being 2.23 Å, the shortest ever reported. In comparison to the SP isomers 
(4 and 8), which were also sucessfully crystallized during the course of this work, the two Cu-N bonds (1.91 
Å) and the two Cu-O bonds (1.82 Å) are significantly shorter, as expected for the higher metal oxidation 
state (1.95 Å and 1.91 Å for 4. 1.94 Å and 1.92 Å for 8). Theoretical studies by Solomon et al. on moleculer 
orbitals of the SP/O isomers has shown that scission of the O-O bond from the SP isomer forming the O 
congener results in the formation of a filled low energy bonding σ* orbital (refer to figure 2.11 of 
introduction). Interaction of this orbital with the Cu-dxy orbitals is the source of increased bond strength and 
covalency in O complexes compared to their SP analogues.[226,227] The Cu∙∙∙Cu bond length (2.86 Å), and 
the O∙∙∙O separation (2.23 Å) in 10 also suggests the O form to be more compact in comparison to the SP 
form. Structural evidences revealed the absence of any axially bound ligand to the copper centers, unlike 
that observed in the SP counterpart. This implies that the anionic scaffold in conjunction with the oxo ligand 
suffice the coordination sphere of the copper centers with respect to number, and electronic requirements. 
The combined data clearly indicate that the intermediate is indeed [([L2]-)2Cu2(µ-O)2], the second 
structurally characterized ‘neutral’ bis(µ-oxo) dicopper(III) complex reported to date.[171]  
 
Figure 6.5 Left: Plot (30% probability thermal ellipsoids) of the molecular structure of 10 (hydrogen atoms and solvent 
molecules omitted for clarity). Selected distances [Å] and angles [°]: Cu1–O3 1.8196(16), Cu1–O4 1.8204(15), Cu1–N1 
1.909(2), Cu1–N2 1.909(2), Cu1∙∙∙Cu1' 2.8706(6); O3–Cu1–O4 75.89(9), O3–Cu1–N1 97.49(9), O4–Cu1–N1 161.38(8), O3–
Cu1–N2 161.19(7), O4–Cu1–N2 97.30(9), N1–Cu1–N2 93.98(9), Cu1–O3–Cu1' 104.15(13), Cu1–O4–Cu1' 104.08(12). 
Symmetry transformation used to generate equivalent atoms: (') x, ½–y, ½–z. Right: Side view of 10 demonstrating the tilt 


















UV-vis; λ, nm 















iPr4dtne SbF6- CH2Cl2 2.783 2.351 XRD 316(13), 414(14) 600(582) [169] 
LME CF3SO3- CH2Cl2 2.743 2.344 XRD 306(21), 401(28) 610(23) [168] 
[But2P(NSiMe3)2]- a Pentane 2.906 2.338 XRD 315(sh), 444(10)  [171] 
Me2tpa PF6- Acetone 2.758 2.32 XRD 378(22) 
494(0.33) 
590(26) [167] 
iPr2/TMPDc CF3SO3 THF 2.849 2.30 XRD 398(17) 653(28) [176] 




aNeutral complex, bFermi doublet, c Assembeled in a stepwise process from [(HMe2LiPr2)Cu(O2)] and [(LTMPD)Cu(MeCN)]+ 
 





6.3.2 Properties in solution 
Oxygenation of 13 and 14 at 193 K in THF resulted in dark green colored solutions of [([L2]-)2Cu2(µ-O)2] 
(10) and  [([L3]-)2Cu2(µ-O)2] (11) (Scheme 6.2)  in a matter of seconds. Optical features at 297 nm (ε ≈26800 
M-1cm-1 ), 333 nm (ε ≈ 7440 M-1cm-1 ) and  395 nm (ε ≈ 10140 M-1cm-1) for 10 (Fig. 6.6 left) and 287 nm 
(ε ≈ 36720 M-1cm-1 ), 337 nm (ε ≈ 13620 M-1cm-1 ) and  397 nm (ε ≈ 10740 M-1cm-1) for 11 (Fig 6.6 right) 





These high intensity features are qualitatively similar to those of bis(µ-oxo) dicopper(III) species.[88,166,168] 
The former band at ~290 nm is most likely a ligand based transition. The latter two at ~333 nm and ~400 
nm resemble LMCT transitions. The band at ~333 nm has a similar origin to SP complexes and arises from 
an in plane overlap of the oxo πσ*  to Cu(III) dxy orbital.[93] In most cases, the intensity is far lower compared 
to the SP counterpart. The feature at ~ 400 nm is characteristic for the bis(µ-oxo) core, and is present when 
the O-O bond is cleaved. Absent in SP complexes, it originates from an in plane overlap of the new bonding 
σ* orbital of the bis(µ-oxo) ligand and the dxy orbital of copper (refer to sec. 2.3.3 of introduction, figure 
2.9).[93] In comparsion to other bis(µ-oxo) dicopper(III) complexes with both bidentate and tridentate ligand 
systems,[138,168,169,179,228] the molar absorbtivites exhibited by 10 and 11 are rather low. The dicopper(III) 
bis(µ-oxo) complex synthesized by Tolman et al. with beta-diketiminate ligands[174] exhibits a band at 380 
nm ( ε ~20,000  M-1cm-1) and 420 nm(5000 M-1cm-1 ) with  the feature at 380 nm being far more intense. 
An interesting trend in these CT transitions suggests that longer intermetal distances correlate with lower-
intensity transitions.[138,166,168,169,179,228] The crystallographically characterized motif of 10 displays a fairly 
Figure 6.6 Left: Formation of [([L2]-)2Cu2(µ-O)2] (10) in THF at 193 K monitored by UV/Vis spectroscopy. Formation of 
bands at 333 nm and 395 nm. Right: Formation of [([L3]-)2Cu2(µ-O)2] (11) in THF at 193 K monitored by UV/Vis 
spectroscopy. Formation of bands at 335 nm and 397 nm. 
 
Formation of [(HL1)2Cu2(µ-η2:η2-O2)] (2) in THF at 193K monitored by UV/Vis spectroscopy. Formation of bands at 333nm 
and 500nm. Inset formation of the band at 333nm with time. 
 
 




long Cu···Cu bond distance of 2.86 Å (Fig 6.5) and is in accordance with this observation. In analogy, the 
only other neutral bis(µ-oxo) system apart from 10, reported by Hoffman et al.[171] with the aid of anionic 
imidophosphanamide ligands (refer to sec. 2.3.3 of introduction), displays similarly low intensities for the 
two bands. A reason for 10 and 11 to exhibit the same trend could be the high basicity of the monoanionic 
BOX liagnds with nitrogen donors compared to other ligands employed in Cu/O2 chemistry.  Both CT 
bands are relatively low in energy for LMCT transitions.[171] This fact along with the intensities is suggestive 
of a high degree of Cu-O covalency. In comparison to their  protonated counterparts HL2 and HL3, [L2]- 
and [L3]-  essentially have the same ligand environment but lack a proton in the backbone. This peripheral 
deprotonation causes electronic differences in the ligand scaffold making these deprotonated forms more 
anionic and suitable to support the +3 oxidation state of copper.  Thus preferably the bis(µ-oxo) 
intermediates form with these basic anionic ligands as opposed to the µ-η2:η2 peroxo intermediates. 
Exchanging the solvent to CH2Cl2 or acetone did not result in the formation of the bis(µ-oxo) species. 
 
 
6.3.3 Resonance Raman Spectroscopy 
Further evidence confirming the formation of a dicopper(III) bis(µ-oxo) species was obtained by resonance 
Raman (rR) spectroscopy with a laser excitation of 633 nm. 1:1 THF:pentane solutions of 13 and THF 
solutions of 14 were exposed to naturally abundant (16O2)  or isotopically labelled dioxygen (18O2) at 193 
K and 77 K respectively in young NMR tubes. Solutions of 10 in a dry-ice/acetone bath revealed only one 
oxygen isotope sensitive feature seen with a single peak at 598 cm-1 which shifted to 572 cm-1 on labelling 
(Δ16O-18O = 26 cm-1) (Fig 6.7 left); the corresponding feature for 11 was found at 601 cm-1 and 573 cm-1  
(Δ16O-18O = 28 cm-1) (Fig 6.7 right). These features have been assigned to the Cu2(µ-O)2 core vibration and 
are signature breathing modes of the O core.[145] In several other bis(µ-oxo) dicopper (III) systems, having 
bidentate and tridentate ligands, often more than one oxygen isotope sensitive feature is obsereved on rR 
analysis.[88,168,179] Normal modes of vibration for a D2h Cu2O2 core from normal coordinate analysis reveal 
two ag modes being Raman active in nature (118.6 cm-1 (ν1 ) and 611.5 cm-1  (ν3)).[93] The additional isotope 
responsive features have been assigned as difference and combination bands between the fundamentals ν1 
and ν3.  In case of complexe 10 however, though it exhibits a D2h Cu2O2 core, most probably the difference 
and combination bands have a rather low intensity and are thus not observed in the rR spectra. In 
comparison to other related [M2(µ-O)2]3+ units (M= Fe or Mn),[229–231] the vibrational mode of the oxo core 
is observed around 660-700 cm-1. These slightly higher values result from a combination of factors such as 
the small mass and high charge of the metal centers, and changes in the M-O-M angles. Several O2 isotope 
independent peaks were also observed in the rR spectra of complexes 10 and 11 in the 450-550 cm-1 region. 
These could be assigned to the Cu-N stretching modes and have shown to be highly ligand dependent.[93]  
There was no evidence of the side on peroxo dicopper(II) species which is expected to exhibit the O-O 








   
 
6.3.4 1H NMR Spectroscopy 
The +3 oxidation state of the copper centers in dicopper(III) bis(µ-oxo) complexes makes them EPR silent 
and diamagnetic in nature.[138] This enabled 1H-NMR spectroscopy as a means of characterization for 10 
and 11 in solution. Solutions of 13 and 14 were individually prepared in THF-d8 and exposed to dioxygen 
at 193 K in Young NMR tubes. Low temperature 1H-NMR spectra were measured at 193 K which enabled 
assignment of the peaks as shown in figure 6.8 for 10 and figure 6.9 for 11. The chemical shifts associated 
with the starting material, the Cu(I) complexes are absent in these solutions, suggesting total conversion to 
the dicopper(III) bis(µ-oxo) species. The small change in shifts signify the absence of paramagnetic 
contributions ruling out the formation of potential SP complexes. For complex 10, the copper bis(µ-oxo) 
complex of ligand [L2-], the signals at 1.21 ppm assigned to the CMe2 groups, and 3.77 ppm assigned to the 
Me group in the ligand backbone (Fig. 6.3) shift downfield by 0.17 ppm in complex 13 Cu (I) complex of 
ligand [L2-] (Fig. 6.8). The protons for the CH2 groups however shift upfield from 1.68 ppm to 1.58 ppm. 
These changes in δ values could be explained by the change in electron density over the ligand scaffold. 
The external binding of the bis(µ-oxo) ligand to the copper centers increases their oxidation state from +1 
to +3, resulting in an increase in electron deficiency over the metal centers. This stimulates an increase in 
the extent of overlap between the anionic ligands and the copper centers, causing a shift in the overall 
electron distribution and a change in δ values. The sharp clean peaks present with chemical shifts between 
0-10 ppm clearly indicate the compounds to be diamagnetic bis(µ -oxo) dicopper(III) complexes.  
 
 
Figure 6.7. Left:  Resonance Raman spectrum of 10 in a 1:1 THF:pentane solution at 193 K. 16O2 spectrum indicated in black 
and  18O2 indicated in red. Residual solvent signals are marked with an asterisk (*). Right: Resonance Raman spectrum of 11 
in a THF solution at 77 K. 16O2 spectrum indicated in black and 18O2 indicated in red. Residual solvent signals are marked 









Figure 6.8 1H NMR spectrum of 10 in THF-d8 at 193 K. Solvent molecules marked with . 
 
Figure 6.9 1H NMR spectrum of 11 in THF-d8 at 193 K. Solvent molecules marked with . 
 




6.4 The effect of temperature on the bis(µ-oxo) core 
The CT features executed by bis(µ-oxo) dicopper(III) complexes makes it convenient to characterize these 
intermediates in solution. The transition arising from πσ* bis(µ-oxo) to the Cu(III)dxy orbital is expressed 
between 300-350 nm, and that of σ* bis(µ-oxo) to Cu(III)dxy is expressed around 400 nm, the latter being 
characteristic of the bis(µ-oxo) core. Complexes 10 and 11 were characterized in THF solutions at 193 K, 
where both expressed similar transitions. In case of 10, the transitions at 333 nm and 395 nm had an intensity 
ratio of 1:1.3 (333:395, Fig 6.6 left) and for 11  at 337 nm and 397 nm with an intensity ratio of 1:0.7 
(337:397, Fig 6.6 right). These bis(µ-oxo) species revealed an interesting effect with temperature variation.  
On warming a solution of 10 from 193 K to 243 K, the band at 333 nm started to increase in intensity 
whereas that at 395 nm started to decrease as obsereved by UV-vis spectroscopy (Fig 6.10 left). The ratio 
of the two bands changed from 1:1.3 to 1:0.8 (333:395), with the band at 333 nm being higher than that of 
395 nm (Fig 6.10 left inset).  Maintaing the solution at 243 K for a substantial duration of time revealed no 
further changes in the spectra. Successive cooling of the solution from 243 K back to 193 K revealed the 
spectra to regain its original form (Fig. 6.10 right). The ratio of the two bands reverted back to 1:1.3 (Fig. 
6.10 right inset) and the spectrum obsereved on initial formation of the complex was restored. 
 
 
Figure 6.10 Top: UV-vis spectroscopic features of 10 with characteristic bands at 333 nm and 395 nm at 193 K. Left: 
Temperature variation from 193 K to 243 K depicting a gain in intensity at 333 nm, with a loss in intensity at 395 nm. Inset 
shows the final spectra at 243 K. Right: Spectra obtained on cooling down the solution from 243 K to 193 K. Resultant spectra 
obtained at 193 K is shown in the inset. 







The change in the intensity of the two bands with temperature (333 nm and 395 nm) for complex 10 is 
depicted in figure 6.11, also showing the reversibility. A slight loss in overall absorbance of both the bands 
when reverting back from 243 K to 193 K indicates a possible onset of decomposition of the complex on 
warming the solution. 
 
The same phenomenon was observed for 11, as well as for bis(µ-oxo) complexes formed from their 
respective SP counterparts with a base (complexes 9 and 12, refer to Chapter 7). In case of 10 and 11, rR 
spectra of their frozen solutions revealed only one oxygen sensitive isotope feature belonging solely to the 
O isomer (Fig. 6.7). Moreover, characterization of these complexes via low temperature 1H NMR 
spectroscopy gave rise to clean sharp signals between 0-10 ppm indicative of diamagnetic species within 
solution (Fig. 6.8 and 6.9). Additionally, DOSY NMR of 10 at 193 K in THF-d8 revealed only a single 
species in solution. These results suggest the absence of any SP species.  
In order to investigate weather solvent binding/dissociation occurs with temperature, a VT-1H NMR studies 
of complex 10 between 193 K and 243 K was analyzed (Fig 6.12 and 6.13). The spectra obtained 
demonstrated no major shift in peaks of the bis(µ-oxo) dicopper (III) complex, except for a slight 
broadening as a result of change in viscosity of the deuterated solvent at low temperatures. Additionally, 
no new peaks appeared on warming or cooling of the solution.  This implied that spectroscopic changes 
with temperature variation did not result from solvent binding/dissociation and corroborates the absence of 





Figure 6.11 Plot of the absorbance of bands at 333 nm(blue) and 395 nm(red) for 10 on warming up (193 K to 243 K) and 
cooling down (243 K to 193 K). 











Figure 6.12 Left: VT-1H NMR spectra of 10 on warming up from 193 K to 253 K. As evident no new peaks or shifts in peaks 
were observed. Right: UV-vis monitoring of 10 on warming up. 
Figure 6.13 Left: VT-1H NMR spectra of 10 on cooling from 243 K to 173 K. As evident no new peaks or shifts in peaks were 
observed. Right: UV-vis monitoring of 10 on cooling down. 




For the O complex 12 that was formed from its SP counterpart by a base (Scheme 6.3; fig 6.14 left; refer 
also to chapter 7), a similar change in intensity of the bands at 337 nm and 398 nm was observed with 
temperature variation (Fig 6.15). A plot of the change in absorbance of both the bands (337 nm and 398 
nm) showed no alteration with excess base (Fig 6.14 right). This demonstrates complete deprotonation of 
the SP species with the resultant spectra belonging solely to the O complex. Both these findings from 
systems 10 and 11 of monoanionic ligands, and 9 and 12 obtained by deprotonating their SP complexes 
imply that within solution there exists only the O isomer. Thus one can rule out the effect of temperature 













Figure 6.14 Left: UV-vis spectroscopic features on the O complex 12 (green) being formed from it SP counterpart 7 (purple) 
in solution by a base. Right: Plot of change in absorbance of bands at 337 nm (blue) and 398 nm (red) with addition of 
equivalents of base, depicting no further change in the presence of excess base. 
Scheme 6.3. O complex 12 being formed from its SP counterpart 7 by a base. 






Since the effect of temperature has been ruled out as an extension of equilibrium between SP and O isomers, 
the change in absorbance of the bands could be explained as follows. X ray characterization of complex 10 
(Fig 6.5) reveals it to be rather twisted than planar. Plausibly, the average degree of this twist could depend 
upon temperature variation. On warming the solution from 193 K to 243 K, a change in the degree of twist 
leads to a change in the extent of overlap between the bis(µ-oxo) ligand and metal orbitals (Refer to fig. 2.9 
of introduction). The πσ* orbital of the oxo ligand decreases in energy at 243 K relative to that at 193 K, 
resulting in a higher degree of overlap with the Cu-dxy orbitals. This increase in orbital overlap results in a 
higher intensity of transition at 333 nm. Contrastingly, the low energy bonding σ * orbital, which shows a 
high-intensity transition at 400 nm in O complexes 10 and 11, tends to increase in energy. This results in a 
decrease in orbital overlap between the Cu-dxy and σ * orbital of the oxo ligand, leading to a loss in intensity 
of the band at 400 nm. On cooling the solution down again to 193 K, the initial degree of twist within the 
complex is regained, with the ligand and metal orbitals reorienting themselves to their original forms. Thus 
the spectra obtained on initial formation of the complex is restored. It is noteworthy to mention that though 
a large number of studies have been conducted on several O complexes with different ligand classes, the 
Figure 6.15 Left: Temperature variation of 12 in solution from 193 K to 243 K depicting a gain in intensity at 337 nm, with a 
loss in intensity at 398 nm. Inset, final spectra at 243 K Right: Spectra obtained on cooling down the solution again from 243 
K to 193 K. Resultant spectra obtained at 193 K depicted inset. 
 
Figure 6.16 Plot of the absorbance of bands at 337 nm(blue) and 398 nm(red) for 12 on warming up (193 K to 243 K) and 





effect of temperature on the bis(µ-oxo) core has not yet been reported. 
 
6.5 Conclusion 
In conclusion, the two new ligands [L2]- and [L3]-, which had been introduced to extend the range of BOX 
ligand scaffolds on Cu/O2 chemistry could indeed find application in this research. As was demonstrated in 
chapter 5, the protonated counterparts of [L2]- and [L3]- gave rise to their respective SP complexes with their 
Cu(I) analogues and dioxygen at low temperatures. However, the deprotonated form of these ligand 
generate their respective O complexes from their Cu(I) analogues and dioxygen at low temperatures.  
Peripheral deprotonation of the ligands forms scaffolds that are strong donors, capable of supporting the +3 
oxidation state of copper as opposed to +2. This increased Lewis basicity of the ligands leads to their 
preferential formation of bis(µ-oxo) dicopper(III) intermediates. 
The two new Cu(I) complexes 13 and 14 were characterized in solution via 1H NMR spectroscopy and ESI-
MS. Their corresponding O complexes 10 and 11 were fully characterized in solution. UV-vis features, rR 
data and low temperature 1H NMR studies evidence the formation of dicopper(III) bis(µ-oxo) complexes. 
The unambiguous binding mode of dioxygen was confirmed by the structural characterization of complex 
10. The measured copper-ligand bond lengths were observed to be shorter than in its corresponding SP 
analogue 6, as is expected. Moreover, 10 is a rare example of a neutral bis(µ-oxo) dicopper(III) synthetic 
system that has been structurally characterized, only the second of its kind to be reported to date. 
In addition to the characterization of these novel Cu/O2 intermediates in solution and in the solid state (for 
10), an additional effect of temperature on the bis(µ-oxo) core was investigated. Temperature variation as 
analyzed by UV-vis spectroscopy revealed a change in intensity of LMCT bands for both the bis(µ-oxo) 
dicopper(III) complexes generated from their deprotonated ligands (10 and 11) as well from their SP 
analogues by virtue of a base (9 and 12, refer to Chapter 7). This was explained by a plausible fluxional 
twist of the complex with temperature. A temperature change may result in a change of the average degree 
of twist, resulting in a change of the extent of orbital overlap between the oxo ligand and the copper centers. 
Moreover, this change is reversible in nature. rR data, VT-1H-NMR spectroscopy as well as analysis of the 
UV-vis spectra after deprotonation (for O complexes generated from their SP congeners), suggests the 
absence of any potential SP complex within the solution, thus ruling out temperature variation to effect the 
equilibrium between the SP/O isomers.  
Though the O isomer has yet shown to be of biological relevance, its existence in equilibrium with the SP 
counterpart has raised pertinent questions with respect to the active intermediate responsible for catalytic 
activity in enzymes such as CO and Ty. Most recently, a bis(µ-oxo) dicopper(III) intermediate has been 
proposed for the active site of the pMMO enzyme responsible for methane monoxygenation, highlighting 
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In comparison to the SP isomer that has been synthetically investigated in great detail by a large number of 
groups[38] and also proved to be the O2 binding mode of the active site of Hemocyanin,[42] the O isomer, a 
second Cu/O2 intermediate has yet to be biologically discovered. Its first observation in 1996 by Tolman et 
al. led to further investigations of this binding motif which revealed it to be in rapid equilibrium with the 
SP isomer (Fig. 7.1).[88,132] Detailed theoretical calculations by Solomon et al. on various systems has 
established a rapid equilibrium between the two isomers to be attributed to a flat potential energy surface 
of interconversion.[93] Moreover, the large extent of backbonding in the SP isomer that is observed in its 
fairly low rR stretching frequency triggers the reductive cleavage of the O-O bond, en route to the O species. 
Several factors such as solvent, counterion, ligand steric demands, and temperature have proved to control 






In Chapter 5, the Cu(I) complexes of proton responsive ligands HL1, HL2, and HL5 were shown to bind 
dioxygen at low temperatures in a µ-η2:η2-peroxo binding mode. These complexes were characterized in 
solution as well as in the solid state (6), which confirmed them to be SP complexes. The following section 
describes two new factors previously unknown to have an influence on the equilibrium between these SP 
and their corresponding O complexes. All equilibrium studies have been conducted with proton responsive 
ligands HL1, HL2, HL5 and ligand system HL3 (Fig. 7.2, the dioxygen reactivity of Cu(I)HL3 was 








Fig 7.2 Proton responsive ligands HL1, HL2, HL3 and HL5 that have been employed in equilibrium studies between SP/O 
complexes.  
Fig 7.1 Equilibrium demonstrated by SP/O isomers. 




7.2 Equilibrium studies between SP/O complexes of proton-responsive BOX ligands with “pH” 
 
7.2.1 Tuning the equilibrium by virtue of a base 
Addition of dioxygen to Cu(I) complexes of ligands HL1, HL2, HL3 and HL5 at 193 K resulted in purple 
colored solutions of their SP complexes within a matter of seconds (Refer to Chapter 5, Sections 5.3 for 
HL1, HL2 and HL5, SP complex of ligand system HL3 was characterized in a previous project[71]). Addition 
of an external base to these purple colored solutions resulted in an immediate color change from purple to 
dark green. The reactions were conducted at 193 K and the green colored solutions persisted with time. On 
UV-vis monitoring of these reactions, interesting changes in the SP spectra were observed. With gradual 
addition of the base, the band at 333 nm gradually started to decrease in intensity and two completely new 
bands at ~290 nm and ~400 nm started to form. The weak band at ~500 nm characteristic of SP complexes 
no longer persisted. On completion of the reaction the resulting spectra exhibited three bands at ~290 nm, 
~333 nm and ~400 nm, which differed in intensity depending upon the ligand system used (Figs. 7.3-7.6). 
Addition of excess base to these reaction mixtures led to no further changes in the spectra. 
On conducting the similar reaction with the SP complex of the non-proton responsive ligand L6, addition of 
a base resulted in a color change from purple to yellow rather than purple to green (contrary to what was 
observed with proton responsive ligands). Monitoring this reaction via UV-vis spectroscopy did not result 
in any new band formation at ~400 nm but resulted in decomposition of the complex (Fig. 7.7).  
Several bases such as DBU, NEt3, n-BuLi, KOtBu, and NaOtBu were screened to investigate the reaction 
for SP complexes with proton responsive ligands. All bases resulted in similar spectral changes indicating 
the reaction to be independent of the nature of the base. The difference in reactivity between the systems 
HL1, HL2, HL3, HL5 with L6 was attributed to their proton responsive and non-proton responsive nature to 
an external base and essentially the process of deprotonation of the ligands resulted in spectral changes.  
On detailed analysis of the UV-vis spectra formed after deprotonation and in comparison to the spectral 
features of other Cu/O2 intermediates at low temperatures, the new species were assigned to as O 
intermediates of the deprotonated BOX ligands. The spectral features at ~333 nm and ~400 nm are similar 
to those of other O complexes reported in literature. The band at ~400 nm that forms on the process of 
deprotonation is characteristic of O complexes and present only when the O-O bond is cleaved.  
The rationale behind this process of interconversion is as follows. Addition of an external base to SP 
complexes of proton responsive ligands leads to deprotonation within the ligand backbone. This peripheral 
deprotonation causes a change in the electronic properties of the ligand scaffold resulting in the ligand to 
attain a more Lewis basic character. The additional negative charge over the ligand triggers the cleavage of 
the O-O bond within the peroxide complex, converting the peroxide ligand to an oxide motif with 
simultaneous change in the copper oxidation state from +2 to +3. This cleavage of the O-O bond results in 
the formation of a completely new band at ~400 nm. The strong Cu-O bond, and the absence of backbonding 
within the O isomer stabilizes these complexes. This hypothesis in conjunction with the fact that the 
interconversion fails with the non-proton responsive ligand system L6, supports the new species to be O 
intermediates.  Final confirmation of this binding mode was attained on systems wherein the proton 
responsive ligands HL2 and HL3 were already deprotonated to generate ligands [L2]- and [L3]-. Addition of 
dioxygen to the Cu(I) complexes of [L2]- and [L3]- at low temperatures resulted in direct formation of their 
O isomers. These were characterized in detail along with structural elucidation for the O complex with [L2]-
, which unambiguously confirmed the oxygen to bind as a bis(µ-oxo) motif (refer to Chapter 6). 




Figures 7.3 - 7.6 demonstrate the spectroscopic changes of the SP complexes of HL1, HL2, HL3 and HL5 
with DBU as an external base (Scheme 7.1). A total of around 1.2 equivalents of base per dinuclear copper 
species was required for complete deprotonation of all SP complexes.  A plot of the change in absorbance 
of the two bands at ~ 333 nm and ~ 400 nm with excess base is shown in the inset for each system. Table 
7.1 describes the optical features with molar absorbtivities and intensity ratios for the SP and O complexes 














Figure 7.3 Left: SP complex of HL1 (5) in black; gradual titration of DBU resulting in the formation of O complex 9 with 
bands at 392 nm and 282 nm arising, and that at 335 nm decreasing in intensity. Shown in the inset is a plot of the change in 
intensity of bands at 335 nm and 392 nm with equivalents of base.  Right: SP complex of HL1 (5) in black with its O complex 
(9) in red after complete deprotonation. Shown in the inset is the schematic representation of the interconversion from 5 to 9.  
Scheme 7.1 Schematic representation of the interconversion between SP and O complexes of proton responsive ligands by 
virtue of a base (DBU). 










Figure 7.4 Left: SP complex of HL2 (6) in black; gradual titration of DBU resulting in the formation of O complex 10 with 
bands at 395 nm and 296 nm arising, and that at 335 nm decreasing in intensity. Shown in the inset is a plot of the change in 
intensity of bands at 335 nm and 395 nm with equivalents of base.  Right: SP complex of HL2 (6) in black with its O complex 
(10) in red after complete deprotonation. Shown in the inset is the schematic representation of the interconversion from 6 to 
10. 
Figure 7.5 Left: SP complex of HL3 in black; gradual titration of DBU resulting in the formation of O complex 11 with bands 
at 397 nm and 288 nm arising, and that at 336 nm decreasing in intensity. Shown in the inset is a plot of the change in intensity 
of bands at 336 nm and 397 nm with equivalents of base.  Right: SP complex of HL3 in black with its O complex (11) in red 
after complete deprotonation. Shown in the inset is the schematic representation of the interconversion from SPHL3 to 11. 
 












Figure 7.6 Left: SP complex of HL5 (7) in black; gradual titration of DBU resulting in the formation of O complex 12 with 
bands at 398 nm and 293 nm arising, and that at 337 nm decreasing in intensity. Shown in the inset is a plot of the change in 
intensity of bands at 337 nm and 398 nm with equivalents of base.  Right: SP complex of HL5 (7) in balck with its O complex 




Figure 7.7 Addition of DBU to SP complex of non-proton responsive ligand L6, leading to decomposition of the complex with 
no new band formation at ~ 290 nm or ~ 400 nm. 




7.2.2 Reverting the equilibrium with an acid 
In order to test the reversibilty of the equilibrium demonstrated above, various Lewis acids such as 
HLutOTf, HLutBF4, [HLut: lutidinium], HBF4·Et2O, [Et2OH]BArF- were titrated into the O solutions of 
complexes 9-12 (Fig. 7.8 and 7.9). Unfortunately, addition of an external acid/H+ did not revert the 
equilibrium back to the SP isomer, but led to gradual decomposition of the corresponding O complexes. 
The reactions were monitored via UV-vis spectroscopy which demonstrated a gradual decrease in the 





Figure 7.8 UV-vis monitoring of the adddition of HLutOTf to O complex 10 demonstrating decomposition. 
Figure 7.9 Left: UV-vis monitoring of the adddition of HBF4·Et2O to O complex 11 demonstrating decomposition. Right: 
UV-vis monitoring of the adddition of  Et2OH+BArF-  to O complex 12 demonstrating decomposition. 




Analysis of the solution after the addition of an acid via ESI-MS did not yield major insights into the nature 
of the decomposed product. In most cases, the  dominant major peaks corresponded to the base used for 
deprotonation and the ligand system. No peaks corresponding to a dicopper(II) bis(µ- hydroxo) species 
were observed. A potential hypothesis to this observation suggests that perhaps the proton preferentially 
attacks the oxygen centers of the bis(µ-oxo) core due to its high nucleophilicity, as opposed to the ligand 
backbone (Scheme 7.2). This inhibits the equilibrium to revert back from the O to the SP isomer.  
Protonation of the O species then leads to the formation of a dicopper(III) bis(µ-hydroxo) complex as a 
kinetic product, which, due to its high reactivity makes it difficult to isolate and observe. This instability 
leads to gradual decomposition as is observed when the bis(µ-oxo) complexes are protonated in solution. 
 










7.2.3 Cleavage of the O-O bond and insights into conversion 
Detailed theoretical investigation has led to insights into the mechanism of interconversion between SP/O 
complexes.[93] This explains comprehensively the differences in spectroscopic features between the two 
isomers. As described  in the MO diagram in figure 7.10, the UV-vis spectral features for SP complexes 
arise from an in plane and out of plane overlap of the π* peroxide and Cu dxy orbitals. Within the molecular 
orbitals of SP complexes, there exists an unoccupied high energy σ*u orbital. This orbital is antibonding in 
nature and participates in backcbonding with the filled Cu dxy orbitals. On cleavage of the O-O bond, this 
high energy unoccupied antibonding orbital becomes a new, low energy bonding orbital of the oxide ligand. 
This new donor orbital which is present only when the O-O bond is cleaved, gives rise to the characteristic 
σ*u to Cu dxy transition that is exhibited at ~400 nm for O complexes. As previously described in chapter 5, 
the rR features exhibited by SP complexes are rather low in comparison to what is expected, which is a 
result of backbonding between the Cu dxy and the σ*u  oribital. The process of O-O cleavage is an extension 
of this back-donation of electron density from the Cu dxy into the O22-  σ*u orbitals.  
 
 
Scheme 7.2 Plausible hypothesis for the decomposition of O complexes with proton responsive ligands with an acid. 
Protonation of the O intermediates forms a reactive bis(µ-hydroxo) dicopper(III) species that decomposes with time. 


















The high intensity optical features of the O complexes formed on deprotonation of their SP counterparts 
with proton responsive ligands are qualitatively similar to those of bis(µ-oxo) dicopper(III) species reported 
in literature.[88,166,168] Each of the O complexes, 9, 10, 11 and 12 exhibits three bands at ~290 nm, ~333 nm, 
and ~400 nm (Table 7.1). For a detailed molecular orbital explanation, refer to Chapter 6, section 6.3.2. 
 
7.2.4 Intensity ratio differences of O complexes  
The spectra of O complexes formed on deprotonation of their SP counterparts differ in intensity ratio of the 
bands at ~ 333 nm and ~ 400 nm (Table 7.1) 
The MO diagram (Fig. 7.10) for the isomerization of SP/O complexes reported by Solomon et al., describes 
the energetic crossover of the σ*u orbital from the SP to the O binding motif, resulting in the reductive 
cleavage of the O-O bond within the peroxde ligand, giving rise to two µ-oxo bridges.[93] This results in an 
increase in O···O bond length, with a simultaneous shortening of the Cu-O and Cu-N bond lengths. The 
shortening of these two bonds however, leads to a destabiliazation of the Cu dxy orbitals. 
In case of the bis(µ-oxo) MO energy levels, these two orbitals have crossed with the σ*u orbital being lower 
in energy compared to Cu dxy. Moreover, the ligand substituents for each system differ and this results in 
an overall electronic difference over their O systems.  A possibility for the different intensities of transition 
could be the relative difference in the crossover of the Cu dxy and the σ*u orbital in each case, in conjunction 
with a variation of orbital overlap between the metal and the bis(µ-oxo) ligand. 
 
Figure 7.10 Orbital correlation diagram for the SP/O isomerization.[93] 

















330 nm (ε = 7420 M-1cm-1) 
501 nm (ε = 450 M-1cm-1) 
282 nm (ε = 11980 M-1cm-1)  
335nm (ε = 5420 M-1cm-1)  





330 nm (ε =19113 M-1cm-1) 
500 nm (ε = 1350 M-1cm-1) 
296 nm (ε = 9850 M-1cm-1) 
335 nm (ε = 2910 M-1cm-1) 





332 nm (ε = 18920 M-1cm-1) 
501nm (ε = 1220 M-1cm-1) 
288 nm (ε = 28680 M-1cm-1) 
336 nm (ε = 9520 M-1cm-1) 





333 nm (ε = 4400 M-1cm-1) 
504 nm (ε = 360 M-1cm-1) 
293 nm (ε = 6850 M-1cm-1) 
337nm (ε = 1910 M-1cm-1)  
398 nm (ε = 1960M-1cm-1) 
 
1:1.03 
Table 7.1 Optical features of SP and O complexes with proton responsive BOX ligands. 




7.3 Equilibrium studies between SP/O isomers of proton responsive BOX ligands with stoichiometry 
 
Stoichiometric effects on Cu/O2 chemistry: The POP Switch! 
Described in the previous section, addition of an external base to SP solutions of proton responsive BOX 
ligands yields their corresponding O isomers. The reactions were monitored via UV-vis spectroscopy. In 
addition, deprotonated forms of the ligands HL2 and HL3 generate directly their O complexes with 
dioxygen and Cu(I) at low temperatures (described in Chapter 6), which further corroborates the new 
species to be O complexes indeed. 
Besides tuning the equilibrium between the SP/O isomers of proton responsive BOX ligands with “pH” 
(addition of a base), the stoichiometry of the ligand also seemed to have an effect on this equilibrium. 
Surprisingly, addition of the ligand HL1 to its purple colored SP complex 5 at low temperatures resulted in 
a color change from purple to green. The reactions were monitored via UV-vis spectroscopy and the 
resultant spectra matched exactly that when an external base was used with this SP system (Fig.7.11 left). 
Similar changes in spectroscopic features were observed with the band at 335 nm decreasing in intensity, 
and a new band at 392 nm forming. A total of 1.5 equivalents of ligand HL1 per dinuclear copper species 
was required to bring about total conversion of P1 (5) to O (9) (Scheme 7.3). 
Subsequent addition at low temperatures of a Cu(I) source ([Cu(I)(MeCN)4]ClO4; 5 equivalents per 
dinuclear copper species) to the green colored O solution 9, resulted in a color change back to purple. On 
analysis via UV-vis spectroscopy, the band at 392 nm started to gradually decrease in intensity with a 
shoulder at 500 nm being formed (Fig.7.11 right). The 335 nm band started to increase in intensity and the 
resulting spectra P2 resembled that of P1 (Fig. 7.12). However, the overall intensity of the bands in P2 were 
much higher compared to P1 due to an increase in the concentration of the solution (addition of external 
ligand and Cu(I) solutions). Scheme 7.3 describes the subsequent interconversion of SP/O species with the 
effect of stoichiometry for ligand system HLx (x=1, 2, 3, 5). 
 
 
Scheme 7.3 demonstrates the addition of the proton responsive ligand HL1 to a solution of its SP complex 
5 (P1) to generate the O complex 9. Ligand HL1 behaves as a base to capture the released proton from 5, 
generating 9. In solution therefore there exists the protonated form of HL1 (H2L1+) and its deprotonated 
complex. Addition of a Cu(I) source to this mixture, wherein excess ligand is present regenerates 5 (P2). 
Scheme 7.3 Schematic representation of the interconversion between SP/O isomers of ligand system HL1, HL2, HL3 and  HL5 
with stoichiometry. Addition of the ligands to their SP solutions to form their O counterparts. Subsequent addition of a Cu(I) 
source in solution reforms the respective SP complex. 




Coordination with the copper ions and reaction with dioxygen liberates the proton from H2L1+, 
reprotonating its deprotonated form. This procedure avoids the potentially detrimental presence of any 
exogenous base in the reaction mixture. UV-vis monitoring of the reaction sequence (Fig. 7.12) confirmed 
that 1 equivalent of 9 is formed during the first step, and a total of  1.8 equivalents of 5 is present after 




As described above, it was possible to tune the equilibrium between the SP/O isomers with stoichiometry, 
starting from the SP (5) complex. Tuning this equilibrium beginning from the O (9) isomer was also possible 
(Scheme 7.4). Besides the ligand behaving as an external base, its basic character was retained when used 
Figure 7.11 Left: Titration of HL1 to a solution of 5 in THF at 193 K resulting in the formation of 9, displaying the ligand to 
behave as a base. Right: Subsequent titration of a [Cu(I)(MeCN)4]ClO4 solution to 9 to reform 5. 
Figure 7.12 UV-vis monitoring of the reaction sequence demonstrating the interconversion of 5 to 9 using HL1 as a base and 
subsequent conversion of 9 to 5 with [Cu(MeCN)4]ClO4 (baseline correction and dilution factor applied) 
 




in excess with a Cu(I) salt. Oxygenation of 2 equivalents of HL1 with 1 equivalent of [Cu(I)(MeCN)4]PF6 
at low temperatures yielded a dark green colored solution, as opposed to the expected purple colored SP 
complex 5. Spectroscopic analysis revealed the direct formation of the O complex 9, with the formation of 
bands at 335 nm and 392 nm on oxygenation (Fig.7.13 left). Subsequent addition of a [Cu(I)(MeCN)4]PF6 
solution resulted in formation of 5, with the band at 392 nm decreasing in intensity and absorbtion bands 




In order to confirm the formation of the O complex 9 when a 2:1 stoichiometric mixture of HL1:Cu(I) was 
used, resonance Raman studies with a laser excitation of 633 nm were carried out. THF solutions of 2:1 
HL1:Cu(I) were exposed to naturally abundant (16O2)  or isotopically labelled dioxygen (18O2) at 193 K in 
young NMR tubes. Frozen solutions in liquid nitrogen at 77 K revealed only one oxygen isotope sensitive 
feature seen with a single peak at 598 cm-1 which shifted to 571 cm-1 on labelling (Δ16O-18O = 27 cm-1)(Fig. 
7.14).  These features have been assigned to the Cu2(µ-O)2 core vibration and are signature breathing modes 
of the O core. In comparison to the other O complexes 10 and 11, with the deprotonated ligands [L2]- and 
[L3]-  respectively (refer to Chapter 7), rR studies revealed similar stretching frequencies at 598 cm-1 which 
shifted to 572 cm-1 on labelling, for the system [L2]- (Δ16O-18O = 26 cm-1)(Fig 6.7 left); and 601 cm-1 which 
shifted to 573 cm-1  (Δ16O-18O = 28 cm-1)(Fig 6.7 right) for the system [L3]-. Complexes 10 and 11 were 
charcterized in detail in solution as well as crystallographically (in case of 10), which confirmed 
Scheme 7.4 Schematic representation of oxygenation of a 2:1 solution of HL1:[Cu(I)(MeCN)4]PF6  in THF at 193 K to form 
9. Subsequent addition of [Cu(I)(MeCN)4]PF6 leading to the formation of 5. 
  
Figure 7.13 Left: Oxygenation of a 2:1 HL1:Cu(I) solution in THF at 193 K with formation of bands at 335 nm and 392 nm, 
demonstrating formation of O complex 9. Right: Titration of a [Cu(I)MeCN]PF6 solution into a solution of 9 to form the SP 
complex 5. 




unambigously the dioxygen to bind as a bis(µ-oxo) motif.  The similarities in the rR features of 10 and 11 
with an oxygenated 2:1 solution of HL1:Cu(I) confirms the formation of the O complex 9 at low 
temperatures. Furthermore, there was no evidence of the side on peroxo dicopper(II) species which is 





In addition to the proton responsive ligand HL1 behaving as a base, the same was demonstrated for ligands 
HL2, HL3 and HL5.  
For the SP complex 6 with ligand system HL2, 8 equivalents of the ligand per dicopper species was required 
for conversion of 6 to its O complex 10 (Fig. 7.15 left). Addition of a Cu(I) source (10 equivalents per 
dinuclear copper species) did indeed revert back the equilibrium to 6, however the absorbance bands were 




Figure 7.14 Resonance Raman spectrum of an oxygenated 2:1 HL1:[Cu(I)(MeCN)4]PF6 frozen solution in THF at 77 K, 
showing the formation of the O complex 9.  16O2 spectrum indicated in black and 18O2 indicated in red.  






For ligand systems HL3 and HL5, 2.5 and 2 equivalents of ligand per dinuclear copper species were required 
for conversion of their SP to O forms respectively (Fig. 7.17 left and 7.19 left). Addition of a Cu(I) source, 
5 equivalents per dinuclear copper species for 11 and 2 equivalents per dinuclear copper species for 12, 
resulted in the distinct formation of the SP band at ~500 nm. However, in both cases, the band at ~333 nm 




Figure 7.15 Left: Titration of HL2 to a solution of 6 in THF at 193 K resulting in the formation of 10, displaying the ligand 
to behave as a base. Right: Subsequent titration of a [Cu(I)(MeCN)4]ClO4 solution to 10 to reform 6. 
 
Figure 7.16 UV-vis monitoring of the reaction sequence demonstrating the interconversion of 6 to 10 using HL2 as a base, 
and subsequent conversion of 10 to 6 with [Cu(MeCN)4]ClO4 (baseline correction and dilution factor applied) 
 








Figure 7.17 Left: Titration of HL3 to a solution of  SPHL3 in THF at 193 K resulting in the formation of 11, displaying the 
ligand to behave as a base. Right: Subsequent titration of a [Cu(I)(MeCN)4]ClO4 solution to 11 to reform SPHL3. 
Figure 7.18 UV-vis monitoring of the reaction sequence demonstrating the interconversion of SPHL3 to 11 using HL3 as a 
base and subsequent conversion of 11 to SPHL3 with [Cu(MeCN)4]ClO4 (baseline correction and dilution factor applied). 









Figure 7.19 Left: Titration of HL5 to a solution of 7 in THF at 193 K reuslting in the formation of 12, displaying the ligand 
to behave as a base. Right: Subsequent titration of a [Cu(I)(MeCN)4]ClO4 solution to 12 to reform 7. 
Figure 7.20 UV-vis monitoring of the reaction sequence demonstrating the interconversion of 7 to 12 using  HL5 as a base 







In conclusion, during the course of this work, a new factor “pH” was shown to affect the equilibrium 
between SP/O complexes of proton responsive BOX ligands.  
By virtue of a base, it was possible to successfully shift the equilibrium from the SP to the O isomers of 
ligands HL1, HL2, HL3 and HL5. All reactions were monitored via UV-vis spectroscopy wherein addition 
of an external base led to changes in spectroscopic features from the SP to the O complexes. However, the 
same was not observed for the non-proton responsive ligand system L6. The deprotonated ligands form 
suitable scaffolds to stabilize the +3 oxidation state of copper which facilitates a cleavage of the O-O bond, 
shifting the equilibrium from the dicopper(II) (µ-η2: η2)-peroxo isomer to the dicopper(III) bis(µ-oxo) 
isomer. Addition of an acid did not revert the equilibrium back to the SP complexes but lead to their 
decomposition. This was attributed to the high nucleophilicity of the bis(µ-oxo) core. As discussed in 
Chapter 6, the Cu(I) complexes of the deprotonated ligand systems [L2]- and [L3]- directly form their O 
complexes with O2 at low temperatures, which have been characterized in detail confirming the dioxygen 
binding mode to be the bis(µ-oxo) motif. This further confirms the new intermediate formed by addition of 
a base to be an O species. 
The stoichiometry of the proton responsive ligands was shown to affect the Cu/O2 intermediate that formed 
at low temperatures and resulted in the POP (peroxo-oxo-peroxo) switch. For ligand HL1, a 1:1 
stoichiometric mixture of HL1:Cu(I) lead to the formation of the SP intermediate (Chapter 5), whereas a 2:1 
stoichiometric mixture of 2HL1:Cu(I) favored the O intermediate. This was confirmed by UV-vis 
spectroscopy as well as rR studies, and was attributed to the ligand behaving as a base. The ligands HL2, 
HL3 and HL5 also displayed base like character wherein addition of these ligands to their respective SP 
complexes resulted in their O isomers. In all cases the equilibrium could be reverted by the external addition 
of a Cu(I) source. 
The external affect of “pH” is a new factor that contributes to tuning the equilibrium between SP/O 
intermdiates. It is interesting to note that in type III dicopper proteins as well as in the dicopper active site 
of pMMO, all copper ions are coordinated by histidine imidazoles. These offer a backside N atom amenable 
to potential (de)protonation equilibria in response to local pH changes. In fact, (de)protonation of histidine 
imidazole ligands in metalloproteins is widely used for tuning redox potentials and electronic structures of 
the metallocofactors.[232–234] The ability to tune the equilibrium between these novel intermediates in a 
synthetic system via pH puts forward a plausible theory that perhaps, pH forms a pertinent factor in 
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The contrasting reactivity demonstrated by different Cu/O2 intermediates, (SP, O, TP, and CP) towards 
organic substrates is attributed to the nature of their dioxygen binding modes (Fig. 8.1).[196] The end-on 
bound peroxo moieties TP and CP, which are not considered to be biologically relevant but contribute to 
understanding the mechanism of dioxygen binding, tend to be more basic and nucleophilic in nature. 
Though in 2010, Garcia-Bosch et al. proposed a TP model system to demonstrate electrophilic catalytic 
behavior,[211] further analysis of this Cu/O2 synthetic system revealed it to be in equilibrium with an O 
species which was responsible for catalytic reactivity, with the nucleophilic reactivity of the TP binding 
mode being retained.[212] A number of SP model systems that parallel the dioxygen binding mode of Ty 
have shown electrophilic reactivity towards organic substrates emulating the enzyme (refer to sec. 2.5 of 
introduction).[95,200,201] Synthetic O complexes known to be in equilibrium with their SP congeners in the 
majority of cases carry out H-atom abstraction reactions to form unphysiological radical based products. 









The following sections describe the reactivity patterns displayed by Cu2O2 complexes that have been 
synthesized and described in Chapters 5 and 6. A series of external substrates (Fig. 8.2), such as the sodium 
salt of 2,4-di-tert-butyl phenolate (DTBP-Na), 2,4-di-tert-butyl-phenol (DTBP-H), triphenyl phosphine 
(PPh3), and thioanisole (PhSMe) were screened for reactivity. In addition, radical substrates were also 




Figure 8.1 Different reactivity patterns observed in Cu2O2 adducts.  
Figure 8.2 Substrates that have been screened for reactivity during the course of this work.  




8.2 Substrate reactivity of SP complexes with proton-responsive BOX ligands 
Of the substrates mentioned above, PPh3 and PhSMe showed no external reactivity with SP complexes of 
proton responsive BOX ligands. Addition of these substrates to SP solutions 5, 6, SPHL3, and 7 at 193 K in 
THF resulted in no spectral changes when analyzed by UV-vis spectroscopy, and analysis of the organic 
products by 1H-NMR spectroscopy after workup revealed peaks corresponding only to the starting material. 
In contrast, addition of the external substrates DTBP-Na and DTBP-H:NEt3 (1:2) to SP solutions of these 
ligands demonstrated interesting reactivity.  
Gradual titration of DTBP-Na or DTBP-H:NEt3 (1:2) 193 K in THF to SP complexes 5, 6, SPHL3, and 7 
resulted in a change of their characteristic LMCT bands (refer to Chapter 5). The band at ~333 nm started 
to decrease in intensity with a new band forming at ~400 nm. The shoulder at ~500 nm diminished with the 
resulting spectra resembling the O complexes 9, 10, 11, 12 respectively (refer to Chapter 7). On comparing 
the resultant UV-vis spectra of SP complexes with external substrates DTBP-Na or DTBP-H:NEt3  (1:2) 
with those formed by deprotonation of their SP congeners, the spectra were identical suggesting that these 
external substrates behave as a base. Figure 8.3 (left) demonstrates the reactivity of SP complex 6 with 
DTBP-Na where a total of 4 equivalents of substrate were required for full conversion of 6 to 10. The figure 
on the right, (Fig. 8.3 right) demonstrates the deprotonation of complex 6 with DBU to form 10.  As is 
evident from these figures, the resulting spectra in both cases have similar bands at 333 nm and 395 nm. 
Further addition of the substrate, ~300 equivalents, led to gradual fading of the O bands at 333 nm and 395 
nm. The same was observed for SP complexes 5, SPHL3 and 7. In case of DTBP-H:NEt3, (1:2) a neutral 
phenol in the presence of a base, similar spectral changes were observed.  
On workup of the reaction mixtures according to standard procedures and analysis of the organic products 
by 1H-NMR spectroscopy, a 33% conversion of substrate to the unphysiological radical based C-C coupled 
product was observed (Scheme 8.1). No catalytic conversion of the external phenols to catechols or 
quinones resulted from SP complexes of proton responsive BOX ligands.  
 
 
Scheme 8.1 Reactivity of SP complexes (5, 6, SPHL3, 7) of proton responsive BOX ligands with DTBP-Na or DTBP-H:NEt3 
(1:2) to generate their O isomers 9, 10, 11 and 12, which after acidic workup results in the formation of 33% C-C coupled 
product. 





Thus the proton responsive nature of BOX ligands inherently forbids reactivity of their corresponding SP 
complexes with basic substrates such as phenolates. These substrates trigger formation of the O complexes 
by deprotonation of the ligand backbone, facilitating O-O bond cleavage. Further reactivity of these O 
complexes in the presence of an excess of substrate leads to formation of unphysiological products. 
 
8.2.1 Potential PCET Reactions 
As PCET reactions form an integral part of various biological processes, reactivity of SP complex 6 with 
suitable radical reactors such as TEMPO and the 2,4,6 tri-tert-butyl phenoxy radical were screened to test 
their feasibility (Scheme 8.2). However, addition of these substrates did not result in any spectral changes 
corresponding to formation of any mixed-valent peroxo species. The only changes in UV-vis features were 
caused by the substrate itself upon addition. Though TEMPO/TEMPOH redox couple stands as an excellent 
example of a PCET reagent, due its feasible BDFE and low O-H bond strength,[235] the inability to meadiate 
PCET reactions on SP systems discussed in Scheme 8.2 sugessts that the BDFE of the C-H bond within the 
SP complex is much higher than that of radical substarte. The same was demonstrated by the 2,4,6 tri-tert-








As is discussed in Chapter 7, the O complexes of proton responsive ligands were formed on deprotonating 
their SP congeners. A second route to generate these was by reacting the Cu(I) analogues of the monoanionic
Figure 8.3 Left: UV-vis monitoring of SP complex 6 with DTBP to generate the O isomer 10. Right: UV-vis monitoring of 6 
with DBU to generate 10. 
Scheme 8.2 Reactivity scheme to test the feasibility of PCET reactions with SP complex 6. 




ligands [L2]- and [L3]- with dioxygen at low temperatures (Chapter 6). For both these cases, a bis(µ-oxo) 
dicopper(III) complex resulted. A third route to generate a bis(µ-oxo) dicopper(II) complexe from its bis 
(µ-hydroxo) counterpart with the assistance of a base was attempted. The Cu(I) complex of ligand HL2 was 
exposed to dioxygen at room temperatures to generate directly the bis(µ-hydroxo) species. This solution 
was cooled to 193 K and an external base, DBU/nBuLi was gradually titrated into the solution. However, 
no spectral changes corresponding to an O complex was observed (Scheme 8.3).  Generating the SP 
complex 6 with the TEMPO radical (Scheme 8.3) from the bis(µ-hydroxo) complex was also unattainable. 
On UV-vis monitoring, addition of TEMPO to a bis(µ-hydroxo) solution of HL2 resulted in no spectral 








The unfeasibility of generating the SP and O complexes from their bis(µ-hydroxo) counterparts in Scheme 
8.3 could be attributed to the thermodynamic unfavorability of these reactions. The deprotonation of the 
hydroxide moiety to an oxide, in order to generate a dicopper(II) bis(µ-oxo) species is disfavoured plausibly 
due to the +2 oxidation state hosted by the copper ions which is unsuited for such a binding mode. The 
inability of the potential PCET reaction to generate the SP complex from its bis(µ-hydroxo) counterpart, 
could be attributed to the BDFE of the O-H bond of the bis(µ-hydroxo) complex being higher than that of 
the radical substrate.[235]  Though only a few radical substrates were screened, it is worthwhile attempting 
alternative comparable substrates given the importance of PCET reactions within biological systems. 
 
 
8.3 Substrate reactivity exhibited by SP complex of non-proton-responsive BOX ligands 
The substrate reactivity demonstrated by 8, a SP motif of a non-proton responsive ligand L6 differed from 
systems of proton responsive ligands. Addition of DTBP-Na to a purple colored solution of 8 at 193 K in 
THF resulted in a color change to brown, and  warming the solution to room temperature resulted in a color 
change to green. UV-vis monitoring of the reaction revealed a gradual decrease of the bands at ~333 nm 
and ~500 nm with formation of a shoulder like region at ~400 nm (Fig. 8.4 left). A total of 2.1 equivalents 
of substrate was required for total decomposition of 8. On working up the reaction mixtures according to 
standard procedures, a yellow colored oil was obtained. Analysis of this oil by 1H-NMR showed 13.5% 
conversion of the DTBP-Na to DTBP-Q (quinone) (Scheme 8.4) with no other side products (Fig. 8.5). 
Scheme 8.3 Reactivity scheme to test the feasibility of generating SP  complex 6 and a bis(µ-oxo) dicopper(II) complex from 
the respective bis(µ-hydroxo) complex. 










Scheme 8.4 Reactivity of SP complex 8 with 2.1 equivalents of DTBP at 193 K in THF. Acidic workup of the reaction mixture 
revealed 13.5% conversion of the starting material to DTBP-Q.  
Figure 8.4 Left: Titration of SP complex 8 with 2.1 equivalents of DTBP-Na over 15 minutes, bands at 333 nm and 500 nm 
decrease in intensity with a slight shoulder formation ~400 nm. Right: UV-vis spectra of DTBP-Q in THF at rt with a band at 
411nm. 
Figure 8.5 1H-NMR of end product of the reaction of 8 with 2.1eq DTBP-Na in acetone-d6 at 293 K after workup. Shown in 
red squares are the signals corresponding to the protons of the DTBP-Q(quinone). Signals marked in  belong to the starting 
material after workup. 




DTBP-Q was further characterized via UV-vis spectroscopy. Measurements at room temperature in THF 
resulted in a band at 411nm characteristic of quinones (Fig.8.4 right) in agreement to the observed shoulder 
like region that appeared for the eaction mixture on addition of the substrate. Analysis via HPLC-MS 
confirmed the product to have a mass of 221 (m/z)+ in accordance with protonated DTBP-Q. In order to 
gain deeper insight into the mechanism of the reaction, ESI-MS experiments using 16O2 and 18O2 labelled 8 
were conducted. Unfortunately, the spectra showed a large mixture of products with unfeasible assignment 
to any potential intermediates.  
Reactivity of a slightly larger amount of substrate, (~10 equivalents) with 8 resulted in the formation of 
both the DTBP-Q as well as the C-C coupled product with 6% and 14% conversion respectively, whereas 
addition of a large excess, (~100 equivalents of DTBP-Na) formed exclusively the C-C coupled product 
with 9% conversion (Scheme 8.5). The reactions were carried out similar to that with 2.1equivalents of 
substrate and the products were analyzed via 1H-NMR spectroscopy. 
In contrast to DTBP-Na, the neutral phenol DTBP-H in the presence of NEt3 did not show the same effect. 
A total of ~150 equivalents of DTBP-H:NEt3 (1:2) was required for total decomposition of 8 in contrast to 
2.1 equivalents of DTBP-Na. The solution was then worked up and analyzed via 1H-NMR spectroscopy 
which revealed a 10% conversion of the starting material to the C-C coupled product and no catalytic 
conversion of the phenol to catechol or quinone.  
This difference in the reactivity between DTBP-Na and DTBP-H:NEt3 (1:2) can be attributed to the 
substrate being deprotonated before the reaction (DTBP-Na), or being deprotonated during the course of 
the reaction (DTBP-H:NEt3). In case of DTBP-Na, the deprotonated phenolate easily approaches the Cu/O2 
intermediate leading to reactivity favoring physiological hydroxylation. However, the neutral phenol even 
in the presence of a base favors unphysiological reactivity suggesting the importance of deprotonation of 
the phenolic substrate before the aromatic hydroxylation step. 
 
 
Scheme 8.5 Reactivity of SP complex 8 with 10 equivalents of DTBP-Na to generate a mixture of products, and with 100 
equivalents of DTBP-Na to generate only the C-C coupled product. 




In conclusion, the nature of the ligand plays a crucial role in determining substrate reactivity. Contrary to 
the proton responsive ligand systems, the SP complex 8 of the non-proton responsive ligand L6 did not yield 
its O complex. Substoichiometric o-hydroxylation mimicking Ty reactivity was observed with 
deprotonated phenolates. Unfortunately, catalytic conversion of the substrate did not occur suggesting the 
mechanism of the reaction to be dependent on the concentration of the substrate. A detailed insight into the 
mechanism of this reaction is presently under investigation. 
 
 
8.4 Substrate reactivity exhibited by O complexes of monoanionic BOX ligands 
The O complexes 10 and 11 were screened with PPh3, PhSMe, DTBP-Na, and DTBP-H. PPh3 and PhSMe 
showed no reactivity with these complexes. Addition of these substrate to O solutions (10 and 11) at 193 
K in THF resulted in no spectral changes when analyzed by UV-vis spectroscopy and analysis of the organic 
products by 1H-NMR spectroscopy after workup revealed peaks corresponding only to the starting material.  
Addition of a large excess of DTBP-Na and DTBP-H:NEt3 (1:2) (~250 equivalents) at 193 K over two 
hours resulted in decomposition of 10 and 11 on monitoring by UV-vis spectroscopy. The reaction mixtures 
were worked up according to standard procedures. 1H-NMR spectroscopy revealed a 50% conversion of 









Unphysiological C-C coupled products are observed in a majority of cases with bis(µ-oxo) dicopper(III) 
complexes. The O complexes of monoanionc BOX ligands presented herein carry out an impressive 50% 
conversion of the neutral phenol (in the presence of a NEt3) to the C-C coupled product. This can be 
attributed to the small size of the system which facilitates a fast outer-sphere one electron transfer reaction 
leading to the phenoxyl radical, similar to the L3 system reported by Herres-Pawlis et al.[208] 
Scheme 8.6 Reactivity of O complex 10 and 11 with DTBP-Na to generate the C-C coupled product. 50% conversion occurs 
over 2 hours. 




8.5 Stability of SP complexes vs O complexes 
The new SP complexes 7 and 8 as well as the O complexes 10 and 11 that were characterized during the 
course of this work showed gradual decomposition with time on warming up to room temperature. All 
decomposition reactions were monitored via UV-vis spectroscopy. Gradual warming of a solution of 7 from 
193 K to rt resulted in a decrease in the intensity of the bands at 333 nm and 504 nm over a period of one 
hour (Fig. 8.6 left). For complexes 10 and 11, warming of the solutions to rt resulted in a decrease of the 
bands at 333 nm and 395 nm over one hour for 10 (Fig. 8.6 right) and a decrease in the bands at 337 nm 
and 397 nm over a period of four hours for 11 (Fig. 8.7) signifying decomposition of the complexes. 
Analysis of these products via ESI-MS did not yield valuable information about the nature of the 
decomposed products. The spectra individually showed a mixture of products comprising mainly of ligand 
peaks. In case of complex 8 however, the end product was isolated as a dicopper(II) bis(µ-hydroxo) species. 
Further investigation of this process is discussed within this chapter. 
 
Figure 8.6 Left: Decomposition of 7 monitored by UV-vis spectroscopy depicting a decrease in bands at 333 nm and 504 nm 
with warming up of the solution from 193 K to rt. Shown in the inset is a decrease in the intensity of the band at 333 nm with 
time. Right: Decomposition of 10 monitored by UV-vis spectroscopy depicting a decrease in bands at 333 nm and 395 nm 
with warming up of the solution from 193 K to rt. Shown in the inset is a decrease in the intensity of the band at 333 nm. 
Figure 8.7 Decomposition of 11 monitored by UV-vis spectroscopy. A decrease in bands at 337 nm and 397 nm with warming 
up of the solution from 193 K to rt. Shown in the inset is a decrease in the intensity of the band at 337 nm with time. 





8.5.1 Decomposition of SP complex 8 
8.5.1.1 Characterization in solution 
Warming up a solution of 8 from 193 K to rt resulted in a change of the purple colored solution to light blue 
within a span of 10 minutes. The reaction was monitored by UV-vis spectroscopy which displayed a distinct 
decrease in the intensity of the bands at 333 nm and 500 nm (Fig. 8.8 left). The solution was maintained at 
room temperature for a while for complete decomposition and the spectrum was measured again. No bands 
at 333 nm or 500 nm corresponding to 8 were observed, but a band with a broad shoulder like region at 680 
nm (ε = 250M-1cm-1) and rather low intensity appeared (Fig. 8.8 right). This was assigned to the dicopper(II) 











Scheme 8.7 Decomposition of SP complex 8 to the bis(µ-hydroxo) dicopper(II) analogue 16 with gradual warming up from 
193 K to room temperature. 
Figure 8.8 Left: Decomposition of 8 monitored by UV-vis spectroscopy depicting a decrease in bands at 333 nm and 500 nm 
with warming up of the solution from 193 K to rt over 10 minutes. Shown in the inset is a decrease in the intensity of the band 
at 333 nm with time. Right: UV-vis spectra of 16 in THF measured at rt. 




8.5.1.2 Solid state characterization of 16 
The bis(µ-hydroxo) dicopper(II) species (16) was also isolated in the solid state by addition of excess of 
Et2O to a THF solution of 16. A blue powder precipitated, which was filtered under aerobic conditions and 
dried under vacuum. 16 was characterized by IR spectroscopy (KBr pellet). A distinct peak at 3484 cm-1 
was observed which was assigned to the hydroxo stretch of the complex (Fig. 8.9 left). The powder was 
also analyzed by solid state UV-vis spectroscopy whose features were similar to those of 16 in solution 





8.5.1.3 Structural elucidation of 16 
Single crystals suitable for X-ray diffraction were grown at room temperature by slow diffusion of Et2O 
into a THF solution of 16 (Fig. 8.10). X-ray diffraction analysis revealed the two cooper centers to be 
coordinated in a distorted square pyramidal geometry. The metal centers were coordinated to the nitrogen 
atoms of the ligand and oxygen atoms of the triflate counterion axially. The molecule crystallizes in a P21 
monoclinic space group. The Cu···Cu bond distance of 2.99 Å, and the Cu-O bond length of 1.93 Å were 
smaller compared to its peroxide analogue 8 (Cu-Cu 3.52 Å and Cu-O 2.32 Å). The O···O distance between 
the two hydroxide moieties was 2.48 Å, thus much larger than what was found for 8 (1.56 Å), a result of 
the cleavage of the O-O bond. In addition, the triflate ion was shown to be bound to the hydroxide units via 
hydrogen bonds.
Figure 8.9 Left: IR spectra of 16 measured in a KBr pellet displaying the OH stretch at 3484 cm-1 .   Right: Solid state UV-










To summarize, most interesting about the Cu/O2 complexes of proton responsive, non-proton responsive 
and monoanionic BOX ligands presented herein was the finding that all species exhibit different reactivity 
towards external phenolic substrates. In case of the SP complexes of proton responsive BOX ligands 5, 6, 
7 and SPHL3, reactivity with external phenolic substrates led to the formation of their O complexes. 
Comparing this to reports by Stack et al. wherein the SP complex of the DBED ligand system led to 
formation of the O isomer upon coordination of the substrate, herein, deprotnation by the substrate leads to 
O formation.[206] These corresponding O complexes  of proton-responsive BOX ligands, upon reaction with 
external phenolic substrates produced the unphysiological C-C coupled product with a 33% conversion of 
the substrate. 
Complex 8, a SP system of the non-proton responsive BOX ligand L6 demonstrated stoichiometric reactivity 
with the external phenolic substrate DTBP-Na, hydroxylating it to the quinone with 13.5% conversion. The 
quinone was characterized by 1H-NMR spectroscopy, UV-vis spectroscopy, as well as HPLC. 
Unfortunately, catalytic reactivity was not observed. Addition of excess substrate led to the undesired C-C 
coupled product. A detailed insight into the mechanism of reactivity was prevented by the high instability 
of the intermediates.  
For O complexes 10 and 11, reaction with external phenolic subsrstrates DTBP-Na or DTBP-H produced 
the C-C coupled product with 50% conversion of the substrate.  
The relatively high stability of these Cu/O2 intermediates was evident on warming the solutions of 7, 8, 10 
and 11 to rt. UV vis monitoring of these reactions displayed a decrease of their characteristic LMCT bands 
over the course of one hour (for 7 and 8), four hours (for 11) and 10 minutes (for 8), signifying gradual 
decomposition of the complexes. In case of complex 8, the decomposed product was identified as the bis(µ-
Figure 8.10. Plot (30% probability thermal ellipsoids) of the molecular structure of 16 (most hydrogen atoms omitted for 
clarity). Selected distances [Å] and angles [°]: Cu1–O3 1.9338(14), Cu1–O3' 1.9596(14), Cu1–N1 2.0120(16), Cu1–N2 
2.0272(16), Cu1–O11 2.4364(15), Cu1∙∙∙Cu1' 2.9994(4), O3∙∙∙O3' 2.482(2), O3∙∙∙O12' 2.907(2); O3–Cu1–O3' 79.22(6), O3–
Cu1–N1 159.53(6), O3'–Cu1–N1 96.72(6), O3–Cu1–N2 98.00(6), O3'–Cu1–N2 171.57(6), N1–Cu1–N2 88.59(6), O3–Cu1–
O11 104.61(6), O3'–Cu1–O11 88.65(6), N1–Cu1–O11 95.28(6), N2–Cu1–O11 84.34(6), Cu1–O3–Cu1' 100.78(6), O3–






hydroxo) dicopper(II) species which was characterized by UV-vis spectroscopy, IR spectroscopy and X-
ray crystallography. For complexes 7, 10 and 11, the nature of the decomposed product was inconclusive. 
This could result from a more complex mechanism of decomposition for these complexes.  
The differences in reactivity of the systems mentioned above suggests that the nature of the ligand plays a 
crucial role in the reaction mechanism and formation of the end product. The SP complexes of proton 
responsive BOX ligands generated their O congeners. In comparison to Type 3 dicopper proteins that have 
histidine imidazole scaffolds with backside N-atoms amenable to deprotonation, these results speculate the 
reactive intermediate responsible for the catalytic behavior of Tyrosinase. Weather a SP intermediate 

































In conclusion, bis-oxazoline (BOX) ligands are simple and bidentate in nature. Termed as a privileged class 
of ligands, they have been used extensively in asymmetric catalysis but not explored in the context of 
activating small molecules in bioinspired systems. During the course of this work, their use in Cu/O2 
chemistry has proved to be of significant benifit. A detailed investigation of neutral and monoanionic BOX 
ligands of Cu(I) complexes with dioxygen was conducted which suggested that the nature of the ligand was 
crucial in determining the Cu2/O2 intermediate that formed at low temperatures and their subsequent 
reactivity towards external substrates. 
The Cu(I) complexes of  neutral ligands were shown to bind dioxygen in a μ-η2:η2 binding mode. The SP 
complexes 5, 6, 7 and 8 were characterized in solution. Complete characterization of 8 in solution as well 
as solid state was possible. Moreover, structural elucidation of SP complexes 6 comprising of a proton 
responsive ligand and 8 comprising of a non-proton responsive ligand system was achieved during this 
study, which emulated similar dioxygen binding modes in type III dicopper proteins. The exceptionally 
long O-O bond in 6 in comparison to all other synthetic and biological systems reported so far gives it its 
noteworthy character. These two structures contribute to the hand-full of structurally elucidated complexes 
of this type characterized over the last 27 years and are rare examples of SP complexes with bidentate 
ligands. Kinetic and activation parameters for the formation of SP complexes with the new ligand systems 
HL5 and L6 were determined.  
As mentioned earlier, the finding that certain BOX ligands exist in a tautomeric equilibrium mixture 
suggested that they may serve as proton responsive ligands. This was exploited in successfully tuning the 
equilibrium between their SP/O complexes. By virtue of a base the SP complexes (of proton responsive 
ligands), 5, 6, 7, and SPHL3 generated their O congeners with a bis(µ-oxo) dicopper(III) core. This was 
attributed to deprotonation of the ligand backbone, which triggered cleavage of the O-O bond shifting the 
equilibrium in the direction of the O isomer. The reactions were monitored by UV-vis spectroscopy with 
final confirmation of the dioxygen binding mode being attained from the dioxygen reactivity of Cu(I) 
complexes with new, monoanionc BOX ligands [L2]- and [L3]- (introduced during this study). The basic 
nature of the proton responsive BOX ligands gave rise to the POP (peroxo-oxo-peroxo) switch, a back and 
forth shift between the SP/O species with simple changes in stoichiometry of the ligand and copper(I) 
source. “pH” is now a new factor that now contributes to tuning the equilibrium between SP/O complexes.  
The new monoanionic ligands  [L2]- and  [L3]- that were introduced to study the electronic effects on Cu/O2 
chemistry could indeed find application in this research area. Their Cu(I) analogues formed O complexes 
10 and 11 with dioxygen at low temperatures. These were characterized in solution along with structural 
elucidation of 10 which unambiguously determined the dioxygen to bind in a bis(µ-oxo) mode. 10 is the 
second example of a neutral bis(µ-oxo) dicopper(III) species reported to date. An interesting effect of 
temperature variation on O complexes was also observed. UV-vis monitoring of the O complexes with 
temperature variation resulted in intensity changes of their characteristic LMCT bands. This was explained 
by the fluxional twist of the core with temperature change, an effect that has not been reported to date. 
Though the O motif has not been biologically observed, a recent proposal of the active site of the pMMO 
enzyme to comprise a bis(µ-oxo) intermediate has been reported. This highlights the importance of this 
Cu/O2 binding mode. 
Finally, substrate reactivity of the SP and O complexes synthesized during this study revealed differences 
in reactivity which were attributed to the nature of the ligand system. While SP complexes of proton 
responsive ligands generated their O congeners with basic phenolic substrates, complex 8 which hosts a 
non-proton responsive scaffold emulated similar activity as Tyrosinase in stoichiometric amounts. The O 
complexes of the monoanionic BOX ligands demonstrated formation of the C-C coupled product with a 





Though dioxygen binding in Ty is known to generate a SP species, the reactive intermediate responsible for 
catalytic activity is still under speculation. Moreover, the existence of SP complexes to exist in equilibrium 
with their O isomers has been investigated in detail in synthetic systems, though not yet biologically 
observed. Through this work with simple BOX ligands, key Cu2/O2 intermediates were isolated proving 
BOX ligands to be privileged not only in the field of asymmetric catalysis, but also in the field of bio-
inorganic chemistry. The key Cu2/O2 intermediates with SP and O cores could readily be interconverted by 
peripheral deprotonation/protonation events at the terminal ligand backbones. Interestingly, Type 3 
dicopper proteins as well as the dicopper active site of pMMO contain copper ions coordinated by histidine 
imidazoles. These offer a backside N atom amenable to potential (de)protonation equilibria in response to 
changes in local pH. The work presented herein puts forward a plausible enquiry. Do changes in local pH 
deterime the active intermediate responsible for catalytic activity in novel dicopper enzymes? In fact, 
(de)protonation of histidine imidazole ligands in metalloproteins has widely been used for tuning redox 
potentials and electronic structures of the metallocofactors,[232–234]and forms an integral part of important 
biological proton coupled electron transfer (PCET) reactions (such as in the Rieske proteins).[236][237–239] It 
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10.1 Diiron Enzymes activating Dioxygen 
The high abundance of elemental iron in nature has resulted in a large number of diiron proteins performing 
a variety of biochemical functions. Both heme and non-heme diiron enzymes are involved in the binding 
and activation of dioxygen which gives rise to reactive intermediates essential for physiological processes, 
though the mechanism varies in each case.[240,241]. Depending on the nature of the enzyme, four electrons 
and four protons are required for cleavage of the O-O bond when dioxygen is finally reduced to water.[242] 
Scheme 10.1 illustrates the binding mode of dioxygen at the active sites in heme iron and non-heme diiron 
metalloenzymes.[243] Dioxygen binds to the metal centers in either a superoxide or a peroxide fashion, 
oxidizing the metal centers. Further activation of these peroxides by certain cofactors or by the diiron core 
itself gives rise to high-valent iron oxo compounds. These pertain a high oxidizing power and are considered 
to be active intermediates responsible for oxidation and oxygenation chemistry.[241,244–246] The following 
sections describe three well studied diiron metalloenzymes that activate dioxygen; Hemerythrin, 
Ribonucleotide reductase (RNR), and soluble methane monoxygenase (sMMO). All three comprise 
carboxylate bridges between the iron centers resulting in these enzymes belonging to the class of 
carboxylate-bridged diiron proteins.[247,248] While Hemerythrin and RNR are associated with bio-
physiological processes, the enzyme sMMO is associated with impressive catalytic oxygenation of organic 
substrates.[249] This has attracted much attention in modern catalysis with large efforts being made to 
















Similar to Hemocyanin, Hemerythrin (Hr) which is present in several marine invertebrates reversibly binds 
dioxygen and carries out the function of O2 transport.[244] The active site of deoxy Hr consists of two iron 
centers bridged by carboxylate groups of a glutamate and an aspartate residue and a µ-hyroxo unit (Scheme 
Scheme 10.1 Dioxygen activation mechanisms for heme and non-heme diiron enzymes.[243] 




10.2).[28] One of the iron centers is linked to three histidine residues while the other binds to only two 
histidine residues making the iron centers asymmetrical in nature. The vacant coordination site present at 
the five coordinated iron center allows for dioxygen binding. O2 binds in a peroxide fashion with the distal 
hydroxo-proton being transferred to the peroxo oxygen, generating a high valent diiron(III) hydroperoxo 
motif which is known to be the active intermediate responsible for transport (Scheme 10.2).[25] The final 
release of dioxygen with simultaneous reduction of both the metal centers along with proton transfer 










10.1.2 Ribonucleotide Reductase 
The enzyme ribunucleotide reductase (RNR) is essential in the transformation of RNA to DNA and is 
present in all living organisms. The R2 subunit of the enzyme interacts with dioxygen to form what is called 
a tyrosyl radical which enables conversion of ribonucleotides to deoxyribonucleotides.[250] The active site 
of the reduced form of RNR contains a diiron(II) center bridged by two carboxylate ligands, a terminal 
histidine, and a terminal monodentate carboxylate at each iron. The pseudo tetrahedral iron centers bind O2 
to form a µ-oxo-µ-carboxylato diiron(III) core (Scheme 10.3).[251] The carboxylate shift of one of the 
glutamate residues provides a vacant site for dioxygen binding. This provides oxidizing equivalents which 











Scheme 10.2 Reversible dioxygen binding in Hemerythrin.[25] 
Scheme 10.3 Active site of RNR R2 in reduced and oxidized states.[251] 




10.1.3 Soluble Methane Monoxygenase (sMMO) 
One of the most impressive enzymes in the family of non-heme diiron enzymes is soluble methane 
monoxygenase (sMMO). Present in several methanotrophic bacteria, this enzyme catalyzes the conversion 
of methane to methanol which requires activation of a C-H bond, the BDE being 105 kcalmol-1.[253–255] As 
methane is a major component of natural gas, understanding the catalytic mechanism of sMMO under 
ambient conditions would benefit future fuel and feedstock generation. A significant amount of effort has 
been applied in synthesizing synthetic analogues capable of emulating the catalytic activity of this enzyme.  
Composed of multiple components, sMMO contains two iron atoms within its active center bound to 
histidine and glutamate residues.[256] In its reduced form MMOHred, the diiron centers are bridged by two 
glutamates in a µ-η1:η1 and a µ-η1:η2 binding mode.[32] Two additional water molecules complete the pseudo 
octahedral spheres of the metal centers (Scheme 10.4). Binding dioxygen eventually results in the oxidized 
form MMOHox,  a bis(µ-hydroxo) diiron(III) core. The sMMO enzyme consists of several additional 
subunits responsible for different reactivity. Substrate hydroxylation is carried out by the MMOH subunit, 
whereas electron transfer and substrate oxidation are mediated by the MMOR subunit. The regulation and 
control of  regioselectivity and kinetics is carried out by the MMOB subunit.[257–259]Apart from activating 









Extensive investigations on sMMO have led to a better understanding of its catalytic cycle.[261–263] Though 
the catalytic cycle comprises a total of seven intermediates, two are of special interest. The first, a µ-1,2-
peroxo diiron(III) motif P which forms on dioxygen binding to the diiron centers in MMOHred.[187,264–267] 
This reconfigures to form a second intermediate Q, which has recently been characterized by extensive 
Raman spectroscopic studies and confirmed to be a bis(µ-oxo) diiron(IV) core.[261,263,268]  Intermediate Q is 
responsible for hydroxylation reactions of the substrate. As mentioned earlier, sMMO belongs to the class 
of carboxylate-bridged non-heme diiron enzymes. Scheme 10.5 depicts the importance of this bridge 
leading up to the carboxylate shift that facilitates availability of vacant coordination sites for dioxygen 




Scheme 10.4 Active site of the hydroxylase unit of sMMO in its active reduced form (MMOHred), and its resting state 
(MMOHox). 



















10.1.3.1 Synthetic model systems for sMMO 
Efforts in replicating the active site of sMMO have led to a variety of synthetic analogues which have 
contributed to a better understanding of the enzyme.[187,243,246] Dating back to 1980, the groups of Weighardt 
and Lippard independently reported two diferric oxo bridged complexes I and II respectively, bearing the 
typical µ-oxo-bis(µ-carboxylato)-diiron(III) core commonly found in diiron enzymes.[270,271] Both 
complexes were obtained with acetate co-ligands and capping ligands triazocyclononane (tacn) (for I) and 
tris(pyrazole)borate ligand (for II). Analysis of these complexes via magnetic and spectroscopic 









Scheme 10.5 A more detailed representation of dioxygen activation by MMOH with intermediates P and Q.[245] 
Figure 10.1 Model systems I and II featuring the µ-oxo-bis(µ-carboxylato)-diiron(III) core.[270][271] 




A diferrous iron complex was later isolated with the aid of tacn and acetate co-ligands comprising a hydroxo 
bridge between the iron(II) cores (III).[272] The reactivity of complex III with dioxygen led to the formation 
of a diiron(III) µ-oxo bridged species IV (Scheme 10.6), which was the first model system reported to 
mimic the active site of deoxyhemerythrin. Following this, a large number of synthetic analogues have been 
reported in literature that target mimicking the structural and functional aspects of non-heme diiron 
proteins.[240,273,274]These model systems have helped in explaining the importance of the bridging 
carboxylate units which have shown to switch their binding modes in order to provide vacant coordination 
sites for substrate binding.[247,248,275,276] A variety of high-valent iron oxo intermediates such as peroxides, 
mixed-valent oxides, and high-valent diamond oxo cores have been isolated with the aim of mimicking the 








Distinct synthetic diiron(III)-peroxo intermediates similar to the active intermediate P in sMMO were first 
reported in 1996 almost simultaneously and independently by Lippard, Suzuki and Que. This is regarded 
as a seminal achievement in search for model complexes of transient iron-oxygen intermediates. The 
diiron(III) peroxo species V reported by Lippard et al., was synthesized with a modified 
tris(pyrazolyl)borate ligand in combination with carboxylate ligands in a self-assembly reaction.[265,278] The 
compounds VI and VII synthesized by Que and Suzuki, respectively, were obtained with pre-organized 
ligand systems.[249,266,267,279] The structural and spectroscopic features of V, VI and VII (Fig. 10.2) were in 
good agreement with that of P.[262,280] Figure 10.2 depicts a schematic representation of the µ-1,2 peroxo 
moieties of V, VI and VII. The O-O bond lengths of 1.42 Å and resonance Raman stretching frequencies 
of ~900 cm-1 were in the similar range of P. Complex V reported by Lippard et al. beared closest 
resemblance to the peroxo intermediate of MMOH with respect to UV-vis and Mössbauer parameters. Table 
10.1 gives a comparative overview of spectroscopic features of V, VI and VII with P. 
The tris(pyridyl)amine ligand (TPA) as well as the hexa-pyridyl substituted analogue of TPA (6-HPA) have 
helped in developing a large number of high valent diiron model compounds (Fig. 10.3). Dating back to 
1995 Que et al. developed a series of diamond core complexes with the aid of the TPA capping 
ligand.[114,268,281–287] A few years later, successful structural elucidation of a mixed valent valence-
delocalized system unambiguously determined the dioxygen to bind in a diamond core motif. Addition of 
H2O2 to an open core diiron(III) precursor was reported to convert intermediate P to Q, an intriguing 
similarity in the sMMO enzyme.[282] The usage of isotopically labelled O2 confirmed the formation of a 
peroxide diiron(III) intermediate. The mechanism of interconversion with ligand exchange suggested the 
rate of C-H cleavage to be much higher in an open core diiron(III, IV) terminal high spin (S=2) iron (IV)oxo 
unit, as opposed to a bis(µ-oxo) diiron(IV) low spin S=1 species.[281,283–285,287] In parallel, with the aid of the 
6-HPA ligand system, Kodera et al. reported a diiron compound with two iron(IV) oxo units and an S=2 
Scheme 10.6 Model system III emulating the active site of deoxyhemerythrin and its reaction with dioxygen to give 
the diiron complex(IV).[272] 




spin state for both metal centers.[288–290] This intermediate was shown to be in equilibrium with its diiron(III) 
peroxo motif, an interesting finding that could help provide further insights into the mechanism of 



























Figure 10.2 Structurally characterized diiron(III)peroxo complexes, V, VI and VII that serve as model systems for 
intermediate P in sMMO.[249,265–267,278,279] 















Table 10.1 A comparative overview of the spectroscopic features of V, VI and VII with P 
 Fe···Fe (Å) O···O (Å) λ (nm) ε (M-1cm-1) δ (mms-1) |ΔEq| (mms-1) ν (O-O) (cm-1) 
P 
 
  625-650 1500 0.66 1.51 905 
V 
 
4.00 1.41 694 2650 0.66 1.40 876 
VI 
 
3.33 1.43 500-800 1700 0.58/0.65 0.74/1.70  
VII 
 
3.46 1.42 588 1500 0.52 0.72 900 
Figure 10.3 Ligands used to isolate high valent iron-oxo intermediates that have helped in elucidating the mechanism of 
sMMO. 





10.2 Nonheme iron enzymes and Nitric oxide 
The activation of small molecules by dinuclear non-heme iron enzymes is not limited to dioxygen. Nitric 
oxide, another small molecule with its radical nature and high affinity for FeII has been long known to bind 
non-heme iron enzymes.[291,292] Its function as a signaling molecule and an immune defense agent in 
mammals gives it its importance. At nanomolar concentrations, the functioning of NO is well regulated 
within the body. However, higher concentrations of NO can be toxic and fatal, leading to a series of harmful 
effects such as septic shock, the onset of cancer, and several other diseases.[292] Proteins such as RNR,[34,293] 
sMMO,[37] and NORs (nitric-oxide reductases)[36,294] are capable of activating NO and reducing it to nitrous 
oxide, a less toxic form. The former two reduce NO only in small amounts while the latter NORs, found in 
several bacteria, catalyze rapid reduction of NO. The c-type NOR (NorBC, cNOR, or heme b3-FeB), present 
in denitrifying bacteria, catalyzes the two electron reduction of NO to N2O. The structurally characterized 
NorBC comprises two subunits, NorB and NorC.[295] The smaller NorC unit hosts a low-spin heme c redox 
center that transfers electrons to the NorB subunit. The NorB subunit, wherein the actual active site is 
located, consists of a heme b center that transports electrons to the active site. The actual active site of the 
enzyme responsible for NO reduction hosts a heme b3 iron center and a non heme-FeB iron center. X-ray 
characterization has shown the non heme-FeB center to be coordinated by three histidine units, an aspartic 
acid, and an oxo bridge connecting it to the heme-b3 center.[296,297] Investigations of NO binding at heme 
b3-FeB active sites have suggested the possible formation of both heme and non-heme FeII NO adducts. 
Though actual intermediates for this enzyme have not yet been isolated, a mononuclear Fe-NO species for 
the non-heme FeB center has been proposed. 
Other than denitrifying bacteria, several pathogenic microbes such as bacteria, cyanobacteria and protozoa 
contain nitric oxide reducing enzymes that function as a protective mechanism against excess NO.  These 
flavo-diiron proteins (FDPs) are subclassified into flavo-diiron dioxygen reductases (FO2R) which activate 
dioxygen, and flavo-diiron nitric oxide reductases (FNOR) that reduce NO.[35] The crystallized form of 
Desulfovibrio gigas containing a FNOR was shown to comprise two non-heme iron centers within its active 
site (Scheme 10.7).[298] One iron center is coordinated to two histidine residues and a glutamic acid, while 
the second is coordinated to a histidine, aspartic acid residue and a water based ligand. The two iron centers 
are bridged by an aspartic acid and a water based ligand completing the coordination spheres of the metal 
centers, making them asymmetric in nature. Crystallographic analysis of these FDPs have shown the flavin 
cofactor to be located in close proximity to the diiron active site. Though the mechanistic significance has 
not been clearly explained till date, the possibility of rapid electron transfer between the cofactor and the 
active site is considered important for catalysis in FDPs. 
 
  
Scheme 10.7 Active site of FNOR in Desulfovibrio gigas and the catalyzed reaction in red also mediated by NORs in 
denitrifying bacteria.[298] 




Besides the reduction of NO in conjunction with NOR’s, NO is also known to interact with several other 
nonheme iron containing enzymes. The uptake of NO with the ferric uptake regulatory proteins (Fur) has 
attracted much attention over the last decade.[299–301] Fur behaves as a global regulator in Gram-negative 
bacteria, E. coli, which controls the expression of genes and iron content within the cell.[302] The 
concentration of iron within the cell is critical for its functioning and needs to be regulated in order to avoid 
undesirable reactions such as Fenton’s reaction. In its active form, FeFur comprises a nonheme iron center 
bound by nitrogen and oxygen ligands. When the iron content in the cell is low, FeFur loses Fe2+, which 
disables further binding of the protein to DNA, increasing iron acquisition within the cell.[303] Studies have 
shown NO to bind to FeFur generating an iron-nitrosyl species unable to bind DNA. This creates a link 
between defense against NO and iron control. However, weather binding of NO to FeFur results in a 
mononitrosyl (MNIC) or dinitrosyl iron complex (DNIC) is still unclear.[300,304,305] 
The interaction of nitric oxide with several iron-sulfur cluster proteins leads to the formation of RSNO (S-
nitrosothiols) or DNICs.[306,307] These DNICs behave as NO storage and transport units that are responsible 
for NO delivery to different targets within the cell. EPR characterization of these complexes in comparison 
to those biologically observed produces a signal at g = 2.03, characteristic of DNICs with sulfur ligated 
systems.[308,309] They are tetrahedral with the iron centers being ligated to sulfur donors such as cysteine 
residues or glutathionine. Though reactivity of NO with iron-sulfur clusters represents pathological targets, 
physiological functions such as the activation of certain transcriptional regulators, SoxR, also results from 
this interaction.[300] However, a detailed analysis of DNICs in the biological system with respect to their 
reactivity and function is not yet well established due to the lack of suitable biomimetic model systems.  
 
10.2.1 Synthetic model systems for FNORs 
The chemistry of nitric oxide activation in contrast to dioxygen activation with iron and diiron model 
systems is still under investigation, resulting in only a handful of well established systems. The first model 
system replicating the binding mode of FNOR was reported by Lippard et al. in 1996.[310] A diferrous 
system VIII (Fig. 10.4), coordinated by bridging alkoxide and benzoate ligands enclosed within a 
dinucleating benzimidazole scaffold, was shown to react with NO to form a diiron dinitrosyl complex. The 
NO was bound in a syn fashion to both the iron centers and the compound was characterized by Mössbaeur, 
UV-vis and IR spectroscopy.[311] Further investigations with VIII in 2014 was shown to produce nitrous 
oxide in the presence of light, replicating the function of FNOR.[312]  
A second system IX (Fig. 10.4), reported by Lehnhert et al. in 2013 with the aid of pyridine and alkoxide 
ligand scaffolds showed to bind NO forming a diiron dinitrosyl motif, which subsequently released NO 
under chemical and electrochemical reduction.[313,314] This is reported to be the first functional biomimetic 




















10.2.2 Synthetic model systems for DNICS 
The DNICs that have been synthesized and characterized so far can broadly be categorized into 
mononuclear or dinuclear DNICs, wherein mainly S-, N- and O- ligand donors mimicking biological 
scaffolds have been used.[315] As the name suggests, mononuclear DNICs contain a single iron center with 
two NO groups attached to it. These have further been subclassified based on coordination number and 
geometry around the iron center. The classical DNICs are tetrahedral with a coordination number of 4, 
whereas the nonclassical DNICs are usually square pyramidal or octahedral with coordination numbers of 
5 and 6. The dinuclear DNICs contain two iron centers wherein each iron is bound to two NO molecules. 




Various chelating ligands containing thiolate, imidazolates, phenolates, carboxylates, nitrites and nitrate 
coordinating groups have proved to be suitable scaffolds for generating four coordinated and dinuclear 
DNICs. Distinct reaction pathways with the aid of suitable nucleophiles or bases, starting from a bridging
Figure 10.4 Diiron dintrosyl systems VIII and IX synthesized by Lippard and Lehnert, respectively, that function as 
structural and functional model systems for FNOR.[311,313] 
Scheme 10.8 Schematic representation of mononuclear and dinuclear DNICs. Mononuclear DNICs are subclassified into 
classical and non-classical DNICs based on the coordination number of the iron center.[315]  




diiron dinitrosyl iron complex yields classical mononuclear DNICs, whereas reduction of these bridging 





In case of the nonclassical 5 or 6 coordinated DNICs, multidentate ligands such as bidentate κ2-ONO from 
nitrite or κ2-O2NO from nitrate, tridentate ligands such as iPrPDI or PyImiS and tetradentate ligands such 









10.3 Bis-oxazoline ligands in Iron chemistry 
The use of chiral ligands in conjunction with transition metals has provided a large number of asymmetric 
catalysts for organic synthesis.[54,327] In particular bidentate, tridentate and tetradentate N-donor ligands 
containing chiral oxazoline scaffolds together with their iron complexes have proved to be impressive 
asymmetric catalysts.[327]  
Dating back to 1991 Corey et al. first reported an Fe(III) halide complex with a C2-symmetric chiral 
bidentate bis(oxazoline) ligand, to behave as an efficient catalyst for enantioselective Diels Alders 
reactions.[55] Following this, several systems have been developed for a variety of organic reactions. 
Bidentate bis(oxazoline) ligand systems such as 1,1’-bis(4,4-dimethyl-1,3-oxazolin-2-yl)ethane and 
Spirobox, with their Fe(II) and Fe(III) halide complexes, have proved to be catalysts for efficient atom 
transfer radical polymerization of styrene and O-H bond insertion reactions, respectively.[328,329] Recently 
Yoon et al. have reported high yields for regio and steriochemically controlled asymmetric oxyamination 
Figure 10.5 Ligand systems employed in the synthesis of classical mononuclear and dinuclear DNICs.[315]  
Figure 10.6 Ligand systems employed in the synthesis of non-classical mononuclear DNICs.[315]  




reactions mediated by iron(II) box complexes (Fig. 10.7).[330] Though most of these complexes have not 
been structurally characterized, the system reported by Grassi et al. revealed the iron center to be 





Tridentate Pybox ligands and their iron complexes have been reported to catalyze a series of organic 
reactions such as, the hydrosilylation of ketones,[331][332] formation of carbon-heteroatom bonds (Michael 
addition reactions) and formation of hetero-hetero atom bonds such as sulfur-oxygen and sulfur-nitrogen 
bonds.[327] In most cases, the complexes reported were coordinated solely by the ligand system. However, 
some groups have also utilized additional ligands such as CO in order to enhance catalytic reactivity.[333] 
Ligands that are tetradentate in nature such as (S,S)-bomen and (S,R,R,S)-bomen have generated suitable 













Figure 10.7 Bidentate BOX ligand systems used in conjunction with iron for asymmetric catalysis.[55,328,330] 
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The previous sections described the air sensitive Cu(I)BOX complexes activating dioxygen to yield Cu2O2 
intermediates at low temperatures. Small molecule activation with Fe(II)BOX complexes was similarly 
investigated. Though a large number of FeBOX systems which mediate asymmetric catalysis are known in 
literature, a detailed study of the interaction of such metal-complexes with small molecules has not yet been 
explored or reported till date. The goal was thus to synthesize Fe(II) complexes of neutral BOX ligands, 
similar to those of their Cu(I) analogues, and investigate their reactivity towards small molecules such as 
O2 and NO.  
The following sections describe the synthesis and characterization of mononuclear Fe(II)BOX complexes 
with neutral ligands HL1, HL2, HL3, HL5 and L6. Additionally, a dinuclear Fe(II)BOX complex with the 
ligand L6 was also synthesized and characterized during the course of this work. All of these complexes 
were successfully characterized via X-ray crystallography. Figure 11.1 illustrates the ligand systems used 




11.2 Synthesis and characterization of mononuclear Fe(II) complexes with neutral BOX ligands 
The general scheme employed for the generation of Fe(II) complexes with neutral BOX ligands is depicted 
in Scheme 11.1. Ligands HL1, HL2, HL3, HL5 and L6 were treated individually with 1 equivalent of 
Fe(II)Cl2 to yield yellow colored solutions of their (BOX)FeCl2 complexes 17, 18, 19, 20 and 21 
respectively. In case of 17, 18, 20 and 21, THF was used as a suitable solvent whereas for 19, DCM was 
preferred due to solubility reasons. ESI-MS analysis of all (BOX)FeCl2 complexes with proton responsive 
ligands in solution yielded a similar pattern. The yellow colored solutions of these complexes revealed two 
peaks belonging to the same complex. The minor peak could be assigned to the deprotonated complex 
LxFeCl2 (where Lx represents the deprotonated form of HL1, HL2, HL3 and HL5) and the major peak could 
be assigned to the deprotonated complex LxFeCl2 with additional solvent molecules (CH3CN, CH2Cl2 and 
OH). In case of 21, the complex could not be successfully analyzed via ESI-MS. Figures 11.2 and 11.3 
illustrate the ESI-MS spectra of 17 (Fig. 11.2 left), 18 (Fig. 11.2 right), 19 (Fig. 11.3 left) and 20 (Fig. 11.3 
right). 
Figure 11.1 Neutral ligands employed in the generation of suitable Fe(II)BOX complexes for small molecule activation. 













Scheme 11.1 General scheme for the synthesis of (BOX)FeCl2 complexes with neutral BOX ligands. 
Figure 11.2 Left: ESI-MS of 17 in CH3CN. The two major peaks belong to the same compound as evidenced by MS. The peak 
marked with a red asterisk denotes [L1FeCl2]-. The inset shows an enlargement of this peak at m/z = 335, together with a 
simulation of the isotopic pattern. The larger peak belongs to [L1FeCl2CH3CNCH2Cl2OH]-. Right: ESI-MS of 18 in CH3CN. 
The two major peaks belong to the same compound as evidenced by MS. The peak marked with a red asterisk denotes 
[L2FeCl2]-. The inset shows an enlargement of this peak at m/z = 349.1, together with a simulation of the isotopic pattern. The 




Figure 11.3 Left: ESI-MS of 19 in CH3CN. The two major peaks belong to the same compound as evidenced by MS. The peak 
marked with a red asterisk denotes [L3FeCl2]-. The inset shows an enlargement of this peak at m/z = 411.1, together with a 
simulation of the isotopic pattern. The larger peak belongs to [L3FeCl2CH3CNCH2Cl2OH]-. Right: ESI-MS of 20 in CH3CN. 
The two major peaks belong to the same compound as evidenced by MS. The peak marked with a red asterisk denotes 
[L5FeCl2]-. The inset shows an enlargement of this peak at m/ z = 425.1, together with a simulation of the isotopic pattern. The 








11.2.1 UV-vis and IR Spectroscopy 
Complexes 17, 18, 19, 20 and 21 were further characterized via UV-vis and IR spectroscopy. UV-vis 
measurements of these CH3CN solutions revealed only a shoulder like region between 280-300 nm (ε ≈ 
15,000 M-1cm-1) in all cases which could tentatively be assigned to a π to π* transition originating from the 
ligand system. The UV-vis spectrum of the ligand itself (Fig 11.4 left inset) displayed a similar shoulder 
around 300 nm which could possibly be assigned to a  π to π* transition, which changed slightly on 
complexation with the metal. No MLCT or d-d transition bands were observed. IR spectroscopy of 
crystalline material of these complexes showed bands at ~3000 cm-1 and 1500-1200 cm-1 which could be 
assigned to the C-H stretching and bending modes of the ligand. In all cases, intense sharp peaks at ~1650 
cm-1 and ~1100 cm-1 were also observed which could be assigned to the C=N and C-O stretching modes of 
the BOX ligands, respectively. Weaker bands between 1300-1200 cm-1 were assigned to the C-N stretching 
modes. Figure 11.4 (left) illustrates the UV-vis spectrum of 21 in solution and figure 11.4 (right) illustrates 
its IR spectrum in solid state.  
 
 
11.2.2 Mössbauer Spectroscopy 
Zero field Mössbauer spectra of crystalline material of all mononuclear Fe(II)BOX complexes were 
measured at 80 K. The resulting spectra revealed only an Fe(II) high spin species to be present. In all cases, 
the isomer shifts (δ) of ~0.95 mms-1, quadrupole splitting values (|ΔEq|) of ~3.14 mms-1, and narrow 
Lorentzian profiles of ~0.30 mms-1 were rather similar and typical of a Fe(II) high spin species. These were 
in good agreement to the results obtained from X-ray crystallography confirming that the iron atoms were 
indeed present in a tetrahedral environment in the +2 oxidation state (Refer to sec. 11.2.3). Figures 11.5 to 
11.7 illustrate the Mössbauer spectra of Fe(II)BOX complexes with proton and non-proton responsive 
ligands and Table 11.1 describes the individual isomer shifts, quadrupole splitting values and full width at 
half maximum values of each of these complexes.  
 
Figure 11.4 Left: UV-vis spectra of 21 measured in CH3CN at rt. The shoulder at ~300 nm (ε ≈ 15,000 M-1cm-1) was assigned 
to the π to π* transition originating from the ligand. Sowin in the inset is the UV-vis spectrum of ligand L6. Right: IR 









Figure 11.5 Left: Zero field Mössbauer spectrum of crystalline material of 17 measured at 80 K. Right: Zero field Mössbauer 




Figure 11.6 Left: Zero field Mössbauer spectrum of crystalline material of 19 measured at 80 K. Right: Zero field Mössbauer 
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11.2.3 Structural elucidation of mononuclear Fe(II)BOX complexes 
The Fe(II)BOX complexes of proton and non-proton responsive ligands were successfully characterized 
via X-ray crystallography. Layering of hexane with THF solutions of 17 (Fig. 11.8 left), 18 (Fig. 11.8 right), 
20 (Fig. 11.9 right) and 21 (Fig. 11.10) yielded single crystals suitable for X-ray diffraction. In case of 
complex 19 (Fig. 11.9 left), layering of hexane with a DCM solution of the complex yielded suitable 
crystals. The molecular structures of all of these complexes reveals the iron to be coordinated in a distorted 
tetrahedral geometry by the bidentate BOX ligands and two chloride atoms. The angles N-Fe-N are acute 
~88º but compensated by larger metal chloride angles ~116º. The Fe-N bond lengths in the range of 2.07-
2.08 Å are, however, shorter than in other related α-diimine complexes.[335] Similar to what was observed 
with the Cu(I)BOX complexes (refer to Chapter 5), the BOX ligands take up a boat shaped coordination.  
The metal center along with part of the ligand scaffold comprising of the nitrogen atoms and bridging 
carbon, form a six membered chelate ring in an essentially single plane. The two methyl groups along with 
the chloride atoms and alkyl or aryl substituents present within the ligand backbone, lie above and below 
the plane. Contrary to the Cu(I)BOX analogues, no exogenous solvent molecules were bound to the 
Fe(II)BOX complexes. It should be noted that though a large number of Fe-BOX complexes are known in 
literature, only two of them have been characterized via X-ray crystallography.[328,336] Figures 11.8 to 11. 
10 illustrate the structurally elucidated complexes of Fe(II)BOX ligands and Table 11.2 describes the 




















Figure 11.9 Left: Molecular structure of 19 in the crystal with partial labelling scheme. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å] for 19: Fe1-N1 2.0821(18), Fe1-N2 2.0844(18), Fe1-Cl2 2.2525(6), Fe1-Cl1 2.2540(6). Right: 
Molecular structure of 20 in the crystal with partial labelling scheme. Hydrogen atoms are omitted for clarity. Selected bond 






Figure 11.10 Molecular structure of 21 in the crystal with partial labelling scheme. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å] for 21: Fe1-N2 2.0826(13), Fe1-N1 2.0854(15), Fe1-Cl2 2.2458(6), Fe1-Cl1 2.2556(6). 
 




Figure 11.8 Left: Molecular structure of 17 in the crystal with partial labelling scheme. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å] for 17: Fe1-N2 2.080(5), Fe1-N1 2.081(5), Fe1-Cl2 2.2529(15), Fe1-Cl1 2.2551(15). Right: 
Molecular structure of 18 in the crystal with partial labelling scheme. Hydrogen atoms are omitted for clarity. Selected bond 
















11.3 Synthesis and characterization of a dinuclear Fe(II)BOX complex with BOX ligand L6 
In addition to the mononuclear (BOX)FeCl2 complexes that have been described in the previous section, a 
dinuclear Fe(II) complex with ligand L6 was successfully synthesized according to Scheme 11.2. The ligand 
was treated with 1 equivalent of Fe(OTf)2(MeCN)2 under inert conditions in THF to yield a light yellow 
colored solution. Workup with DCM and THF, followed by layering with dry hexane yielded single crystals 








11.3.1 Properties in solid state 
11.3.1.1 Structural elucidation of 22 
Single crystals of 22 were successfully grown from a THF/hexane solution of the complex at rt in10% yield 
revealing a dinuclear (BOX)Fe(II) species. 22 crystalizes as two crystallographically independent 
molecules per unit cell in the triclinic space group P 1 and possesses a crystallographically imposed Ci 
symmetry. X-ray diffraction analysis (Fig. 11.11) showed the iron centers to be identical and coordinated 
in a distorted octahedral environment. Each metal atom was bound to the nitrogen donors of the BOX ligand 
with the metal centers being bridged by two triflate molecules. The bridging triflate moieties were bound 
asymmetrically to the iron centers with a single oxygen atom being coordinated to one metal while the other 
two oxygen atoms were coordinated to the second. An additional triflate molecule was coordinated to each 
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Scheme 11.2 Schematic representation for the synthesis of a dinuclear Fe(II)BOX complex 22 with ligand L6. 




iron center completing its octahedral coordination sphere. The Fe-N bond lengths in the dinuclear complex 
were similar to those of the mononuclear Fe(II) complexes in the range of 2.07-2.08 Å, suggesting no 
change in metal to ligand coordination.  The Fe-O bond lengths of bridging triflate moieties were measured 
between 2.1-2.2 Å and were slightly longer compared to those of the terminally bound triflate at each iron 
center (2.02 Å). This can be attributed to the bridging triflate molecules having to span between the two 
metal centers compared to the those terminally coordinated to a single metal center. The different binding 
modes result in a difference of their respective Fe-O bond lengths. The Fe···Fe separation was measured at 
5.32 Å which was rather high compared to other dinuclear Fe(II) complexes. A plausible explanation for 
the formation of a dinuclear species with Fe(OTf)2(MeCN)2 as opposed to mononuclear complexes with 
FeCl2 and BOX ligands could be, that the counterion in the former case being much larger with the ability 
to coordinate at multiple sites, prefers the formation of a dinuclear species. Moreover, as triflate is a far 
weaker donor than chloride, it fails to satisfy the electronic environment around the iron center, leaving the 
Fe(II) center relativiely acidic. This results in further binding of ligands to the metal center, forming a 











11.3.1.2 Mössbauer Spectroscopy 
Zero field Mössbauer spectroscopy of crystalline material of 22 (Fig. 11.12) at 80 K revealed only one 
Fe(II) species to be present indicating both iron sites to exhibit identical Mössbauer parameters, in line with 
the crystallographic equivalence of the two metal sites. 22 displayed an isomer shift (δ) of 1.24 mms-1 with 
a quadrupole splitting (|ΔEq| ) of 3.84 mms-1 typical for Fe(II) high spin complexes with a high coordination 





Figure 11.11 Molecular structure of 22. Hydrogen atoms are omitted for clarity. Selected bond lengths [Å] for 22: Fe1-O6A 
2.020(9), Fe1-O6B 2.026(10), Fe1-N1 2.078(4), Fe1-N2 2.084(4), Fe1-O3 2.156(3), Fe1-O4' 2.219(4). 







11.3.1.3 Magnetic Measurements 
Since 22 represents a dinuclear high spin Fe(II) species, magnetic susceptibility measurements were carried 
out in order to investigate the presence of any coupling between the two metal centers. Measurements at 
0.5 T within the range of 2 to 210 K generated a χmT value of 6.17 cm3Kmol-1 at 210 K which corresponded 
to a magnetic moment of 7.05 µB (Fig. 11.13 left). This was in reasonable agreement with the spin-only 
value of two iron(II) ions, each with a spin state of S = 2 (6.92 µB). The values of χmT between 50 K to 210 
K remained virtually constant signifying the absence of  strong exchange interaction between the two metal 
centers. However, on reducing the temperature from 50 K to 0 K the magnetic susceptibly dropped 
indicating a possible presence of ZFS within the molecule. Variable temperature/variable field (VTVH) 
measurements carried out at 1 T, 3 T and 5 T indeed corroborated this assumption (Fig. 11.13 right).  
Figure 11.13 Left: Magnetic susceptibility measurements (χmT vs T) of crystalline material of 22 measured between 2 K to 
210 K at 0.5 T. Right: Variable temperature/ variable field (VTVH) measurements at 1 T, 3 T, and 5 T confirming the presence 












A simulation of the susceptibility along with VTVH data sets confirmed the presence of two iron(II) centers 
with negligible coupling. A weak antiferromagnetic coupling of J = -0.144 cm-1 was observed with an 
isotropic g value of 2.04. The ZFS value was measured at D = +13.34 cm-1 with E/D = 0.23.  
11.3.1.4 IR Spectroscopy 
IR spectra of crystalline material of 22 were obtained via IR-ATR. Peaks with frequencies observed at 1650 
cm-1 and 1370 cm-1 could be assigned to the C=N and C-N stretching modes of the ligand. A large number 
of peaks between 1000 cm-1 to 1300 cm-1 was assigned to the C-H modes with a sharp peak at 1024 cm-1 
being assigned to the C-O stretch of the ligand scaffold.  
11.3.2 Properties in solution 
In addition to characterizing 22 in the solid state, UV-vis spectroscopy and ESI-MS of a solution of 22 were 
measured. The UV-vis spectrum of a solution of 22 in THF displayed a band at 287 nm (ε ≈ 14,500 M-1cm-
1) which was tentatively assigned to a π to π* transition originating from the ligand (Fig. 11.15 left). No 
MLCT or d-d transitions bands were observed similar to mononuclear Fe(II)BOX complexes. ESI-MS 
analysis of 22 in CH3CN showed a large number of signals, belonging to fragmented portions of the 
complex, with additional solvent molecules in some cases. A peak at m/z = 1206.8 could be assigned to the 
complex with an additional sodium ion, though the intensity was rather low (Fig. 11.15 right).  





Figure 11.15 Left:  UV-vis spectrum of 22 in THF with a band at 287 nm originating from the ligand. Right: ESI-MS of 22 
in CH3CN. The peak marked in red denotes [(L6Fe(OTf)2)2Na]+.The inset shows an enlargement of this peak at m/z = 1206.8  
together with a simulation of the isotopic pattern. 










To summarize, a series of mononuclear (BOX)FeCl2 complexes with neutral bidentate BOX ligands were 
successfully synthesized during the course of this work. They were all fully characterized in solution as 
well as in the solid state, including characterization by X-ray crystallography. Mössbauer spectroscopy 
suggested the iron centers to be in a +2, high spin oxidation state which was in line with results obtained 
from X-ray analysis. Structural elucidation of all 5  (BOX)FeCl2 revealed the iron centers to be coordinated 
in a distorted tetrahedral environment. The complexes were also characterized by UV-vis spectroscopy, IR 
spectroscopy and ESI-MS (except 21). 
Interestingly, a dinuclear complex  [{L6Fe(OTf)}2(µ-OTf)2] was also synthesized and was fully 
characterized in solution and in the solid state. X-ray characterization of the complex revealed both the iron 
centers to be coordinated in a similar distorted octahedral environment. These results were in good 
agreement with the parameters obtained from Mössbauer spectroscopy which revealed the presence of a 
single Fe(II) high spin species. Further magnetic susceptibility measurements confirmed very weak 
antiferromagnetic coupling between the two iron Fe(II) ions, but substantial zero-field splitting. 
Though a large number of Fe-BOX complexes are known in literature, there are only few that have been 
characterized via X-ray crystallography. Through this work, successful X-ray characterization of 
mononuclear and dinuclear Fe(II)BOX complexes adds to the list of structurally elucidated complexes 
belonging to this ligand class. Moreover, the feasibility to synthesize such complexes puts forward 
opportunities to investigate interesting chemistry of these systems. For example, small molecule activation 
of dioxygen or nitric oxide, similar to those investigated with Cu(I)BOX systems could potentially be 
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The chemistry of mononuclear and dinuclear Fe(II) complexes with small molecules such as dioxygen and 
nitric oxide has attracted much attention over the last few decades. Extensive investigations with suitable 
ligand scaffolds capable of supporting active intermediates have helped in elucidating the mechanism and 
functional principles of the analogous enzymes activating such molecules. The previous sections have 
described small molecule activation of dioxygen with neutral and monoanionic Cu(I)BOX complexes, that 
yielded Cu2O2 intermediates. These were isolated and structurally elucidated at low temperatures which 
highlighted the nature of the ligand scaffold to be crucial in determining the dioxygen binding mode. 
Moreover, the nature of the ligand scaffold also had an effect on substrate reactivity. As a large number of 
mononuclear (BOX)FeCl2 complexes and a dinuclear (BOX)Fe(II) complex of a non-proton responsive 
ligand were successfully synthesized and characterized during the course of this work (refer to Chapter 11), 
their reactivity with small molecules such as dioxygen and nitric oxide was investigated for potential 
formation of novel intermediates.  
Reactions of both mononuclear and dinuclear (BOX)Fe(II) complexes were screened with dioxygen as well 
as PhIO in  various solvents at low temperatures to investigate the formation of iron-oxo intermediates. 
Unfortunately, unlike their Cu(I) analogues, the Fe(II) systems did not yield any detectable intermediates. 
The reactions were monitored via UV-vis spectroscopy and the end products were analyzed by Mössbuaer 
spectroscopy and ESI-MS. In all cases a clear oxidation of iron from the +2 to +3 oxidation state occurred. 
However, the nature of the decomposed product was inconclusive. In case of reactivity with nitric oxide, 
mononuclear (BOX)Fe(II) complexes demonstrated promising reactivity. The following sections describe 
the attempt to activate dioxygen with mononuclear and dinuclear (BOX)Fe(II) complexes and the nitic 
oxide reactivity of a mononuclear Fe(II)BOX complex with a proton responsive ligand. 
 
12.2 Dioxygen reactivity of mononuclear and dinuclear Fe(II)BOX systems 
The mononuclear (BOX)FeCl2 complexes 17, 18, 19, 20 and 21 were treated with dioxygen in a solution 
of THF at 193 K which resulted in a gradual change of the yellow colored solutions to brown (Scheme 
12.1). Monitoring the reactions via UV-vis spectroscopy displayed no major changes in the spectra of the 
starting material. Increasing the temperature of the reaction from 193 K to 233 K and changing the solvent 
to MeCN also resulted in no major spectral changes. In a final attempt, PhIO as a dioxygen source was used 
which too, unfortunately, did not yield any detectable iron-oxygen intermediate. Scheme 12.1 illustrates 






Scheme 12.1 General scheme for dioxygen activation or reaction with PhIO of  (BOX)FeCl2 complexes. 




Mössbauer spectroscopy of the crude products from the reaction of (BOX)FeCl2 complexes with O2 
demonstrated a clear change in the oxidation state of the metal center. Figure 12.2 illustrates the Mössbauer 
spectrum of the product resulting from complex 18 with O2, measured at 80 K. The spectrum displayed a 
single iron species with isomer shift and quadrupole splitting values that differed from the starting material. 
The isomer shift value of 0.37 mms-1 and a quadrupole splitting value of 1.27 mms-1 are typical for a Fe(III) 
high spin system. ESI-MS analysis of this complex displayed peaks belonging to the ligand as well as a 
diiron species. However, the exact nature of the decomposed product could not be determined.  
 
Though the mononuclear (BOX)FeCl2 systems reacted with dioxygen, no detectable intermediates could 
be isolated. The same was displayed by the dinuclear (BOX)Fe(II) system (22). Reactions of 22 with PhIO 
in MeCN at 233 K resulted in no new bands that could be assigned to potential iron-oxo intermediates when 
monitored by UV-vis spectroscopy. Mössbauer spectroscopy of the sample after the reaction with PhIO 
displayed an iron species with isomer shift value of 0.48 mms-1 and quadrupole splitting value of 0.93 mms-
1, differing from those of the starting material and indicating an oxidation of the metal centers. ESI-MS 
analysis of the solution revealed a major peak belonging to the oxidizing agent. No peak corresponding to 
any iron species could be observed.  
In comparison to systems wherein their Fe(II) analogues have yielded potential iron-oxo intermediates, the 
ligand scaffolds are far bulkier in nature with a higher denticity,[243,277] and usually coordinate to the iron 
centers in an octahedral environment. Moreover, the scaffolds are designed such that a dinuclear Fe(II) 
complex results with the ligand system, with the Fe···Fe separation being appropriate to host a dioxygen 
moiety in a suitable binding mode. The tetrahedrally coordinated Fe(II) complexes of bidentate BOX 
ligands, despite having potential vacant sites for further coordination, do not result in the formation of 
detectable iron-oxo intermediates. The strong chloride donor ligands in conjunction with the simple nature 
of the ligand scaffold makes the formation of these intermediates a challenging task as was also observed 
with the dinuclear Fe(II)BOX complex. 
Figure 12.1: Zero field Mössbauer spectrum of 18 after reaction with dioxygen measured at 80 K,  depicting one iron (III) 
high spin species. 





12.3 Nitric oxide reactivity of a Fe(II)BOX complex with a proton responsive ligand 
12.3.1 Preliminary NO reactivity of a dinuclear Fe(II)BOX complex 
In analogy to attempting dioxygen activation of Fe(II)BOX complexes, a second small molecule, nitric-
oxide, was screened to investigate potential reactivity and formation of Fe-NO intermediates. Indeed, the 
dinuclear Fe(II)BOX complex with bridging triflate ligands (22) demonstrated reactivity with nitric oxide. 
A colorless solution of 22 in THF was reacted with NO gas under an atmosphere of argon which resulted 
in an immediate color change from colorless to brown (Scheme 12.2). The reaction was monitored via UV-
vis spectroscopy at 193 K which revealed the formation of distinct bands at 334 nm (ε = 1900 M-1cm-1), 
460 nm (ε = 786 M-1cm-1), and 600 nm (ε = 373 M-1cm-1) (Fig 12.2 left). IR analysis of the brown solution 
demonstrated the formation of two new stretching frequencies at 1745 cm-1 and 1823 cm-1 (Fig.12.2 right). 
The data obtained from UV-vis and IR spectroscopy suggested the formation of a DNIC species.[315] 
However, Mössbauer spectroscopic analysis demonstrated a mixture of iron species to be present within 
the crude product. A comparison of the isomer shift values and quadrupole splitting values with those of 
the starting material indicated the reacted product to contain an iron species corresponding to the starting 
material, an iron-NO reacted product as well as undesired side products. ESI-MS analysis of this mixture 
yielded no conclusive results and X-ray characterization of any Fe-NO intermediate was challenging.  
A plausible explanation for such reactivity of the dinuclear Fe(II)BOX complex with NO could be that 
though the labile triflate molecules allow substitution by NO, the excess of NO causes perhaps degradation 







Scheme 12.2 Scheme for the reactivity of a dinuclear Fe(II)BOX complex (22) with NO at rt. 
Figure 12.2 Left: UV-vis monitoring of a solution of 22 in THF at 193 K treated with NO(g). Shown are bands forming at 
334 nm, 460 nm and 600 nm. Right: IR spectra of 22 in THF shown in black, and a solution of 22 after NO reactivity shown 
in red. Stretching frequencies at 1745 cm-1 and 1823 cm-1 are tentatively assigned to a DNIC species. 




The mononuclear (BOX)FeCl2 complexes 17-21 did not demonstrate any direct NO reactivity. This was 
attributed to the strong chloride ligands that have no tendency to dissociate or to undergo substitution 
reactions  with NO, thus resulting in no Fe-NO intermediates.  
  
12.3.2 NO reactivity of a mononuclear Fe(II)BOX complex with a proton responsive ligand 
In view of the results discussed above, a third route was attempted to isolate an Fe-NO intermediate. The 
mononuclear Fe(II)BOX complex 18 was treated with two equivalents of AgOTf, in order to replace the 
chloride ligands with more labile triflate counterions, thus facilitating substitution reactions. This solution 
was treated with two equivalents of Ph3SCNO instead of NO(g) in order to avoid the excess of NO. On 
addition of the NO source, the colorless solution gradually turned brown. The reaction mixture was stirred 









12.3.2.1 Structural elucidation 
The first evidence of formation of a DNIC species was obtained from X-ray crystallography. Single crystals 
of 23 ([L9Fe(NO)2(OTf)2], where L9 represents the modified ligand scaffold) suitable for X-ray diffraction 
were grown from a THF/hexane solution at rt (Fig. 12.3 left). The molecule crystallizes in the triclinic space 
group P 1. Structural elucidation revealed the iron center to bear a coordination number of four, in a 
distorted tetrahedral environment. This represents a classical DNIC and is in agreement with the ΔνNO value 
observed by IR spectroscopy (refer to sec. 12.3.2.2). 23 was shown to be dicationic in nature with two 
triflate molecules. The iron center was coordinated to two NO moieties and to the nitrogen atoms of a 
slightly altered ligand scaffold. The simple bidentate BOX ligand HL2 was shown to undergo modification, 
giving rise to a scaffold that comprised the neutral ligand coupled to a second ligand moiety. This second 
ligand moiety which was not directly coordinated to the metal center displayed alterations within the ligand 
backbone, forming a C-C bond with a neutral ligand and being twisted such that the oxygen atoms were 
trans to each other (Scheme 12.3). Stoichiometric analysis of complex 23 suggested a positive charge 
contribution from the modified ligand scaffold over the cationic portion of the complex. The geometric 
modification in scaffold of the second ligand moiety was in agreement with the IR spectra of the complex 
measured in solution, wherein the stretching frequency at ~1650 cm-1 assigned to the C=N bond was slightly 
altered (Fig. 12.4 left). Intramolecular hydrogen bonding between the nitrogen and a neighboring oxygen 
Scheme 12.3 Scheme for the generation of a DNIC (23) [L9Fe(NO)2(OTf)2] with a proton responsive BOX Fe(II) complex. 
18, where L9 represents the modified ligand scaffold. 




atom of the ligand scaffold was also observed. The two ligand moieties coupled at the backbone were 
oriented in a cis fashion with the NO molecules lying on the same side (Fig. 12.3 right).  
The angles formed between the ligand and the metal center were acute ~91.9º but compensated by the 
metal-NO angles (~113º). The Fe-NO (avg.) bond lengths of 1.69 Å and N-O (avg.) bond lengths of 1.16 
Å were in the range of cationic DNICs.[316,337] The Fe-N bond lengths of 2.07-2.08 Å were similar to those 
of the mononuclear and dinuclear Fe(II)BOX complexes described previously (refer to Chapter 11). Though 





12.3.2.2 Properties in solution: IR and UV-vis Spectroscopy 
Addition of the NO source to a colorless solution of 18 after treatment with AgOTf resulted in a gradual 
color change to brown, forming a classical DNIC species (23). The DNIC was characterized via IR 
spectroscopy in solution. Two new stretching frequencies at 1752 cm-1 and 1827 cm-1 were observed that 
were absent in the starting material (Fig. 12.4 left). These features are typical for N-O stretching frequencies 
of dinitrosyl iron complexes and are comparable to the cationic DNIC isolated with a Sparteine ligand 
system reported by Liaw et al..[316] Moreover, the ΔνNO of 23, defined as the separation of two NO stretching 
frequencies exhibited by DNICs, was measured at ~70 cm-1 indicating the DNIC to be of classical 
nature.[315] This was in agreement with the results obtained from X-ray crystallography. A second 
interesting feature that was displayed in the IR spectrum of 23 was the band at ~1650 cm-1. This was 
assigned to the C=N stretching frequency originating from the ligand system. However, this feature seemed 
slightly altered in comparison to that of the starting material, indicating a change in bonding within the 
ligand system. This was further highlighted on structurally elucidating the complex which displayed 
interesting ligand changes when bonded to the metal as is discussed in section 12.3.2.1. 
 
Figure 12.3: Left:  Molecular structure of the cationic part of 23. Only hydrogen atoms of the protonated nitrogens are shown. 
Others are omitted for clarity. Right: Molecular structure of the cationic part of 23 depicting the two ligand moieties to be 
oriented in a cis fashion with the NO molecules lying on the same side. Selected bond lengths [Å] for 23: Fe1-N4 1.6905(19), 
Fe1-N3A 1.692(4), Fe1-N3B 1.716(15), Fe1-N1 2.0001(14), Fe1-N2 2.0078(16). 
 




The UV-vis spectrum of a solution of 23 in THF at rt displayed two shoulders at 427 nm (ε = 1820 M-1cm-
1) and 579 nm (ε = 432 M-1cm-1) (Fig. 12.4 right). In comparison to the absorption features exhibited by 
FDPs and other synthetically characterized DNICs, these transitions are assigned to iron-nitrosyl LMCT 
and d-d transitions.[36,293,337] In the case of DNICs, the unambiguous determination of the oxidation state of 
the iron centers remains a matter of speculation. This stems from the fact that the NO molecule itself readily 
switches between different redox levels of NO+, NO·, and NO-, with the exact nature of the NO binding 
moiety being ambiguous.[338,339] Hence, distinctive spectroscopic features for DNICs in terms of the nature 
of ligand and metal orbitals remains a challenging task. ESI-MS of a solution of 23 revealed peaks 
belonging only to the ligand scaffold.  
 
 
 12.3.2.3 Mössbauer spectroscopy 
Zero field Mössbauer spectra of crystalline material of 23 measured at 80 K revealed a single iron species 
to be present as the best fit with a single quadrapole doublet was obtained (Fig. 12.5). The isomer shift 
values of 0.33 mms-1 and quadrupole splitting values of 1.43 mms-1 point towards an iron species present 
in either a +3 oxidation state with an S = 5/2 spin state or a +1 oxidation state with an S = 3/2 spin state. As 
mentioned earlier, the metal oxidation state in Fe(NO)x moieties is not well defined. Since structural 
elucidation of the DNIC (23) revealed it to be dicationic in nature, with one cationic charge on the second 
ligand, and in comparison with Mössbauer paramteres of other DNICs, a tentative +1 oxidation state to the 
iron center was assigned. This would mean that both the NO molecules bind as neutral NO·, resulting in a 
[Fe(NO)2]9 system according to the Enemark-Feltham notation. The full width at half maximum obtained 
from the Lorentzian profile of the Mössbauer spectra was measured at 0.68 mms-1.  
The coupling of the ligand backbone displayed by 23  was investigated  by replacing AgOTf with NaOTf, 
in order to eliminate possible oxidation. However, this yielded no valuable insights. As BOX ligands are 
known to display redox non-innocent behavior, [225] one could speculate that perhaps the AgOTf oxidizes 
Figure 12.4 Left: IR spectrum of 23 in THF shown in red with NO stretching frequencies at 1752 cm-1 and 1827 cm-1 
assigned to a DNIC species, and the spectra of the starting material shown in black. Right: UV-vis spectra of a solution of 
23 in THF at rt displaying shoulder like regions at 427 nm and 579 nm. 




the ligand, which leads to C-C coupling resulting in the formation of a modified ligand scaffold. As 






Fe(II)BOX complexes have long been known to mediate asymmetric catalysis, with small molecule 
activation of such systems being unexplored. Through the course of this work, the reactivity of (BOX)Fe(II) 
complexes with dioxygen and nitric oxide was investigated. Though no detectable iron-oxo intermediates 
could be isolated with these complexes and dioxygen, unlike their Cu(I) analogues, the (BOX)Fe(II) 
complexes demonstrated promising reactivity with nitric oxide.  
The Fe(II) complex of a proton responsive ligand HL2 yielded a Fe-NO complex, though the elucidation of 
its mechanism of formation remained challenging. The BOX ligand proved to be a suitable scaffold for 
generating a DNIC, which was characterized in solution and via X-ray crystallography.  The stretching 
frequencies observed by IR spectroscopy were characteristic of classical DNICs which was in agremment 
to results obtained by X-ray crystallography. Structural elucidation of 23 exhibited a dinitrosyl iron species, 
ligated to a modified ligand scaffold present in a tetrahedrally coordinated environment, with measured 
bond lengths being in the realm of cationic DNICs. The Mössbauer parameters were suggestive of the iron 
existing in a +1 oxidation state,  resulting in a [Fe(NO)2]9 system according to the Enemark-Feltham 
notation. Through this work it was possible to successfully isolate and structurally elucidate a DNIC 
complex with a simple bidentate BOX ligand. This puts forward opportunities to investigate Fe-NO 
chemistry of structurally and electronically modified BOX ligand systems.  
 
Figure 12.5: Zero field Mössbauer spectrum of 23 measured at 80 K, showing a single quadrapole doublet with isomer shift 




















































In conclusion, a series of mononuclear Fe(II)BOX complexes were synthesized with proton and non-proton 
responsive ligand systems. These were characterized via IR, UV-vis, ESI-MS and Mössbauer spectroscopy. 
All of these complexes were structurally elucidated, which revealed the iron center to be coordinated in a 
distorted tetrahedral environment. These results were in corroboration with the parameters obtained from 
Mössbauer spectroscopy which revealed the iron species to be present in a +2 high spin oxidation state. 
Additionally, a dinuclear Fe(II)BOX complex with a non-proton responsive ligand was synthesized and 
structurally characterized. Mössbauer spectroscopy described the iron centers to be present in an identical 
environment which was finally confirmed by X-ray analysis of the complex. Structural elucidation revealed 
the iron centers to be coordinated in an octahedral environment with bridging triflate ligands. Magnetic 
measurements were suggestive of negligible coupling between the two metal centers, but revealed 
substantial ZFS.  
Dioxygen reactivity of both the mononuclear and dinuclear (BOX)Fe(II) systems proved challenging in 
isolating any detectable iron-oxo intermediates. This was attributed to the simple nature of the ligand 
scaffold in conjunction with the strong chloride donor ligands attached to the metal center. Nitric oxide 
reactivity of a Fe(II)BOX system with a proton responsive ligand successfully generated a  DNIC. The 
complex was characterized in solution by IR and UV-vis spectroscopy. The IR stretching frequencies 
observed were characteristic of DNICs. Analysis by Mössbaeur spectroscopy suggested the iron to host a 
possible +1 oxidation state which resulted in a [Fe(NO)2]9 system according to the Enemark-Feltham 
notation. Through the course of this work, it was shown that bidentate BOX ligands form suitable scaffolds 
for DNICs. This gives an opening for further investigations of such systems in terms of modifications in 



























Through the course of this work, we have successfully been able to demonstrate small molecule activation 
by copper and iron complexes with structurally and electronically modified bis(oxazoline) ligand systems. 
A series of ligands comprising neutral and anionic BOX ligands were synthesized with their corresponding 
Cu(I) and Fe(II) complexes. Their reactivity towards dioxygen and nitric oxide were screened in order to 
investigate reaction pathways and the formation of potential intermediates. 
The Cu(I) complexes of BOX ligands yielded key Cu2O2 intermediates with dioxygen at low temperatures. 
The nature of the ligand scaffold was crucial in determining the dioxygen binding mode and subsequent 
reactivity of the intermediate. While neutral BOX ligands preferentially formed their SP complexes, a 
dioxygen binding mode similar to those of Type 3 copper proteins, the anionic ligands preferred O 
formation. Moreover, it was possible to tune the equilibrium between the SP/O isomers with “pH”, a new 
factor that was previously unknown. The Cu(I) complexes of proton responsive (HL1, HL5) and non-proton 
responsive ligands (L6) were structurally elucidated, besides characterization in solution. A SP complex of 
a non-proton responsive ligand (8) as well as a proton responsive ligand (6) was isolated and characterized 
by X-ray crystallography. Both the systems demonstrated a rather long O-O bond in comparison to other 
reported systems, with complex 6 having the longest O-O bond reported to date, giving it its noteworthy 
character. These two new structures add to the handful of SP complexes that have been structurally 
elucidated over the last three decades. 
The Cu(I) complexes of anionic BOX ligands and their corresponding O complexes were characterized in 
solution. A neutral O complex 10 was successfully characterized by X-ray crystallography, making it the 
second of its kind. Though this binding mode has not yet been biologically observed, recent studies have 
proposed the active intermediate of pMMO to bind in a similar fashion. While the O systems of anionic 
BOX ligands demonstrated unphysiological reactivity with basic phenolic substrates, the SP systems of 
proton responsive ligands isomerized to their O congeners. Activity similar to that of Tyrosinase was 
emulated by a SP system 8 hosting a non-proton responsive ligand scaffold.  
Contrastingly, isolation of any detectable iron-oxo intermediates with (BOX)Fe(II)Cl2 complexes and 
dioxygen was challenging. Reactivity of these systems with nitric oxide successfully generated a DNIC. A 
series of mononuclear (BOX)FeCl2 complexes were structurally elucidated in addition to characterization 
in solution. Furthermore, a dinuclear (BOX)Fe(II) complex was also synthesized and structurally 
characterized. These now add to the list of Fe(II) complexes belonging to this ligand class, of which only 
two had previously been characterized by X-ray crystallography. The nitric oxide reactivity of a Fe(II) 
complex with a proton responsive ligand generated a DNIC which was characterized in solution and 
structurally elucidated.  
In view of the results obtained from copper dioxygen reactivity with BOX systems, the ability to 
peripherally deprotonate the ligand systems resulting in isomerization between the SP/O congeners, and in 
conjunction with the isomerization of SP systems of proton responsive ligands with substrates puts forward 
an interesting notion. As the analogous biological ligand scaffolds with nitrogen donors are susceptible to 
(de)protonation events, one could speculate whether a local pH change consequentially affects the active 
intermediate in Type 3 copper proteins responsible for catalytic activity. Given the fact that redox potentials 
and electronic structures of metallocofactors have been tuned by deprotonation of histidine imidazole 
ligands in various metalloproteins, which forms a fundamental part of PECT reactions, similar reactivity 
with proton-responsive ligands and Cux/O2 intermediates would form an interesting study. Moreover, the 
ability of BOX ligands to stabilize DNICs introduces opportunities to investigate these systems with 





In conclusion, the ability of BOX ligands to isolate intermediates analogous to those observed in nature 
highlights their nobility in simplicity. Termed as a privileged class of ligands that have been used 
extensively in asymmetric catalysis, through the course of this work, have proved to be a privileged class 
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Materials and Methods 
 
15.1 General Remarks 
The syntheses of air or moisture sensitive ligands, building blocks or complexes were carried out using 
standard Schlenk technique or in a glovebox. All glassware was dried at 120 ºC overnight prior to use. 
Solvents were purified and dried according to established procedures. They were distilled  prior to use and 
degassed by bubbling with argon. Deuterated solvents were dried and distilled the same way as the 
undeuterated analogues. [Cu(MeCN)4](ClO4) was synthesized from commercially available copper(II) 
perchlorate hexahydrate and copper metal.[135] 2,6- Lutidinium triflate was synthesized from 2,6-lutidine in 
pentane via addition of neat triflic acid.[340] DBU was distilled prior to use and stored over 4A molecular 
sieves in a glovebox. All other chemicals were purchased and used without further purification. 
 
1H and 13C{1H} NMR spectra were recorded on a Bruker Avance 300 MHz spectrometer. Low Temperature 
1H NMR, VT-1H-NMR and DOSY were recorded on a Bruker Avance 500 MHz spectrometer. Chemical 
shifts are reported in ppm relative to residual proton signals of the solvents. Low resolution ESI mass spectra 
were recorded on a Bruker (HCT Ultra) spectrometer coupled to a glovebox. Microanalysis were performed 
by the “Analytic Laboratory of the Institute for Inorganic Chemistry at the University of Göttingen”, using 





IR spectra were either recorded using a Cary 630 FTIR spectrometer (Agilent) placed in a glovebox 
(MBRAUN UNIlab, argon atmosphere) with a DialPath and Diamond ATR accessory, or with a Bruker 
VERTEX 70 using KBr pellets. 
 
Resonance Raman Spectroscopy 
 
Raman spectra under resonant and non-resonant conditions were recorded using a HORIBA Scientific 
LabRAM HR 800 (400-1100 nm) spectrometer with an open-electrode CCD detector and a confocal 
pinhole with user controlled variable aperture in combination with a free space optical microscope. For 
excitation either a He:Ne (633 nm) or a diode laser (457 nm) was used, as indicated for each experiment. 
18O2 labelled samples were prepared according to procedures described in the main text. Resonance Raman 
spectra were recorded in suitable solvents, according to description in the main text, and prepared by direct 
addition of 16O2 or 18O2, respectively, to solutions of the complexes in a Young NMR tube. Low temperature 
frozen solution spectra were recorded placing the tube in a liquid nitrogen bath using a transparent cold 
finger dewar. Solution samples were measured at Low temperature in an acetone-dry ice bath prepared in 
the finger dewar.  
 
Magnetic measurements  
 
Temperature-dependent magnetic susceptibilities were measured using a Quantum-Design MPMS XL-5 
SQUID magnetometer equipped with a 5T magnet within the temperature range of 300 K to 2 K. The 
polycrystalline sample was contained in a gelatin capsule, fixed with polyfluorinated oil if necessary, and 
placed in a non-magnetic sample holder. Each raw data file for the magnetic moment was corrected for the 




diamagnetic contribution of the gelatin capsule according to Mdia(capsule) = χg × m × H, with an 
experimentally obtained gram susceptibility of the gelatin capsule. The molar susceptibility data were 
corrected for the diamagnetic contribution using the Pascal constants and the increment method according 
to Haberditzl[341,342] Simulation of the experimental data with full matrix diagonalization of exchange 
coupling was performed with the julX program. Temperature independent paramagnetism (TIP) and 
paramagnetic impurity (PI) were included according to  
 
χcalcd =  χ · (1-PI) + χmono·PI + TIP 
 
The coupling constant JAB was calculated from the Heisenberg-Dirac-vanVleck (HDvV) Hamiltonian 
 




UV-vis spectra at ambient temperature were measured with a Cary 5000 Bio spectrophotometer using 
quartz cuvettes sealed by a rubber septum. Solid state spectra were recorded using the Cary Bio 
spectrophotometer but with a Praying MantisTM diffuse reflection attachment equipped with a sample 
chamber with quartz windows (Harrick Scientific Products). Low temperature UV-vis spectra were  
recorded with an Agilent Cary 60 equipped with an Unisoku Cryostat (CoolSpek) and magnetic stirrer using 




X-ray data were collected on a STOE IPDS II diffractometer with an area detector (graphite 
monochromated MO-K radiation, λ=0.710 73 Å) by use of ω scans at 133 K. The structures were solved 
using direct methods and refined against F2 using all reflections with SHELX-2013. Non-hydrogen atoms 
were refined anisotropically, unless stated otherwise. Hydrogen atoms were placed in calculated positions 
and assigned to an isotropic displacement parameter of 1.2/1.5 Ueq(C) or 1.5Ueq. Face-indexed absorption 
corrections were performed by the program X-RED (STOE & CIE GmbH, Darmstadt, Germany,2002).[343] 
For further details on crystal data and refinement see Appendix. 
 
15.2 Ligand Synthesis  
 
15.2.1 BOX ligands HL1, HL2, HL3, HL5 and L6 were prepared in a three step synthesis route according 
to literature procedures.[344]  
Step 1. Synthesis of X 
The respective diethyl malonate (50-70 mmol) with 2.00 equivalents of aminoalcohol and 0.02 equivalents 
of sodium hydride (60% dispersion in mineral oil) were stirred together at room temperature under argon. 
The mixtures were heated in a round bottom Schlenk flask at 135-140 ºC for 3-4 hours. After cooling the 
mixtures back to room temperature, the excess pressure was first slowly released. The yellow viscous oils 
were put under vaccum for approximately 2 hours in order to remove ethanol. The respective malonamides 
were used in the next step without further purification.  
Step 2.  Synthesis of Y 




To the respective bishydroxy malonamides, 5.00 equivalents of NEt3 and ~400 ml CH2Cl2 were gradually 
added. The solutions were stirred for 15 mins at room temperature. To these solutions under ice-cold 
conditions, 2.5 equivalents of MsCl were added. The reaction mixtures were warmed to room temperature 
and stirred for 2 hours. The mixtures were then washed with a saturated solution of NH4Cl (3x500 ml). and 
the solvent was removed under vaccum to yield orange/yellow oils.  
Step 3. Ring closure of the Bis(oxazoline)s 
The respective mesylates prepared in the previous step, were dissolved in 500 ml 1:1 MeOH:H2O solution 
with  5.00 equivalents of NaOH. The mixtures were refluxed for 2.5 hours. The solutions were cooled and 
concentrated under vacuum. The aqueous phase was extracted with CH2Cl2 (3x300 ml), and the combined 
organic phase was dried over Na2SO4. The solvent was removed to yield yellow colored oils (HL1, HL2 and 
L6) that were purified with Kugelrohr distillation (~90 ºC, 1x10-2 bar) 
 
Analysis of ligands 
HL1: yield: 6.8 g, 32.2 mmol, 52%. 
1H-NMR (300 MHz, CDCl3): δ (ppm) = 3.90 (s, 4H, 2CH2), 3.24 (s, 2H, bridging CH2), 1.21 (s, 12H, 4Me) 
13C{1H}-NMR (75 MHz, CDCl3): δ (ppm) = 160.1 (2C=N), 79.7 (2 oxazoline-CH2), 67.5 (2 CMe2), 28,8 
(bridging-CH2), 28.3 (4 Me) 
MS (ESI(+)), MeCN: m/z = 211 ( [M+H]+), 233 ( [M+Na]+) 
 
HL2: yield: 5 g, 22.3 mmol, 77%. 
1H-NMR (300 MHz, CDCl3): δ (ppm) = 3.88 (s, 4H, CH2), 3.43 (q, J=7.2 Hz, 1H, CHMe), 1.42 (d, J=7.2 
Hz, 3H, CHMe), 1.21 (s, 12H, 4Me) 
13C{1H}-NMR (75 MHz, CDCl3): δ (ppm) = 164.4 (2C=N), 79.5 (2CH2), 67.2 (2CMe2), 34.1 (CHMe), 
28.25 (2Me), 28.20 (2Me), 15.31 (CHMe) 
MS (ESI(+)), MeCN: m/z  = 225 ( [M+H]+) 
 
 
HL3: yield: 7.2 g, 25.1 mmol, 42%. 
1H-NMR (300 MHz, CDCl3): δ (ppm) = 7.40-7.24 (m, 5H, Ph), 4.69 (s, 1H, bridging CH), 3.95 (d, J = 8.1 
Hz, 2H, CHH), 3.90 (d, J = 8.1Hz, 2H, CHH), 1.25 (s, 6H, 2CMeMe), 1.22 (s, 6H, 2CMeMe) 
13C{1H}-NMR (75 MHz, CDCl3): δ (ppm) = 161.5 (2C=N), 134.6 (Ph), 128.6 (Ph), 127.6 (Ph), 125.2 (Ph), 
79.7 (2 oxazoline-CH2), 66.8 (2 CMe2), 44.45 (CHPh), 27.0 (CMeMe), 26.8(CMeMe) 
MS (ESI(+)), MeCN: m/z  = 287 ( [M+H]+)  
 
HL5: yield: 6.8 g, 32.2 mmol, 52%. 
1H-NMR (300 MHz, CDCl3): δ (ppm) = 7.01-7.26 (m, 4H, Ph), 4.61 (s, 1H, bridging CH), 3.92-3.84 (m, 
4H, 2CH2), 1.29 ( s, 6H, 2Me), 1.22 (d, 6H, 2Me) 
13C{1H}-NMR (75 MHz, CDCl3): δ (ppm) = 161.5 (2C=N), 136.5 (Ph), 130.6 (Ph), 127.6 (Ph), 125.2 (Ph), 
79.7 (2 oxazoline-CH2), 66.2 (2 CMe2), 44.45 (CHPh), 27.0 (CMeMe), 26.8 (CMeMe), 20.1 (PhMe) 
MS (ESI(+)), MeCN: m/z = 301 ( [M+H]+) 
 
L6: yield: 4.2 g, 17.6 mmol, 70%. 
1H-NMR (300 MHz, CDCl3): δ (ppm) = 3.85 (s, 4H, 2CH2), 1.43 (s, 6H, CMe2), 1.21 (s, 12H, 4Me) 




13C{1H}-NMR (75 MHz, CDCl3): δ (ppm) = 168.1 (2C=N), 79.9 (2CH2), 67.5 (2CMe2), 38.7 (CHMe), 28.5 
(4Me), 24.9 (CMe2) 
MS (ESI(+)), MeCN: m/z = 239 ( [M+H]+) 
 
15.2.2 Synthesis of monoanionic BOX ligands [L2]- and [L3]- 
 
The monoanionic BOX ligands were prepared according to the literature known procedure.[344] 1 g of HL2 
(4.48 mmol) was transferred into a Schlenk flask containing 15 ml of dry pentane under a stream of argon. 
The reaction mixture was cooled to 233 K in a dry-ice/acetone bath. Under a stream of argon 2.8 ml of 
1.6M nBuLi in Hexane (4.48 mmol) was added dropwise, which resulted in a white powder. The flask was 
left open under argon for 1 minute and then sealed. The reaction mixture was warmed to room temperature 
and stirred overnight. The white solid was filtered through a glass frit under inert conditions and washed 
with cold pentane (15 ml x 3). The powder [L2]- was dried under vacuum for one hour and then transferred 
into the glovebox.  
 
[L2]-: yield: 0.65 g, 13.8 mmol, 63%. 
1H NMR (300 MHz, THF-d8): δ (ppm) = 3.59 (s, 4H, 2CH2), 1.69 (s, 3H, CMe), 1.14 (s, 12H, 4Me) 
13C{1H}-NMR (75 MHz, THF-d8): δ (ppm) = 170.4 (2C-N), 77.74 (2CH2), 65.2 (2CMe2), 56.9 (CMe), 
29.91 (4Me), 12.27 (CMe) 
MS (ESI(+)), MeCN: m/z = 224 (M-Li+H)+ 
 
The synthesis of [L3]- was carried out similar to [L2]-. 1.5 g of HL3 (5.2 mmol) was reacted with 3.2 ml of 
1.6M nBuLi in hexane (5.2 mmol). A total of 20 ml of pentane was used for the reaction, and for washing 
of the yellow colored powder [L3]- (20ml x 3). 
 
[L3]-: yield: 0.98 g, 3.3 mmol, 65%. 
1H NMR (300 MHz, THF-d8): δ (ppm) = 7.14-6.65 (m, 5H, Ph), 3.58 (s, 4H, 2CH2), 1.18 (s, 12H, 4Me) 
13C{1H} NMR (75 MHz, THF-d8): δ (ppm) = 133.5 (Ph), 126.3 (Ph), 122.0 (Ph), 121.4 (Ph) 77.8 (2CH2), 
65.2 (2CMe2), 29.7 (4Me) 
MS (ESI(+)), MeCN: m/z = 286 (M-Li+H)+ 
 
 
15.3 Experimental Section: Chapter 5  
15.3.1 Synthesis of Cu(I) BOX complexes 
15.3.1.1 Synthesis of [HL1Cu(I)MeCN]PF6 (1) 
70 mg of HL1 (333.3 µmol) was dissolved in 10 ml of dry THF under argon in a Schlenk flask. The flask 
was then transferred into the glovebox. To this solution 136.6 mg of [Cu(I)(MeCN)4]PF6 (366 µmol) was 
added and the colorless solution was stirred for 2 hours. The mixture was then filtered and divided into two 
portions. Slow diffusion of Et2O into the reaction mixtures resulted in single crystals of 1. 
Yield: 76 mg, 166 µmol, 50% 
MS (ESI(+) MeCN): m/z = 273.0 [HL1Cu(I)]+,  314.0 [HL1Cu(I)MeCN]+ , 483.1 [(HL1)2Cu(I)]+  
1H-NMR (300 MHz, CD3CN):  δ (ppm) = 4.34 (s, 4H, 2CH2), 3.38 (s, 2H, bridging CH2), 1.34 (s, 12H, 
4Me) 
 





15.3.1.2 Synthesis of [HL2Cu(I)MeCN]ClO4 (2) 
55 mg of HL2 (245.5 µmol) was dissolved in 8 ml of dry THF under argon in a Schlenk flask. The flask 
was then transferred into the glovebox. To this solution 88.3 mg of [Cu(I)(MeCN)4]ClO4 (270 µmol) was 
added and the colorless solution was stirred for 2 hours. The solvent was removed under vacuum to yield 
an air sensitive white powder of 2.  
Yield: 42 mg, 98.2 µmol, 40.2% 
MS (ESI(+) MeCN): m/z = 287.0 [HL2Cu(I)]+,  328.1 [HL2Cu(I)MeCN]+ , 600.2 [(HL2)2Cu2(I)CN]+  
1H-NMR (300 MHz, THF-d8):  δ (ppm) = 4.22 (s, 4H, 2CH2), 3.68 (q, 1H, bridgingCH; weak) 1.53 (d, 
J=6.0 Hz, CMe), 1.40 (d, J=9.0 Hz, 12H, 4Me), 2.05 (MeCN) 
 
15.3.1.3 Synthesis of [HL5Cu(I)MeCN]PF6 (3) 
65 mg of HL5 (216.6 µmol) was dissolved in 10 ml of dry THF under argon in a Schlenk flask. The flask 
was then transferred into the glovebox. To this solution 88.8 mg of [Cu(I)(MeCN)4]PF6 (238.3 µmol) was 
added and the colorless solution was stirred for 2 hours. The solvent was reduced to half the volume. 5 ml 
of CHCl3 was added to this solution, and the solution was then filtered. Slow diffusion of Et2O yielded 
single crystals of 3. 
Yield: 71 mg, 130 µmol, 60% 
MS (ESI(+) MeCN): m/z = 363.1 [HL5Cu(I)]+,  404.1 [HL5Cu(I)MeCN]+ , 663.2 [(HL5)2Cu2(I)CN]+  
1H-NMR (300 MHz, CD3CN):  δ (ppm) = 7.29-7.21 (m, 4H, Ph), 4.58 (s, 3H, PhMe) 4.11 (d, 2H, bridging 
CH), 3.94 (d, 2H, bridging CH), 1.38 (s, 6H, 2Me), 1.28 (s, 6H, 2Me) 
 
 
15.3.1.4 Synthesis of [L6Cu(I)MeCN]ClO4 (4) 
25 mg of L6 (105 µmol) was dissolved in 5 ml of dry THF under argon in a Schlenk flask. The flask was 
then transferred into the glovebox. To this solution 34.3 mg of [Cu(I)MeCN4]ClO4 (105 µmol) was added 
and the colorless solution was stirred for 2 hours.  Slow diffusion of Et2O yielded single crystals of 4. 
 
Yield: 23.2 mg, 52.4 µmol, 50% 
MS (ESI(+) MeCN): m/z = 301.0 [L6Cu(I)]+,  342.1 [L6Cu(I)MeCN]+, 628.2 [(L6)2Cu2(I)CN]+  
1H-NMR (300 MHz, CD3CN):  δ (ppm) = 4.32 (s, 4H, CH2), 2.30 (MeCN), 1.60 (s, 6H, 2Me), 1.48 (s, 12H, 
4Me) 
  
15.3.2 Synthesis of SP complexes 6 and 8 
 
15.3.2.1 Synthesis of [(HL2)2Cu2(µ-η2:η2-O2)](ClO4)2  (6) 
 
20 mg of 2 (46.7 µmol) was dissolved in a 6 ml of 1:1 THF:Acetone solution in the glovebox. The reaction 
mixture was then filtered and transferred into a test tube that was placed within a Schlenk crystallization 
vessel. The set up was placed in a dry-ice acetone bath, and dry dioxygen was purged into the solution for 
10 minutes. The tube was then layered with Et2O on the outside and the entire set up was flushed with 
argon. The crystallaization vessel was placed in a freezer at -80 ºC. Single crystals of 6 were grown 




successfully after a period of 4 weeks. Due to the high sensitivity of the crystals, determining the exact 
yield was not possible.  
 
Yield: ~20% 
UV/vis (THF) : λmax/nm (ε/(Lmol−1 cm−1)) = 330 nm (ε = 19113 M-1cm-1) , 500 nm (ε = 1350 M-1cm-1) sh 
 
 
15.3.2.2 Synthesis of [(L6)2Cu2(µ-η2:η2-O2)](ClO4)2  (8) 
 
 25 mg of 4 (56.5 µmol) was dissolved in a 8 ml of 1:1 THF:Acetone solution in the glovebox. The reaction 
mixture was then filtered and transferred into a test tube that was placed within a Schlenk crystallization 
vessel. The set up was placed in a dry-ice acetone bath, and dry dioxygen was purged into the solution for 
10 minutes. The tube was then layered with Et2O on the outside and the entire set up was flushed with 
argon. The crystallaization vessel was placed in a freezer at -80 ºC. Single crystals of 8 were grown 
successfully after a period of 4 weeks. Due to the high sensitivity of the crystals, determining the exact 
yield was not possible.  
 
Yield:~30% 
UV/vis (THF) : λmax/nm (ε/(Lmol−1 cm−1)) = 333 nm (ε = 21440 M-1cm-1) , 500 nm (ε = 895 M-1cm-1) sh 
 
15.3.3 UV-vis solutions 
 
[(HL1)2Cu2(µ-η2:η2-O2)](PF6)2  (5) : Single crystals of 1 (7 mg, 0.015 µmol) were dissoleved in 4 ml of dry 
THF in the glovebox to make a stock solution of 3.8 mM. UV-vis solutions of 0.07 mM/3 ml were prepared 
in a UV-vis cuvette with a screw cap and septum, that was additionaly wrapped with parafilm. Dioxygen 
addition was monioted by UV-vis spectroscopy at 193 K to yield 5. 
UV/vis (THF) : λmax/nm (ε/(Lmol−1 cm−1)) = 330 nm (ε = 7422 M-1cm-1) , 501 nm (ε = 454 M-1cm-1) sh 
 
[(HL2)2Cu2(µ-η2:η2-O2)](ClO4)2  (6) : White powder of 2 (9.4 mg, 0.022 µmol) was dissolved in 5 ml of 
dry THF in the glovebox to make a stock solution of 4.4 mM. UV-vis solutions of 0.05 mM/ml were 
prepared in a UV-vis cuvette with a screw cap and septum, that was additionaly wrapped with parafilm. 
Dioxygen addition was monitored by UV-vis spectroscopy at 193 K to yield 6. 
 
 
[(HL5)2Cu2(µ-η2:η2-O2)](PF6)2  (7) : Single crystals of 3 (5.9 mg, 0.018 µmol) were dissoleved in 4 ml of 
dry THF in the glovebox to make a stock solution of 2.7 mM. UV-vis solutions of 0.18 mM/3 ml were 
prepared in a UV-vis cuvette with a screw cap and septum, that was additionaly wrapped with parafilm. 
Dioxygen addition was monitored by UV-vis spectroscopy at 193 K to yield 7. 
 
UV/vis (THF) : λmax/nm (ε/(Lmol−1 cm−1)) = 333 nm (ε = 4403 M-1cm-1) , 504 nm (ε = 357 M-1cm-1) sh 
 
[(L6)2Cu2(µ-η2:η2-O2)](ClO4)2 (8) : Single crystals of 4 (9.2 mg, 0.018 µmol) were dissoleved in 6 ml of 
dry THF in the glovebox to make a stock solution of 3.5mM. UV-vis solutions of 0.1 mM/3 ml were 
prepared in a UV-vis cuvette with a screw cap and septum, that was additionaly wrapped with parafilm. 
Dioxygen addition was monitored by UV-vis spectroscopy at 193 K to yield 8. 
 
 




15.3.4 Raman measurements of 8 
 
Single crystals of 4 (13.2 mg, 30 mmol) were dissolved in 1.5 ml of dry THF and transferred into young 
NMR tubes in the glovebox. The NMR tubes were dipped into dry-ice/acetone baths, and connected to the 
Schlenk line. Under inert conditions dry dioxygen (16O2 and 18O2) were purged into the solutions seperatly. 
The solutions were gradually mixed. Measurements were made with the 633nm laser in acetone/dry-ice 
baths within a finger dewar. 
 
15.4 Experimental Section: Chapter 6  
 
15.4.1 Synthesis of Cu(I) BOX complexes 
15.4.1.1 Synthesis of [[L2]- Cu(I)MeCN]ClO4 (13) 
20 mg of [L2]-  (86.9 µmol) was dissolved with 28.4 mg[Cu(I)(MeCN)4]ClO4 (86.9 µmol)  in 5 ml of dry 
THF in the glovebox to yield a yellow colored solution of 13. Compound 13 could not be characterized via 
X-ray crystallography. All characterization was done in solution. 
MS (ESI(+) MeCN): m/z = 376.1 [[L2]- Cu(I)(MeCN)2Li]+ , 328.1 [[L2]-Cu(I)(MeCN)H]+ , 509.1 [([L2]- 
)2Cu(I)]+ 1H-NMR (300 MHz, THF-d8):  δ (ppm) = 3.77 (s, 4H, 2CH2), 1.68 (s, 3H, Me), 1.21 (s, 12H, 
4Me), 2.03 (s, MeCN) 
 
15.4.1.2 Synthesis of [[L3]-Cu(I)MeCN]ClO4 (14) 
25 mg of [L3]-  (85.6 µmol) was dissolved with 28 mg[Cu(I)(MeCN)4]ClO4 (85.6 µmol)  in 5 ml of dry THF 
in the glovebox to yield a yellow colored solution of 14. Compound 14 could not be characterized via X-
ray crystallography. All characterization was done in solution. 
MS (ESI(+) MeCN): m/z = 390.1 [[L3]-Cu(I)(MeCN)H]+ , 349.1 [[L3]-CuH]+  




15.4.1.3 Synthesis of [([L2]-)2Cu2(µ-O)2] (10) 
A solution of compound 13 (90 µmol [L2]- and 90 µmol [Cu(I)(MeCN)4]ClO4 ) was prepared in a 1:1 
mixture of Me-THF and pentane (4ml:4ml) in the glovebox. The solution was then transferred into a 
Schlenk crystallization vessel dipped in a dry ice/ethanol bath at 193 K. Dioxygen was purged into the 
solution, and then the solution was layered with Et2O and stored at 193 K. Single crystals of 10 suitable for 
X-ray diffracition were obtained over a period of 3 to 4 weeks. The high sensitivity of the crystals did not 
allow for precise yield determination. 
Yield: ~20% 
1H-NMR (500 MHz, THF-d8, 193 K):  δ (ppm) = 3.94 (s, 4H, 2CH2), 1.58 (s, 3H, Me), 1.38 (s, 12H, 4Me), 
2.08 (s, MeCN) 
UV/vis (THF) : λmax/nm (ε/(Lmol−1 cm−1)) = 297 nm (ε = 26800 M-1cm-1), 333 nm (ε = 7440 M-1cm-1) , 395 
nm (ε = 10140 M-1cm-1)  
 





15.4.1.4 Synthesis of [([L3]-)2Cu2(µ-O)2] (11) 
A solution of compound 14 (100 µmol [L3]- and 100 µmol [Cu(I)(MeCN)4]ClO4)  was prepared in THF (4 
ml) in the glovebox. Purging dioxygen at 193 K resulted in the formation of compound 11. X-ray 
characterization of 11 was not possible. All characterization was done in solution at 193 K.  
1H-NMR (500 MHz, THF-d8, 193 K):  δ (ppm) = = 7.15-7.03 (m, 5H, Ph), 3.90 (s, 4H, 2CH2), 1.42 (s, 12H, 
4Me), 2.08 (s, MeCN) 
 UV/vis (THF) : λmax/nm (ε/(Lmol−1 cm−1)) = 287 nm (ε = 36720 M-1cm-1), 337 nm (ε = 13620 M-1cm-1) , 
397 nm (ε = 10740 M-1cm-1)  
 
15.4.2 UV-vis solutions 
 
[([L2]-)2Cu2(µ-O)2] (10): 5 mg of [L2]- (21.4 µmmol) was mixed with 7.08 mg of [Cu(I)(MeCN)4]ClO4 
(216.4 µmmol) in 2 ml THF to produce a stock solution of 10.8 mM in the glovebox. A UV-vis solution of 
0.1 mM/3 ml was prepared in a cuvette with a screw cap and septum. The cuvette was further sealed with 
paraffin. Purging dioxygen at 193 K yielded 10. 
 
[([L3]-)2Cu2(µ-O)2] (11): 5 mg of [L3]-  (170.0 µmmol) was mixed with 5.5 mg of [Cu(I)(MeCN)4]ClO4 
(170.0 µmmol) in 4 ml THF to produce a stock solution of 4.2 mM in the glovebox. A UV-vis solution of 
0.1 mM/3 ml was prepared in a cuvette with a screw cap and septum. The cuvette was further sealed with 
paraffin. Purging dioxygen at 193 K yielded 11. 
 
15.4.3 Raman measurements of 10 and 11 
 
30 mM solutions of 10 (27.7 mg of [L2]- (120 µmmol) and 39.2 mg of [Cu(MeCN)4]ClO4 (120 µmmol)) 
and 11 (35.1 mg of [L3]- (120 µmmol) and 39.2 mg of  [Cu(MeCN)4]ClO4 (120 µmmol)) were prepared in 
a 2 ml of 1:1 THF:pentane mixture and THF respectively, and transferred into young NMR tubes in the 
glovebox. The NMR tubes were dipped into dry-ice/acetone baths, and connected to the Schlenk line. Under 
inert conditions dry dioxygen (16O2 and 18O2) was purged into the solutions separately. The solutions were 
gradually mixed. Measurements were made with the 633 nm laser in acetone/dry-ice bath at 193 K for 10 
and N2 bath at 77 K for 11, within a finger dewar. 
 
15.4.4 UV-vis temperature dependence measurements 
 
UV vis solutions for 10 and 11 were prepared according to the procedure mentioned above. UV-vis spectra 
were recorded with an Agilent Cary 60 equipped with an Unisoku Cryostat (CoolSpek), with the 
temperature being maintained at 193 K. Dioxygen was purged into the solution and spectra were measured 
every half minute, until complete formation of 10 and 11. Following this, the temperature was varied by 10 
degrees over a period of half an hour, and spectra were recorded at intervals of every 5 minutes. Spectra 
were recorded from 193 K to 243 K, and again from 243 K to 193 K. 
 
In case of 9 and 12 UV-vis solutions were prepared according to procedures mentioned in Experimental 
section Chapter 7. DBU was titrated into these solutions until complete conversion of 5 and 7 to 9 and 12 
respectively [Refer to titration experiments of SP complexes: Experimental section chapter 7]. The 
temperature variation of UV-vis measurements were carried out similar to 10 and 11. 






15.5 Experimental Section: Chapter 7 
15.5.1 Titration experiments of SP complexes 5, 6, 7 and SPHL3 with DBU  
Preparation of DBU stock solution: 5 ml of 0.01 M DBU (7.47 µL, 0.049 µmol) was prepared in THF in a 
glovebox 
Conversion of 5 to 9 : Single crystals of 1 (7 mg, 0.015 µmol) were dissoleved in 4 ml of dry THF in the 
glovebox to make a stock solution of 3.8 mM. UV-vis solutions of 0.07 mM/3 ml were prepared in a UV-
vis cuvette with a screw cap and septum, that was additionaly wrapped with parafilm. Dioxygen was added 
via a syringe with a 3 way valve at 193 K unitil complete formation of 5. 0.01 M solution of DBU was 
titrated via a 100 µL Hamett syringe until complete conversion of 5 to 9. The UV-vis spectra were measured 
at every half minute intervals.  
 
Conversion of 6 to 10 : White powder of 2 (9.4 mg, 0.022 µmol) was dissolved in 5 ml of dry THF in the 
glovebox to make a stock solution of 4.4 mM. UV-vis solutions of 0.05 mM/ml were prepared in a UV-vis 
cuvette with a screw cap and septum, that was additionaly wrapped with parafilm. Dioxygen was added via 
a syringe with a 3 way valve at 193 K unitil complete formation of 6. 0.01 M solution of DBU was titrated 
via a 100 µL Hamett syringe until complete conversion of 6 to 10. The UV-vis spectra were measured at 
every half minute intervals.  
 
Conversion of SPHL3 to 11 : 5 mg of HL3 (17.6 µmol) was mixed with 5.72 mg of [Cu(I)(MeCN)4]ClO4 
(17.6 µmol) in 6 ml of THF in a glovebox to form a stock solution of 2.91 mmol of 
[HL3Cu(I)(MeCN)4]ClO4. Uv-vis solutions of 0.048 mM/3 ml were prepared in a UV-vis cuvette with a 
screw cap and septum, that was additionaly wrapped with parafilm. Dioxygen was added via a syringe with 
a 3 way valve at 193 K unitil complete formation of SPHL3 . 0.01 M solution of DBU was titrated via a 100 
µL Hamett syringe until complete conversion of SPHL3 to 11. The UV-vis spectra were measured at every 
half minute intervals.  
 
Conversion of 7 to 12 : : Single crystals of 3 (5.9 mg, 0.018 µmol) were dissoleved in 4 ml of dry THF in 
the glovebox to make a stock solution of 2.7 mM. UV-vis solutions of 0.18 mM/3 ml were prepared in a 
UV-vis cuvette with a screw cap and septum, that was additionaly wrapped with parafilm. Dioxygen was 
added via a syringe with a 3 way valve at 193 K unitil complete formation of 7. 0.01 M solution of DBU 
was titrated via a 100 µL Hamett syringe until complete conversion of 7 to 12. The UV-vis spectra were 
measured at every half minute intervals.  
 
Titration experiments with an acid: To the above solutions of 9, 10, 11 and 12, 0.01 M solutions of LuOTf, 
LuBF4, [LuH: lituidinium], HBF4·Et2O, [Et2OH]BArF were titrated via a 100 µL. The UV-vis spectra were 
measured at every half minute intervals. 
 
15.5.2 POP Switch experimets 
Conversion of 5 to 9: 5 was prepared according to the procedure mentioned above. A 21 mM ligand solution 
of HL1( 17.6 mg, 84 µmol) in 4 ml THF was titrated into 5 via a 100 µL Hamett syringe until complete 




conversion of 5 to 9.  A 15.28 mM solution of [Cu(I)(MeCN)4]ClO4 (20 mg, 61.1 µmol) in 4 ml of THF 
was titrated back into the same solution via a 100 µL Hamett syringe. Spectra were recorded at every 1 
minute intervals. The same procedure was carried out for conversion of 6 to 10, SPHL3 to 11 and 7 to 12. 
In these cases the respective ligand solutions were prepared seperately. 21 mM ligand solution of HL2 (18.8 
mg, 84 µmol) in 4 ml THF; 21 mM ligand solution of HL3 (24.0 mg, 84 µmol) in 4 ml THF; 21 mM ligand 
solution of HL5 (25.2 mg, 84 µmol) in 4 ml THF. 
15.5.3 Oxygentation of 2:1 HL1:Cu(I): 4.2 mg of HL1 (20 µmol), was mixed with 3.72 mg of 
[Cu(I)(MeCN)4]PF6 (10 µmol) in 4 ml of THF in the glovebox to form a 5 mM stock solution. A UV-vis 
solution 0.1 mM/3 ml was prepared in a UV-vis cuvette with a screw cap and septum, that was additionaly 
wrapped with parafilm. Dioxygen was added via a syringe with a 3 way valve at 193 K unitil complete 
formation of 9. A 2.5 mM solution of [Cu(I)(MeCN)4]PF6 (3.72 mg, 10 µmol) was titrated back with a 100 
µL Hamett syringe until complete conversion of 9 to 5. 
15.5.4 Resosnance Raman measurements 2:1 HL1:Cu(I): A 30 mM solutions of  2:1 HL1:Cu(I)PF6 (50.4 
mg HL1 240 µmol and 44.7 mg [Cu(I)(MeCN)4]PF6 120 µmol) was mixed in 2 ml THF and transferred into 
young NMR tubes in the Glove-box. The NMR tubes were dipped into dry-ice/acetone baths, and connected 
to the Schlenk line. Under inert conditions dry dioxygen (16O2 and 18O2) was purged into the solutions 
separately. The solutions were gradually mixed. Measurements were made with the 633 nm laser in liquid 




15.6 Experimental Section: Chapter 8 
15.6.1 Substrate reactivity of DTBP-Na/DTBP-H:NEt3 with SP complexes of proton responsive ligands 
To a solution of 6 (71 µmol) in 5 ml of dry THF at 193 K under a stream of dioxygen, 21.3 mmol of DTBP-
Na in dry THF was gradually added and stirred for 20 mins. Initial addition of the substrate resulted in a 
gradual change of color from purple to dark green (6 to 10). Addition of the excess equivalents resulted in 
a change from green to brown. The reaction mixture was warmed up to rt. The solution was then worked 
up by addition of 10 ml 0.5 M HCl. The aqueous phase was extracted three times with 20 ml DCM. The 
solution was then dried over MgSO4, and the combined organic phase was evaporated to dryness, to yield 
a brown colored oil.  
The product was shown by 1H-NMR spectroscopy to be a mixture of DTBP-H and 4,4’,6,6’tetra-(tert-butyl)-
2,2’-biphenol (C-C coupled product) in a ratio of 67:33 
1H-NMR (300 MHz, CDCl3) : a) DTBP-H: δ (ppm) = 7.23 (d, 1H), 6.98-7.02 (dd, 1H), 6.54 (d, 1H) 1.34 
(s, 9H, 4-tert-but), 1.22 (s, 9H, 4-tert-but) 
b) 4,4’,6,6’tetra-(tert-butyl)-2,2’-biphenol: δ (ppm) = 7.32 (d, 2H), 7.04 (d, 2H), 5.15 (s, 2H, OH) 1.38 (s, 
9H, 4-tert-but), 1.25 (s, 9H, 4-tert-but) 
 
The reactivity of SP complexes 5, 7 and SPHL3 were carried out similar to 6. Reactivity with DTBP-H:NEt3 
(1:2) was also carried out similar to that of DTBP-Na.  
 






15.6.2 Substrate reactivity of DTBP-Na/DTBP-H:NEt3 with SP complex 8 of non-proton responsive ligand 
2.1 equivalents of substrate: To a solution of 8 (10 µmol) in 5 ml of dry THF at 193 K under a stream of 
dioxygen, 2.1 equivalents (21 µmol) of  DTBP-Na in dry THF was gradually added and stirred for 20 mins. 
The solution took on a brown color after substrate addition. Gradual warming of the solution to rt resulted 
in a color change from brown to green. The solution was then worked up by addition of 10ml of 0.5 M HCl. 
The aqueous phase was extracted three times with 20 ml DCM. The solution was then dried over MgSO4, 
and the combined organic phase was evaporated to dryness, to yield a yellow colored oil.  
The product was shown by 1H-NMR spectroscopy to be a mixture of DTBP-H and DTBP-Q (quinone) in a 
ratio of 87:13 
1H-NMR (300 MHz, Acetone-d6) : a) DTBP-H: δ (ppm) = 7.26 (d, 1H), 7.01 (dd, 1H), 6.73 (d, 1H) 1.40 (s, 
9H, 4-tert-but), 1.27 (s, 9H, 4-tert-but) 
b) DTBP-Q: δ (ppm) = 7.09 (d, 1H), 6.15 (d, 1H), 1.32 (s, 9H, 4-tert-but), 1.25 (s, 9H, 4-tert-but) 
 
10 equivalents of substrate: To a solution of 8 (10 µmol) in 5 ml of dry THF at 193K under a stream of 
dioxygen, 10 equivalents (105 µmol ) of  DTBP-Na in dry THF was gradually added and stirred for 20 
mins. On total addition of the substrate at 193 K, the solution changed color from purple to light green. On 
warming up to rt there was no further change in color. The workup of the reaction mixture was carried out 
similar to the previous cases.  
The product was shown by 1H-NMR spectroscopy to be a mixture of DTBP-H, 4,4’,6,6’tetra-(tert-butyl)-
2,2’-biphenol, and DTBP-Q (quinone) in a ratio of 80:14:6 
1H-NMR (300 MHz, Acetone-d6) : a) DTBP-H: δ (ppm) = 7.26 (d, 1H), 7.05 (dd, 1H), 6.74 (d, 1H) 1.40 (s, 
9H, 4-tert-but), 1.27 (s, 9H, 4-tert-but) 
b) 4,4’,6,6’tetra-(tert-butyl)-2,2’-biphenol: δ (ppm) = 7.38 (d, 2H), 7.09 (d, 2H), 1.38 (s, 9H, 4-tert-but), 
1.25 (s, 9H, 4-tert-but) 
c) DTBP-Q: δ (ppm) = 7.09 (d, 1H), 6.14 (d, 1H), 1.32 (s, 9H, 4-tert-but), 1.25 (s, 9H, 4-tert-but) 
 
100 equivalents of substrate: To a solution of 8 (10 µmol) in 5 ml of dry THF at 193 K under a stream of 
dioxygen, 100 equivalents (1050 µmol ) of  DTBP in dry THF was gradually added and stirred for 20 mins. 
On total addition of the substrate at 193 K, the solution changed color from purple to light green. On 
warming up to rt there was no further change in color. The workup of the reaction mixture was carried out 
similar to the previous cases.  
The product was shown by 1H-NMR spectroscopy to be a mixture of DTBP-H and 4,4’,6,6’tetra-(tert-butyl)-
2,2’-biphenol in a ratio of 91:09 
1H-NMR (300 MHz, CDCl3) : a) DTBP-H: δ (ppm) = 7.23 (d, 1H), 6.98-7.02 (dd, 1H), 6.51 (d, 1H) 1.34 
(s, 9H, 4-tert-but), 1.22 (s, 9H, 4-tert-but) 
b) 4,4’,6,6’tetra-(tert-butyl)-2,2’-biphenol: δ (ppm) = 7.32 (d, 2H), 7.04 (d, 2H), 1.38 (s, 9H, 4-tert-but), 
1.25 (s, 9H, 4-tert-but) 
 
15.6.3 Substrate reactivity of DTBP-Na/DTBP-H:NEt3 with O complexes of monoanionic ligands 




To a solution of 10 (21 µmol) in 5 ml of dry THF at 193 K under a stream of dioxygen, 5.25 mmol of 
DTBP-Na in dry THF was gradually added and stirred for 2 hours. Addition of the substrate resulted in a 
gradual change of color from dark green to brown. The solution was warmed to rt and worked up similar 
to the procedures mentioned above. After removal of solvent a yellow-brown colored oil was obtained.  
The product was shown by 1H-NMR spectroscopy to be a mixture of DTBP-H and 4,4’,6,6’tetra-(tert-butyl)-
2,2’-biphenol in a ratio of 50:50 
1H-NMR (300 MHz, Acetone-d6): a) DTBP-H: δ (ppm) = 7.23 (d, 1H), 6.98-7.02 (dd, 1H), 6.54 (d, 1H) 
1.34 (s, 9H, 4-tert-but), 1.22 (s, 9H, 4-tert-but) 
b) 4,4’,6,6’tetra-(tert-butyl)-2,2’-biphenol: δ (ppm) = 7.32 (d, 2H), 7.04 (d, 2H), 5.15 (s, 2H, OH) 1.38 (s, 
9H, 4-tert-but), 1.25 (s, 9H, 4-tert-but) 
  
 
15.7 Experimental Section: Chapter 11 
 
15.7.1 Synthesis of Fe(II) BOX complexes 
15.7.1.1 Synthesis of HL1Fe(II)Cl2 (17) 
31 mg of HL1 (147.6 µmol) was dissolved in 4 ml of dry THF in a Schlenk flask under argon. The flask 
was then transferred into the glovebox. To this solution 18.7 mg (147.6 µmol) of FeCl2 was added and the 
yellow colored reaction mixture was allowed to stir overnight. The solution was then taken up in DCM 
which produced a white precipitate. After filtration, the solvent was removed and taken up again in THF. 
The reaction mixture was filtered to yield a light yellow colored solution. Layering with dry hexane in the 
glovebox yielded single crystals of 17. 
Yield: 19.9 mg, 59 µmol, 40% 
MS (ESI(-) MeCN): m/z = 335.0 [L1Fe(II)]-,  478.8 [L1Fe(II)(MeCN)CH2Cl2OH]-  
IR (ATR) (cm-1) = 2973 (w), 1667 (s), 1558 (m), 1447 (m), 1371 (m), 1303 (m), 1159 (m) 1029 (m) 
UV/Vis (MeCN): λmax/nm (ε/Lmol-1 cm-1) = 380 nm (sh, 13,000) 
 
15.7.1.2 Synthesis of HL2Fe(II)Cl2 (18) 
110 mg of HL2 (490 µmol) was dissolved in 6 ml of dry THF in a Schlenk flask under argon. The flask was 
then transferred into the glovebox. To this solution 62.3 mg (490 µmol) of FeCl2 was added and the yellow 
colored reaction mixture was allowed to stir overnight. The solution was then taken up in DCM which 
produced a heavy white precipitate. After filtration, the solvent was removed and taken up again in THF. 
The reaction mixture was filtered to yield a light yellow colored solution. Layering with dry hexane in the 
glovebox yielded single crystals of 18. 
Yield: 103 mg, 294 µmol, 60% 
MS (ESI(-) MeCN): m/z = 349.1 [L2Fe(II)]-,  492.8 [L2Fe(II)MeCNCH2Cl2OH]-  
IR (ATR) (cm-1) = 2973 (w), 1665 (s), 1459 (m), 1372 (m), 1300 (w), 1255 (w), 1088 (m)  
UV/Vis (MeCN): λmax/nm (ε/Lmol-1 cm-1) = 289 nm (sh, 14,500) 
 
15.7.1.3 Synthesis of HL3Fe(II)Cl2 (19) 




23 mg of HL3 (95 µmol) was dissolved in 5 ml of dry DCM in a Schlenk flask under argon. The flask was 
then transferred into the glovebox. To this solution 10.2 mg (95 µmol)  of FeCl2 in 4 ml of dry THF was 
added and the yellow colored reaction mixture was allowed to stir overnight. The solution was filtered and 
then taken up in dry DCM. Layering with dry hexane in the glovebox yielded single crystals of 19. 
Yield: 21.5 mg, 52.2 µmol, 55% 
MS (ESI(-) MeCN): m/z = 411.1 [L3Fe(II)]-,  554.8 [L3Fe(II)MeCNCH2Cl2OH]-  
IR (ATR) (cm-1) = 2973 (w), 1657 (s), 1454 (m), 1415 (m), 1373 (w), 1253 (w), 1037 (m)  
UV/Vis (MeCN): λmax/nm (ε/Lmol-1 cm-1) = 290 nm (sh, 13,500) 
 
15.7.1.4 Synthesis of HL5Fe(II)Cl2 (20) 
30 mg of HL5 (100 µmol) was dissolved in 8 ml of dry DCM in a Schlenk flask under argon. The flask was 
then transferred into the glovebox. To this solution 12.7 mg (100 µmol) of FeCl2 was added and the yellow 
colored reaction mixture was allowed to stir overnight. The solution was filtered. Layering with dry hexane 
in the Glove-box yielded single crystals of 20. 
Yield: 24.3 mg, 57 µmol, 57% 
MS (ESI(-) MeCN): m/z = 425.1 [L3Fe(II)]-,  568.8 [L3Fe(II)MeCNCH2Cl2OH]-  
IR (ATR) (cm-1) = 2971 (w), 1657 (s), 1460 (w), 1415 (m), 1373 (w), 1304 (w), 1038 (m)  
UV/Vis (MeCN): λmax/nm (ε/Lmol-1 cm-1) = 296 nm (sh, 13,300) 
 
15.7.1.5 Synthesis of L6Fe(II)Cl2 (21) 
46 mg of L6 (193 µmol) was dissolved in 4 ml of dry THF in a Schlenk flask under argon. The flask was 
then transferred into the glovebox. To this solution 24.54 mg (193 µmol) of FeCl2 was added and the yellow 
colored reaction mixture was allowed to stir overnight. The solution was then taken up in DCM which 
produced a heavy white precipitate. After filtration, the solvent was removed and taken up again in THF. 
The reaction mixture was filtered to yield a light yellow colored solution. Layering with dry hexane in the 
glovebox yielded single crystals of 21. 
Yield: 45.78 mg, 125.4 µmol, 65% 
IR (ATR) (cm-1) = 2968 (w), 1652 (s), 1459 (w), 1374 (m), 1291 (w), 1112 (m)  
UV/Vis (MeCN): λmax/nm (ε/Lmol-1 cm-1) = 300 nm (sh, 15,000) 
 
15.7.1.6 Synthesis of [(L6Fe(II)]2(CF3SO3)4 (22) 
16 mg of L6 (67 µmol) was dissolved in 5 ml of dry THF in a Schlenk flask under argon. The flask was 
then transferred into the glovebox. To this solution 29.31 mg (67 µmol) of Fe(OTf)2(MeCN)2 was added 
and the yellow colored reaction mixture was allowed to stir overnight. The solution was then taken up in 
DCM which produced a heavy white precipitate. After filtration, the solvent was removed and taken up 
again in THF.  This process was repeated four times. The reaction mixture was filtered to yield a light 
yellow colored solution. Layering with dry hexane in the glovebox yielded single crystals of 22. 
Yield: 7.93 mg, 6.7 µmol, 10% 
MS (ESI(+) MeCN): m/z =  239 [L6H]+, 443.1 [L6FeOTf]+, 681 [(L6)2FeOTf]+, 903 [(L6FeOTf)2OH]+, 1207   
[(L6FeOTf2)2Na]+, 1035 [(L6Fe)2(OTf)3]+ 
IR (ATR) (cm-1) = 1652 (w), 1463 (w), 1377 (w), 1331 (w), 1236 (m), 1211 (m), 1163 (m), 1116 (m), 1025 
(s) 
UV/Vis (MeCN): λmax/nm (ε/Lmol-1 cm-1) = 300 nm (sh, 14,500) 






15.8 Experimental Section: Chapter 12 
15.8.1 Synthesis of [L9Fe(NO)2(CF3SO3)2] (23) 
20 mg of HL2FeCl2 (57 µmol) was reacted with 29.2 mg of AgOTf (57 µmol) in 4 ml of MeCN. The 
reaction mixture was stirred for 15 minutes and then filtered. This was further reacted with 34.3 mg of 
Ph3SCNO (57 µmol). The reaction was allowed to stir for one night. Filtration yielded a clear brown colored 
solution. The solvent was removed and taken up in 4 ml of THF. Layering with hexane yielded single 
crystals of 23. (L9 represents the modified ligand scaffold) 
Yield: 3.4 mg, 4 µmol, 15% 
MS (ESI(+) MeCN): m/z =  447 [(HL2)-H]+ 
IR (THF soln.) = 1826.9 cm-1, 1752.3 cm-1, 1642 cm-1, 1627 cm-1, 1575.2 cm-1, 1491 cm-1  
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 Crystallographic Data 
 
Table A1: Crystal data and refinement details for 1, 3 and 4 
compound 1 3 4 
empirical formula C20H27CuF6N3O2P C13H21CuF6N3O2P C56H94Cl4Cu4N10O24 
formula weight 549.95 459.84 1687.37 
T [K] 133(2) 133(2) 133(2) 
crystal size [mm³] 0.500×0.500×0.090 0.180×0.090×0.080 0.500×0.500×0.320 
crystal system monoclinic monoclinic triclinic 
space group P21/c P21 P-1 
a [Å] 9.8192(3) 10.1613(14) 12.2247(6) 
b [Å] 15.0241(5) 6.0778(10) 12.3904(5) 
c [Å] 16.3164(6) 14.898(2) 15.0274(7) 
 [°] 90 90 106.670(4) 
 [°] 99.576(3) 93.521(12) 96.765(4) 
 [°] 90 90 118.889(3) 
V [Å³] 2373.53(14) 918.3(2) 1817.79(16) 
Z 4 2 1 
 [g/cm³] 1.539 1.663 1.541 
F(000) 1128 468 876 
µ [mm-1] 1.057 1.347 1.381 
Tmin / Tmax 0.5459 / 0.9119 0.8345 / 0.9077 0.5289 / 0.7235 
-range [°] 1.855 - 26.737 1.369 - 26.058 1.486 - 26.739 
hkl-range ±12, ±18, ±20 ±12, ±7, ±18 ±15, ±15, ±18 
measured refl. 29719 10755 25354 
unique refl. [Rint] 5022 [0.0354] 10755 [?] 7693 [0.0396] 
observed refl. (I > 2(I)) 4542 8791 6079 
data / restraints / param. 5022 / 0 / 304 10755 / 133 / 241 7693 / 58 / 471 
goodness-of-fit (F²) 1.038 1.073 0.953 
R1, wR2 (I > 2(I)) 0.0281, 0.0718 0.0719, 0.1519 0.0339, 0.0758 
R1, wR2 (all data) 0.0324, 0.0738 0.0929, 0.1804 0.0490, 0.0799 














Table A2: Crystal data and refinement details for 6, 8 and 10 
compound 6 8 10 
empirical formula C36H64Cl2Cu2N4O17 C40H71Cl2Cu2N5O17 C34H58Cu2N4O8 
formula weight 1022.89 1091.99 777.92 
T [K] 133(2) 133(2) 133(2) 
crystal size [mm³] 0.480×0.200×0.180 0.390×0.350×0.330 0.500×0.480×0.270 
crystal system monoclinic monoclinic orthorhombic 
space group P21/c P21/c Pnna 
a [Å] 16.6993(5) 10.9869(6) 14.5909(4) 
b [Å] 15.6606(5) 18.6852(10) 12.6902(3) 
c [Å] 17.7512(6) 13.1285(7) 20.1350(6) 
 [°] 90 90 90 
 [°] 92.035(2) 108.876(4) 90 
 [°] 90 90 90 
V [Å³] 4639.4(3) 2550.2(2) 3728.23(17) 
Z 4 2 4 
 [g/cm³] 1.464 1.422 1.386 
F(000) 2144 1148 1648 
µ [mm-1] 1.104 1.009 1.194 
Tmin / Tmax 0.7000 / 0.8400 0.6323 / 0.8161 0.5164 / 0.7554 
-range [°] 1.735 - 26.811 1.959 - 25.749 1.897 - 25.664 
hkl-range -21 - 19, ±19, ±22 ±13, ±22, ±15 ±17, -13 - 15, ±24 
measured refl. 64317 31195 43991 
unique refl. [Rint] 9878 [0.0828] 4806 [0.0942] 3522 [0.0693] 
observed refl. (I > 2(I)) 7193 3978 3312 
data / restraints / param. 9878 / 487 / 758 4806 / 257 / 374 3522 / 90 / 279 
goodness-of-fit (F²) 1.055 1.074 1.192 
R1, wR2 (I > 2(I)) 0.0669, 0.1470 0.0566, 0.1478 0.0434, 0.0924 
R1, wR2 (all data) 0.0993, 0.1623 0.0704, 0.1560 0.0462, 0.0938 















Table A3: Crystal data and refinement details for 16 and 17 
compound 16  17 
empirical formula C40H71Cl2Cu2N5O17  C11H18Cl2FeN2O2 
formula weight 1091.99  337.02 
T [K] 133(2)  133(2) 
crystal size [mm³] 0.390×0.350×0.330  0.620×0.090×0.040 
crystal system monoclinic  orthorhombic 
space group P21/c  Pca21 
a [Å] 10.9869(6)  16.388(3) 
b [Å] 18.6852(10)  10.583(2) 
c [Å] 13.1285(7)  17.062(3) 
 [°] 90  90 
 [°] 108.876(4)  90 
 [°] 90  90 
V [Å³] 2550.2(2)  2959.2(10) 
Z 2  8 
 [g/cm³] 1.422  1.513 
F(000) 1148  1392 
µ [mm-1] 1.009  1.375 
Tmin / Tmax 0.6323 / 0.8161  ? / ? 
-range [°] 1.959 - 25.749  1.924 - 26.802 
hkl-range ±13, ±22, ±15  ±20, ±13, ±21 
measured refl. 31195  30624 
unique refl. [Rint] 4806 [0.0942]  6244 [0.0775] 
observed refl. (I > 2(I)) 3978  5389 
data / restraints / param. 4806 / 257 / 374  6244 / 1 / 334 
goodness-of-fit (F²) 1.074  0.977 
R1, wR2 (I > 2(I)) 0.0566, 0.1478  0.0422, 0.0772 
R1, wR2 (all data) 0.0704, 0.1560  0.0540, 0.0805 









Table A4: Crystal data and refinement details for 18, 19 and 20 
compound 18 19  20 
empirical formula C12H20Cl2FeN2O2 C17H22Cl2FeN2O2  C18H24Cl2FeN2O2 
formula weight 351.05 413.11  427.14 
T [K] 133(2) 133(2)  133(2) 
crystal size [mm³] 0.390×0.310×0.140 0.420×0.400×0.340  0.340×0.320×0.220 
crystal system triclinic orthorhombic  orthorhombic 
space group P-1 P212121  P212121 
a [Å] 8.6403(3) 10.2336(3)  10.5991(4) 
b [Å] 11.3187(4) 13.5513(5)  13.8361(5) 
c [Å] 16.8873(6) 13.9699(4)  13.9419(6) 
 [°] 99.563(3) 90  90 
 [°] 90.358(3) 90  90 
 [°] 105.649(3) 90  90 
V [Å³] 1565.94(10) 1937.33(11)  2044.58(14) 
Z 4 4  4 
 [g/cm³] 1.489 1.416  1.388 
F(000) 728 856  888 
µ [mm-1] 1.303 1.065  1.012 
Tmin / Tmax 0.6168 / 0.8385 0.5925 / 0.7174  0.6194 / 0.8397 
-range [°] 1.898 - 26.720 2.094 - 26.698  2.074 - 26.789 
hkl-range ±10, -14 - 13, ±21 ±12, ±17, ±17  ±13, ±17, ±17 
measured refl. 22023 27441  25119 
unique refl. [Rint] 6621 [0.0235] 4101 [0.0487]  4345 [0.0433] 
observed refl. (I > 2(I)) 5889 3945  4113 
data / restraints / param. 6621 / 0 / 353 4101 / 0 / 221  4345 / 0 / 231 
goodness-of-fit (F²) 1.024 1.028  1.040 
R1, wR2 (I > 2(I)) 0.0280, 0.0651 0.0218, 0.0554  0.0270, 0.0677 
R1, wR2 (all data) 0.0336, 0.0671 0.0232, 0.0559  0.0296, 0.0689 










Table A5: Crystal data and refinement details for 21, 22 and 23 
compound 21 22  23 
empirical formula C13H22Cl2FeN2O2 C30H44F12Fe2N4O16S4  C26H39F6FeN6O12S2 
formula weight 365.07 1184.63  861.60 
T [K] 133(2) 133(2)  133(2) 
crystal size [mm³] 0.330×0.290×0.030 0.440×0.400×0.280  0.500×0.500×0.270 
crystal system monoclinic triclinic  triclinic 
space group P21/n P-1  P-1 
a [Å] 8.6844(17) 9.2477(5)  10.5468(6) 
b [Å] 17.826(4) 9.6561(5)  12.9991(7) 
c [Å] 11.602(2) 27.7493(12)  15.2966(8) 
 [°] 90 83.669(4)  109.598(4) 
 [°] 108.16(3) 85.631(4)  104.073(4) 
 [°] 90 73.513(4)  98.565(4) 
V [Å³] 1706.6(6) 2358.9(2)  1854.40(18) 
Z 4 2  2 
 [g/cm³] 1.421 1.668  1.543 
F(000) 760 1208  890 
µ [mm-1] 1.199 0.907  0.614 
Tmin / Tmax ? / ? 0.6557 / 0.7993  0.6246 / 0.8275 
-range [°] 2.172 - 26.732 1.478 - 25.646  1.489 - 26.776 
hkl-range ±10, ±22, ±14 ±11, -11 - 10, ±33  -11 - 13, ±16, ±19 
measured refl. 17130 20609  25719 
unique refl. [Rint] 3598 [0.0557] 8866 [0.1123]  7872 [0.0512] 
observed refl. (I > 2(I)) 3205 6892  6730 
data / restraints / param. 3598 / 0 / 187 8866 / 57 / 698  7872 / 174 / 606 
goodness-of-fit (F²) 0.962 1.020  1.032 
R1, wR2 (I > 2(I)) 0.0253, 0.0691 0.0784, 0.1978  0.0391, 0.1001 
R1, wR2 (all data) 0.0306, 0.0716 0.0953, 0.2143  0.0480, 0.1041 








                                          Table A6: Selected bond lengths (sorted) [Å] for 1. 





                                         Table A7: Selected bond angles (sorted) [°] for 1. 










                                         Table A8: Selected bond lengths (sorted) [Å] for 2. 
Atoms Bond lengths  
Cu1-N3 1.880(14)  
Cu1-N1 1.969(15)  
Cu1-N2 1.986(15)  
 
                                          Table A9: Selected bond angles (sorted) [°] for 2. 






















                                              Table A10: Selected bond lengths (sorted) [Å] for 4. 








                                            Table A11: Selected bond angles (sorted) [°] for 4. 
Atoms  Bond angles  













                     Symmetry transformation used to generate equivalent atoms: (') 1-x, 1-y, 1-z.  
 
                                              Table A12: Selected bond lengths (sorted) [Å] for 6. 






















                                             Table A13: Selected bond angles (sorted) [°] for 6. 
Atoms  Bond angles  
O13''-Cu2-O13   48.20(14) 
O3-Cu1-O3'   48.78(15) 
O3'-O3-Cu1'   65.51(19) 
O3'-O3-Cu1   65.71(19) 
O13''-O13-Cu2   65.85(19) 
O13''-O13-Cu2''   65.95(19) 
O3'-Cu1-O4A   90.0(4) 
N1-Cu1-O4B   90.5(7) 
O3-Cu1-O4A   91.4(3) 
O13-Cu2-O14A   92.5(10) 
O13''-Cu2-O14B   93.2(5) 
O13''-Cu2-O14A   93.3(13) 
O13-Cu2-O14B   93.4(3) 
N11-Cu2-N12   94.23(15) 
N2-Cu1-N1   94.36(15) 
O3'-Cu1-O4B   95.2(9) 
N1-Cu1-O4A   96.5(3) 
N11-Cu2-O14A   96.7(17) 
N12-Cu2-O14B   96.8(4) 
N11-Cu2-O14B   97.3(6) 
N2-Cu1-O4B   97.6(9) 
N12-Cu2-O14A   98.0(14) 
































Symmetry transformations used to generate equivalent atoms: (') 1-x, 1-y, -z; ('') -x, 1-y, 1-z.  
 
                                           Table A14: Selected bond lengths (sorted) [Å] for 8. 








                                           Table A15: Selected bond angles (sorted) [°] for 8. 
Atoms  Bond angles  
O3'-Cu1-O3   47.90(13) 
O3'-O3-Cu1   65.86(18) 
O3'-O3-Cu1'   66.24(18) 
O3-Cu1-O4A   89.55(19) 
N1-Cu1-O4B   91.3(7) 
O3'-Cu1-O4A   92.02(18) 
N1-Cu1-N2   93.09(14) 
O3'-Cu1-O4B   94.6(9) 
N2-Cu1-O4A   98.03(18) 
O3-Cu1-O4B   99.3(8) 





















                                     Table A16: Selected bond lengths (sorted) [Å] for 10. 









                                            Table A17: Selected bond angles (sorted) [°] for 10. 
Atoms  Bond angles  
O3-Cu1-Cu1'   37.93(6) 
O4-Cu1-Cu1'   37.96(6) 
O3-Cu1-O4   75.89(9) 
N1-Cu1-N2   93.98(9) 
O4-Cu1-N2   97.30(9) 











                   Symmetry transformation used to generate equivalent atoms: (') x, 1/2-y, 1/2-z.  
 
                                        
                             Table A18: Selected bond lengths (sorted) [Å] for 16. 









                               Table A19: Selected bond angles (sorted) [°] for 16. 
Atoms  Bond angles  
O3'-Cu1-Cu1'   39.30(4) 





O3-Cu1-O3'   79.22(6) 
N2-Cu1-O11   84.34(6) 
N1-Cu1-N2   88.59(6) 
O3'-Cu1-O11   88.65(6) 
N1-Cu1-O11   95.28(6) 
O3'-Cu1-N1   96.72(6) 
O3-Cu1-N2   98.00(6) 



















Table A20: Selected bond lengths (sorted) [Å] for 17. 










Table A21: Selected bond angles (sorted) [°] for 17. 
Atoms  Bond angles  
N2-Fe1-N1   88.66(19) 
























Table A22: Selected bond lengths (sorted) [Å] for 18. 










Table A23: Selected bond angles (sorted) [°] for 18. 
Atoms  Bond angles  
N12-Fe2-N11   87.88(6) 

























Table A24: Selected bond lengths (sorted) [Å] for 19. 






Table A25: Selected bond angles (sorted) [°] for 19. 
Atoms  Bond angles  











Table A26: Selected bond lengths (sorted) [Å] for 20. 






Table A27: Selected bond angles (sorted) [°] for 20. 
Atoms  Bond angles  
















Table A28: Selected bond lengths (sorted) [Å] for 21. 






Table A29: Selected bond angles (sorted) [°] for 21. 
Atoms  Bond angles  













Table A30: Selected bond lengths (sorted) [Å] for 22. 




















Table A31: Selected bond angles (sorted) [°] for 22. 
Atoms  Bond angles  
O18''-Fe2-O17''   61.38(12) 
O6A-Fe1-O4'   82.4(3) 
O3-Fe1-O4'   84.45(14) 
O16-Fe2-O18''   85.94(13) 
O13-Fe2-O17''   85.96(13) 
O16-Fe2-O17''   86.21(13) 
O13-Fe2-O18''   86.62(14) 
N2-Fe1-O3   87.41(15) 
N12-Fe2-O16   87.57(14) 
N11-Fe2-O16   88.44(15) 
N1-Fe1-N2   89.26(15) 
N1-Fe1-O3   89.95(16) 
N12-Fe2-N11   90.13(14) 
O6B-Fe1-O4'   90.7(4) 
O6B-Fe1-N2   91.2(5) 
S12-O17-Fe2''   93.36(17) 
S12-O18-Fe2''   94.00(18) 
O13-Fe2-N11   97.49(16) 
O6A-Fe1-N1   98.4(4) 































Table A32: Selected bond lengths (sorted) [Å] for 23. 







Table A33: Selected bond angles (sorted) [°] for 23. 
Atoms  Bond angles  








































tBu          tert-butyl 
BDE        bond dissociation energy 
CP  cis-peroxo 
C-C          4,4’,6,6’tetra-(tert-butyl)-2,2’-biphenol 
CHD        cyclohexadiene 
CT           charge transfer 
CO Catechol Oxidase  
DBED      N,N’-di-tert-butyl ethylenediamine 
DCM        dichloromethane 
DFT         density functional theory 
DNA        deoxy ribonucleic acid 
DNIC       dinitrosyl iron complexes 
DTBP       2,4-di-tert-butyl-sodium phenolate 
DTBP-H   2,4-di-tert-butyl-phenol 
DTBP-Q    2,4-di-tert-butyl-quinone 
EPR         electron paramagnetic resonance 
ESI           electrospray ionization 
Et             ethyl 
EXAFS    extended X-ray absorption fine structure 
Fur           ferric uptake regulatory proteins 
FDP         flavo diiron proteins 
FNOR      flavo diiron nitric oxide reductase 
Hc Hemocyanin 
Hr             Hemerythrin 
HDVV      Heisenberg-Dirac-Van-Vleck 
HOMO     highest occupied molecular orbital 
HR            high resolution 
HS             high-spin 





IR              infra-red 
ISC            inter system crossing 
IVCT        intervalence charge transfer 
3L              1,1,3,3-tertamethyl propanediamine 
LMCT       ligand-to-metal charge transfer 
Lut             2,6-lutidine 
Me             methyl 
MO    molecular orbital 
MS             mass spectrometry 
MTBE        methyl tert-butyl ether 
NEt3                  triethyl amine 
NMR          nuclear magnetic resonance spectroscopy 
NOR           nitric oxide reductase 
O     bis(µ-oxo) 
OTf            triflate 
pMMO       particulate methane monooxygenase 
ppm            parts per million 
pz               pyrazole 
PhSMe       thioanisole 
PPh3                 triphenyl amine 
RNA          ribonucleic acid 
RNR           ribonucleotide reductase 
RSNO        nitrosothiol 
rR    resonance Raman 
rt                 room temperature 
R                 residue 
sMMO        soluble methane monooxygenase 
SOC            spin-orbit coupling 
SOMO        single occupied molecular orbital 
SP   side-on peroxo 





SQUID        superconducting quantum interference device 
tacn              triazacyclononane 
TBA            tetrabutylammonium 
tetb              rac-5,5,7,12,12,14-hexamethyl-1,4,8,11,tetraazacyclotetradecane 
THF             tetrahydrofuran 
THP             tetrahydropyran 
MeTHF          methylated-THF 
TP        trans-peroxo 
Tp                tris(pyrazolyl)borate 
TPA             tris(2-pyridylmethyl)amine 
tren             tris(2-aminoethyl)amine 
Ts                tosyl 
Ty               Tyrosinase 
UV              ultraviolet 
vis               visible 
VTVH        variable temperature  variable field 
ZFS            zero field splitting  
 
 
 
 
